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An examination of the first trimethoprim (Tp) resistance plasmid
(R-plasmid) containing strain isolated, Klebsiella sp. D770, revealed
that the host dihydrofolate reductase (DHFR) produced by this strain
was not the precursor of the plasmid enzymes. However, the
introduction of the incompatibility W group plasmid Sa, into
Klebsiella sp. D770 promoted its mutation to high level Tp
resistance. The resistance mechanism was found to involve the
overproduction of a less susceptible chromosomal DHFR.
Plasmid Sa was investigated for its role as a possible precursor
of the Tp R-plasmid R388 by examining its ability to encode the
enzyme DHFR, but no plasmid mediated DHFR could be detected.
However, Escherichia coli strain J53, both with and without Sa, was
found to mutate rapidly during serial subculture to high level Tp
resistance. retailed examination of the resistant strains revealed
that the mutation had resulted in the increased production of an
altered chromosomal DHFR showing several significant similarities to
the R-plasmid enzymes.
The spread of the Tp resistance gene on R-plasmids and trans-
posons was studied by detailed examination of a highly resistant
bacterial population isolated during an epidemic of Tp resistance in
Edenhall Hospital, Musselburgh. A high proportion of the Tp
resistance genes were shown to reside on two different resistance
transposons. Investigations of the transposon gene products showed
that all encoded the production of a DHFR similar, biochemically, to
the Type I plasmid enzyme. However, two separate enzymic entities,
differing significantly in molecular size, could be distinguished
amongst these DHFRs. The marked similarities between these trans¬
poson mediated DHFRs suggest an evolutionary relationship between
them.
"We will new discuss in a little more detail
the struggle for existence."
Charles Robert Darwin
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Plasmid and transposon classification
The plasraids and transposons from this laboratory have recently
been reclassified after consultation with Professor Ester Lederberg
(Plasmid Reference Laboratory, Stanford University, USA). Hie
plasmids have now been given a unique prefix of pUK and this
supercedes the use of pSA in some of our previous publications. The
plasmid numbers remain unchanged. Transposon designations have been
changed considerably and will be identified in the text.
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1. INTRODUCTION
Charles Darwin's reinarkable book, "On the Origin of Species"
(1859), in which he put forward the theory of evolution by natural
selection, marked a turning point in biological thought. However, it
was not until 1903, following the rediscovery of Mendel's vrork on
heritability (1866), and the subsequent publication of the chromosome
theory of heredity (Sutton, 1903), that an explanation was provided
for the source of the inheritable variation, which was of fundamental
importance to Darwin's argument. These discoveries ushered in the
classical period of formal genetics.
In the 1940s it was established that genes must specify the
structure of enzymes (Beadle and Tatum, 1941). Concurrent research
revealed DNA to be the agent of genetic transformation (Avery et al.,
1944). With the identification of DNA as the genetic material of a
bacterial virus (Hershey and Chase, 1952) and elucidation of its
biochemical structure (Watson and Crick, 1953) the concept of the
gene was transformed from an element of formal genetic analysis to a
physical entity.
The understanding of the molecular biology of DNA - its
structure, replication mutation, recombination and expression -
provided at one and the same time a material basis for what had once
seemed irreconcilable - constancy and change: constancy deriving
from the high fidelity of its replication and change arising from




The concept of chemotherapy began with Paul Ehrlich's principles
of selective drug action (1913). The therapy of bacterial
infections, however, remained, for many years, an elusive and
apparently unattainable goal. It v®s not until 1935, when Domagk
(1935) reported the activity of Prontosil rubrum against infections
in animals, that any real practical progress was made. Trefouel et
al. (1935) went on to show that Prontosil rubrum is broken down in
the body to give sulphanilamide, the effective anitbacterial agent.
Consequently many sulphonamide-containing compounds were synthesised
and several were introduced for the treatment of infection.
Despite the success of the sulphonamides, the field of synthetic
antibacterial agents has produced few other successes and today the
only widely-used synthetic compounds apart from the sulphonamides,
are nalidixic acid, the nitrofuran antibacterials, metronidazole and
trimethoprim. The nail dixie acid series now shows considerable
premise. The discovery of the sulphonamides, however stimulated a
renewed interest in the chemotherapy of bacterial infections and the
search for other antibacterial agents. The earlier wark of Fleming
(1929) with the mould Penicillium notatum was re-examined by Chain et
al. (1940), who succeeded in isolating an impure solid preparation
(penicillin) from this mould, which was found to be highly active
against bacteria. The success of penicillin quickly attracted a
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great deal of scientific effort towards the search for other
antibiotics and extensive screening methods were developed. However,
among the thousands of antibiotics isolated, only a few were found to
be suitable for development into effective chemotherapeutic agents.
By the early 1950s, bacterial infection was being successfully
treated with antibiotics and chemotherapeutic agents.... but there
were already signs of trouble ahead.
THE EMERGENCE OF DRUG RESISTANCE
In 1955, Kitamoto et al. (1956) isolated a multiply resistant
strain of Shigella from a patient with bacillary dysentery in Japan.
During the next few years an increasing number of these strains
isolated frcm cases of bacillary dysentery were found to be resistant
to two or more of the commonly used chemotherapeutic agents -
streptomycin, chloramphenicol, tetracycline and sulphanilamide.
Until now, it had been assumed that the appearance of drug resistant
bacteria was the result of a predictable process: the spontaneous
mutation of a bacterium to drug resistance and the selective
multiplication of the resistant strain in the presence of the drug.
However, since the rate of spontaneous mutation was known to occur
about once in every 10^ cell divisions (Lederberg and
Lederberg,1952), simultaneous resistance to all four of the above
antibiotics wculd be predicted to occur once in 102® divisions - an
extremely low probability of occurrence. The familiar process of
mutation and selection seemed, therefore, an improbable explanation
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for the rapid increase in multiple resistance observed in Japan.
Moreover, non-pathogenic strains of Escherichia coli obtained from
these dysentery cases often carried a similar pattern of resistance
to that of the infecting Shigella strain (Mitsuhashi et al., 1960).
These and other observations, ultimately led to the discovery by
Ochiai et al. (1959) and Akiba et al. (1960) that this multiple
resistance is transferable en bloc to sensitive bacteria, not only
among Shigella strains but among the Enterobacteriaceae as a whole,
and that transfer depends on contact between living cells (ie.
conjugation).
The discovery that resistance was transferred by conjugation
suggested similarities to the F-factor of E. coli (Lederberg et al.,
1952; Cavalli-Sforza et al., 1953; Hayes, 1953 a, b). There followed
intensive studies by several groups of Japanese workers which
culminated in the identification of an extrachramosomal element, the
resistance factor - R-factor (Watanabe, 1967), responsible for
infectious drug resistance. The R-factors were subsequently
characterised and ultimately classified as plasmids, defined as
extrachromosomal, autonomously replicating, stably inherited elements
which are neither essential to the cell nor damaging to it
(Lederberg, 1952). The term resistance plasnid (R-plasmid) - defined
as a plasmid that carries genetic information to antibiotics and/or
other antibacterial drugs was introduced in 1976 (Novick et al.) and
now supersedes R-factor.
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Shortly after the initial discovery of multiple drug resistance
in Japan, various investigators demonstrated similar resistant
organisms in countries as diverse as West Germany (Lebek, 1963),
England (Eatta, 1962) and America (Smith and Armour, 1966) and many
subsequent reports have shown transfer to occur to such
phylogenetically remote species as Vibrio cholerae, Past^urella
pestis, Serratia, Proteus, Pseudanonas and more recently Haemophilus
and Neisseria.
RESISTANCE MECHANISMS
Due to the abrupt appearance of resistance to many drugs at once
it was first thought that multiple resistance was attributable to a
single genetic determinant, which conferred a non-specific
permeability barrier on the host. This theory, however, was
abandoned when R-plasmid segregants were found, showing that each
drug resistance was specified by a separate gene (Watanabe et al.,
1964a).
Several mechanisms exist by which a bacterial cell might be
resistant to a particular drug (Goldstein et al., 1968). However,
not all may be applicable to resistance conferred by R-plasmids and
in many instances the plasmid resistance mechanism may differ from
that determined by the chromosome. TP be effective an R-plasmid
resistance mechanism must be 'dominant' over the wild type inhibited
function.
The most common R-plasmid resistance mechanism is drug
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inactivation. The best studied system is the ^-lactamase hydrolysis
of penicillins and cephalosporins. Since their discovery (Abraham
and Chain, 1940) ^-lactamases have been found on plasmids of Staph,
aureus (Novick, 1963), E. coli (Anderson and Datta, 1965) Haemophilus
(Thomas et al., 1974; Elwell et al., 1975) and Neisseria (Ashford et
al., 1976; Percival et al., 1976; Perine et al., 1977). Hie types of
^-lactamase can, however, differ considerably from those
chromosomally mediated (Dale and Smith, 1971).
♦
In contrast to the "inactivating" ^-lactamases, R-plasmid
resistance to aminoglycoside antibiotics is due to the production of
enzymes which modify the antibiotic molecule by either acetylation
(Brzezinska et al., 1972), adenylation (Benveniste and Davies, 1971)
or phosphorylation (Umezawa et al., 1967) thus rendering it inactive.
This plasmid encoded resistance mechanism is quite distinct from
chrcmosomally mediated streptomycin resistance which results from an
alteration of the 30s ribosomal unit (Nomura, 1970) and subsequent
inability of the drug to bind to it (Chang and Flaks, 1972).
Chromosomal resistance to many chemotherapeutic drugs may be due
to decreased uptake of the drug (Chopra and Ball, 1982) but
resistance to the tetracyclines, fusidic acid (Chopra, 1976) and
chloramphenicol (Gaffney et al., 1981) provide the only examples of
specific plasmid-determined resistance mechanisms resulting from
decreased drug accumulation. Tetracycline resistance, however, is
the only well documented example. Recent work indicates that the
mechanism of resistance involves plasmid-mediated synthesis of new
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membrane-located proteins (Levy and McMurray, 1978; Tait and Boyer,
1978; Coleman et al., 1983) which premote energy-dependent efflux of
tetracycline across the cell membrane (Ball et al., 1980; McMurray et
al., 1980; Hedstram et al., 1982; McMurray et al., 1982).
Finally plasmids can direct the synthesis of enzymes capable of
acting themselves as modified targets vrtiich are less susceptible to
the action of antimicrobials. For instance, in the case of
trimethoprim and sulphonamide resistance, plasmid-determined
resistant dihydrofolate reductase and dihydropteroate synthetase are
synthesised respectively (Amyes and Smith, 1974a; Wise and Abou-Donia
1975).
CLASSIFICATION OF RESISTANCE PLASMIDS
Due to the rapidly increasing numbers of R-plasmids which were
being identified it became necessary to produce a suitable method of
classification, in order that effective investigations into plasmid
biology and epidemiology could be carried out. The initial method of
classification was introduced by Watanabe and Fukasawa (1962) and was
based on the interactions which were noted to occur between
resistance plasnids and the F-factor of E. coli K-12. (Lederberg et
al., 1952) These warkers observed that the introduction of certain
R-plasmids (later classified fi+ (fertility inhibition positive) by
Watanabe et al., 1964b) into F+ or intermediate F* donor bacteria
enormously reduced their capacity to transfer the F factor, while the
frequency of chromosome transfer by Hfr strains was reduced to 1% or
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less of its normal value. Those R-plasmids which had no effect on
fertility were termed fi~ plasmids.
It was originally thought that members of each group probably
shared considerable homology but it soon became apparent that a
certain amount of heterogenity existed in both the f i4" and fi~
classes. Further classification was therefore made on the basis of
the interactions which occurred between R-plasmids themselves.
Watanabe and Lyang (1962) noticed that bacteria carrying two fi+
R-plasmids with different drug resistance markers were genetically
very unstable, resulting in either the loss of one of the two
R-plasmids or, the occurrence of genetic recombination between them.
This point was further investigated by Watanabe et al. (1964)
employing many more R-plasmids of both fi+ and fi~ types of
independent origins. Their findings confirmed that 'mutual
exclusion' does not take place between fi+ and fi~ R-plasmids,
whereas it does occur between two different _fi+ R-plasmids. The
presence of one fi+ plasmid within a cell seemed, therefore, to
interfere with the entry and establishment of a second _fi+ plasmid -
a phenomenon now termed superinfection inhibition. These
observations have subsequently led to the method of plasmid
classification used most widely today - plasmid incompatibility,
defined as the inability of two different plasmids to coexist stably
in the absence of selective pressures (Novick et al., 1976) ie.
plasmids belonging to the same incompatibility group are unable to
coexist stably within a cell.
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The use of incompatibility as a criterion for the classification
of bacterial plasmids has resulted in many investigations directed at
determining whether incompatibility is an indication of molecular
(and therefore probably phylogenetic) relatedness between plasmids.
The use of the modern techniques of molecular weight estimations, UNA.
reassociation experiments and restriction endonuclease digest
patterns, ♦ has shown that, in general, plasmids within an
incompatibility group have much DNA in common (Grindley et al., 1973;
Falkow et al., 1974) with highly conserved regions encoding
replication and transfer functions (Gorai et al., 1979; Ward and
Grinsted, 1981; Villarroel et al., 1983). This strongly suggests,
therefore, that classification of plasmids by incompatibility does
indeed appear to reflect true phylogenetic relationships.
Due to the lengthy and laborious experiments involved in
classifying plasmids by their incompatibility it is now becoming more
popular to distinguish plasamids by their resistance patterns,
molecular weights and restriction endonuclease digest patterns
(Richards et al., 1981; Tietze and Tschape., 1983) as these
techniques become more standard.
Despite the similarities in transfer and replication genes,
particular resistance genes do not show much correlation with the
incompatibility group. In contrast, the same resistance genes,
determining identical properties, are often carried by otherwise
unrelated plasmids. This diversity of resistance genes has been
partly explained by the discovery of drug resistance transposons
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which are able to 'jump' from one piece of DNA to another.
MOVABLE GENETIC ELEMENTS
Movable genetic elements were first described by Barbara
McClintock following her analysis of crosses between genetically
marked corn plants (McClintock, 1951). Full understanding of her
observations, however, was not achieved until almost 20 years later
with the discovery of a new class of mutations in genes of a
laboratory strain of Escherichia coli and of bacteriophage A (Jordan
et al., 1968, Shapiro, 1969; Fiandt et al., 1972; Hirsch et al.,
1972).
These mutations, termed polar mutations (Jacob and Monod, 1961)
were unusual in that their effects were detectable beyond the borders
of the mutated genes themselves, a property which could not be
explained by any known mutational mechanism. In addition most of the
mutants could revert spontaneously to wild type, but the reversion
rate was not enhanced by mutagens, indicating that the mutations were
not the result of deletions and were unlikely to be point mutations.
Subsequent investigations (Jordan et al., 1968; Shapiro, 1969)
revealed that the mutations had been caused by the insertion of
sizeable DNA fragments into the mutated gene.
These DNA elements were named insertion sequences or IS
elements. Several unrelated IS sequences have since been described
in E. coli and A(Bukhari et al., 1977; Guyer, 1978) which can insert
themselves within many different genes, intejrupting the continuity of
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the gene and turning off its activity. Further characterisation of
these elements has revealed them to be of a defined length ie.
800-1400 base pairs (Fiandt et al., 1972). Extensive investigations
by Saedler and Heiss (1973) could not reveal the presence of IS
elements in the cytoplasm of E. coli and it is therefore assumed that
these elements do not replicate autonomously. From molecular
hybridization experiments Saedler and Heiss (1973) concluded that two
such elements, IS1 and IS2, are present in the E. coli chromosome in
about 8 and 5 copies respectively. The large number of insertion
sites suggested that some type of non-homologous recombination was
taking place as it seemed unlikely that an IS element could be
homologous with the nucleotide sequences at so many different sites.
Studies by Nevers and Saedler (1978) showed that insertion of IS
elements is indeed independent of the host recA gene product known to
be necessary for homologous recombination. However, IS sequences
have been shown to play a role in the formation of Hfr and F'13 (Hu
et al., 1975) by recombination between pairs of homologous sequences
present on the chromosome and F-factor. This process, in contrast to
IS insertion, requires the host's recombination system. Thus IS
sequences are involved in at least two kinds of recombination.
The mechanisms involved in IS translocation are still unclear.
Grindley (1978) and Calos et al. (1978) have shown that insertion of
IS1 results in the generation of two directly repeated sequences of 9
base pairs (bp) at either end of the inserted sequence. Similar
repeated sequences of 5bp have been shown to occur following
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integration of IS2 (Rosenberg et al., 1978). The explanation
proposed is that integration involves the introduction of two nicks
nine or five bases apart, and the covalent attachment of the 3' ends
of the IS1 element to the free and protruding 5' ends that are
created. The two single-stranded gaps of 9 or 5 bases would then be
filled in by DNA synthesis (Grindley, 1978). Ohtsubo et al. (1980)
studying the mechanism of insertion and cointegration mediated by IS1
demonstrated that mutations occurring inside IS1 markedly reduced or
abolished the frequency of cointegration, suggesting that IS1 may
code for a protein that is required for cointegration, and therefore
for the insertion of IS1. However, genetic identification of
functions specified by these elements is still not evaluated.
At the same time that IS elements were discovered other
microbiologists and geneticists made observations that certain genes,
known to be responsible for resistance to antibiotics by bacteria,
were capable of transfer from one molecule of DNA to another (Dubnau
and Stocker, 1964; Kondo and Mitsuhashi, 1964; Harada et al., 1967;
Datta et al., 1971). The first direct evidence that such transfer is
by a process analogous to the insertion of IS elements was published
in 1974. Hedges and Jacob (1974) found that the transfer from one
plasmid to another of the TEM-/3-lactamase gene, conferring resistance
to ampicillin, was always accompanied by an increase in the size of
the recipient plasmid. The recipient could then donate the
resistance trait to still other plasnids, which thereupon showed a
similar increase in size. Hedges and Jacob (1974) postulated that
the gene for ampicillin resistance was carried by a DNA element that
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could be "transposed" or could move from one molecule of DNA to
another, and they called such an element a transposon (Tn).
Originally transposons were distinguished from IS elements
because they carry detectable genes, often conferring antibiotic
resistance. However, as more information concerning the structure of
transposons and the mechanism of transposition becomes available, it
is clear that there is a very close relationship between the IS and
Tn elements. Kopecko and Cohen (1975), also studying the acquisition
of the TEM-/3-lactamase gene by various plasmids, observed that such
transfer could take place in mutated bacteria lacking the recA gene
product. Thus the transposition event, like IS translocation,
involves recA independent non-homologous recombination.
Electron microscopy of the plasmid DNA further revealed that the
two ends of the transposable DNA segment had a unique feature: they
consisted of nucleotide sequences that were complementary to each
other but in the reverse order. This feature results in the
formation of stem and loop structures following separation and
reannealment of the DNA strands. These repeat segments appear to be
a cannon feature of most of the transposons so far identified
(Kleckner, 1977). They do, however, vary in length, soma transposons
terminating in very long (800-1500 base pair (bp)) inverted or direct
repeats and others in very short (ca. 40bp) repeats. The long repeat
segments of transposons are often IS or IS-like elements. Many
transposons thus represent a segmant of DNA that is mobile because it
is flanked by IS units; for example Tn9 (MacHattie and Jackowski,
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1977) and Tnl681 (So et al., 1979) are flanked by copies of IS1,
which accounts for the mobilization of the intervening genetic
material. Other transposons, notably Tn5, TnlO and Tn903, also
terminate in very long inverted repeats, which are IS-like but which
have not been identified as normal constituents of E. coli (Berg and
Drummond, 1978; Ross et al., 1979). The shorter inverted repeats of
elements such as Tn3 may represent a vestige of what once were two
full insertion sequences. Since the IS elements themselves terminate
in short inverted repeats, a transposon that is flanked by two IS
units, even in direct repeats as in Tn9, will also be flanked by
inverted repeats. Virtually all the insertion sequences and
transposons characterised at the sequence level have a terminal
inverted repeat. The only exception to date is bacteriophage Mu.
Analysis of the nucleotide sequences of bacteriophage Mu revealed
only 2bp at either end to be repeated (Rahman and Ramp, 1979).
As indicated insertion of IS1 results in a 9bp sequence of
target DNA being repeated on either side of the inserted element
(Calos et al., 1978; Grindley, 1978). Nine base pair repeats are
also formed during insertion of Tn5 (Schaller, 1979), Th9 (Johnsrud
et al., 1978), TnlO (Rleckner, 1979) and Tn903 (Oka et al., 1978).
Similarly, 5bp repeats result following insertion of Tn3 (Cohen et
al., 1978, Ohtsubo et al., 1979) and phage Mu (Allet, 1979).
Analysis of the distribution of transposons at various ENA sites and
the different repeated sequences (Johnsrud et al., 1978; Rleckner,
1979; Ohtsubo et al., 1979) indicates that these repeated sequences
are generated during the process of integration.
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Over the last ten years much has been discovered concerning the
mechanism and regulation of transposition. Genetic studies of the
ampicillin resistance transposon Tn3f employing deletion mutants,
suggested the existence of two or more trans-acting transposition
functions encoded by the transposon (Heffron et al., 1977; Gill et
al., 1978). Heffron et al., (1979) went on to identify three
polypeptides encoded by this transposon: the transposase, a high MW
polypeptide encoded by the tnpA gene; the Tn3-specific repressor, a
low MW polypeptide encoded by the tnpR gene and the 286 amino acid
^-lactamase. Mutation studies have demonstrated that the tnpA gene
product is an absolute requirement for transposition and that the
protein encoded by tnpR acts as a repressor to regulate expression of
this tnpA encoded transposase, (Gill et al., 1979; Heffron et al.,
1979). Arthur and Sherratt (1979) proposed that tnpR or some other
gene enocded in this region is required for resolution. Subsequent
studies by Heffron et al. (1980) confirmed that the tnpR gene of Tn3
encodes a site-specific recombination system that will efficiently
resolve cointegrates independent of recA. The tnpR gene product is
therefore responsible for both repression of tnpA gene function and
resolution of cointegrate intermediates during transposition.
In addition to these two essential genes, three sites are
required for Tn3 transposition. Both the right and left inverted
repeats are absolutely required for the complete transposition event
(Heffron et al., 1977). Deletion mutants of Tn3 lacking the 39bp
inverted repeat, are transposition deficient and no complementation
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by wild-type DNA is possible. The termini are therefore thought to
function as possible recognition sites for an enzyme, presumably the
transposase, required for transposition (Heffron et al., 1977). A
third site, IRS (internal resolution site), located between the
inverted repeats, is also required for resolution of cointegrates by
the tnpR gene product resolvase (Heffron et al., 1979). However, if
transposition occurs in recA+ cells this site is not required as the
host cell recombination system resolves the intermediate cointe¬
grates.
In contrast to the functional map of Tn3 (Figure la), the
enzymes required for transposition of the kanamycin resistance
transposon, Tn5, are encoded by the long terminal inverted repeats
(Figure lb). Rothstein et al. (1980a) were able to study some of the
transcription, translation and transposition properties of Tn5, by
construction and analysis of deletion, insertion and substitution
mutants of Tn5. Frcm these and subsequent studies (Rothstein et al.,
1980b) they concluded that five polypeptides are encoded by Tn5, two
being translated by each inverted repeat and the fifth is the
resistance enzyme, neomycin phosphotransferase (NPT II). The four
enzymes coded by the inverted repeats are all different, the active
polypeptides for transposition being encoded by the right inverted
repeat. By construction of a transposon frcm Tn5 that is of the Tn3
'type' with short inverted repeats Rothstein et al. (1980b) were able
to show that the only regions of the left repeat that appear to be
absolutely necessary for the functions of the transposon are its two
ends - the outside being required to provide a substrate for the
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Figure la. The genetic organisation of Tn3 (adapted from Lee et al.,
1983).
IR = inverted repeat sequence; tnpA = transposase gene;
IRS = internal resolution site; tnpR = resolvase gene;
"bla = TEM-1 -lactamase. Circles and arrows indicate
origin and direction of transcription, respectively,
of the appropriate genes.
IR tnp A IRS tnp R bla IR
Figure lb. The genetic organisation of Tn_5 (adapted from Rothstein
et al., 1980b).
IR = inverted repeat sequence; 1, 2, 3 and k = proteins
encoded by Tn5; NPT-II = neomycin phosphotransferase.
Circles and arrows indicate origin and direction of
transcription, respectively, of the appropriate genes.
IR • —NPTII IR
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transposase enzyme and the inside end which carries the prcmoter for
the kanamycin resistance gene.
Several models have been proposed for the mechanism of
transposition (Arthur and Sherratt, 1979; Shapiro, 1979; Galas and
Chandler, 1981; Harshey and Bukhari, 1981). In general it is
believed transposition involves three principle steps (Figure 2).
The first stage involves cleavage of the DNA strands of the
transposon and the recipient replicon at a specific site. The
specificity of insertion differs markedly between different
transposons. Some, such as TnlO (Kleckner et al., 1979) and Tn5
(Miller et al., 1980), show a tendency to insert repeatedly at
particular preferred positions or 'hot-spots'. Other transposons
such as Mu, Th3 and Tn9 insert efficiently at a great many different
sites even within a region as short as a single gene (Bukhari and
Zipser, 1972; Weinstock et al., 1979; Miller et al., 1980). Such
transposons are said to be regionally specific but locally
non-specific. The endonucleases responsible for these cleavage
events are probably specified by the transposon and the bacterial
cell respectively (Grindley and Sherratt, 1978). Next the donor and
target strands are ligated and formation of a cointegrate
intermediate follows with the semi-conservative replication of the
transposable element. Formation of the cointegrate is mediated by
the transposase enzyme. Finally, resolution of the cointegrate takes
place restoring the original donor and giving rise to a recipient
replicon containing the transposon. Resolution results from
recombination mediated by the hosts own recombination system, or by
Figure7.











site-specific recombination mediated by the tnpR gene product
resolvase.
Recently it has been proven that formation of cointegrates are
not obligatory in the transposition of certain transposons (Galas and
Chandler, 1981; Harshey and Bukhari, 1981; Bennet et al., 1983). It
is suggested that if only one strand of the element is cut, or cut
more efficiently than the other, direct transposition would occur as
opposed to formation of intermediate cointegrates (Bennet et al.,
1983). In any event transposition results in the transfer of a
segment of DNA from one replicon to another without concomittant loss
from the original donor.
Many different insertion sequences and transposons have now been
described. Transposons encoding resistance to a wide variety of
antimicrobials have been identified. The ability of these elements
to transpose efficiently between different replicons, provides not
only an explanation for the diversity of identical resistance genes
among plasmids of different incompatibility groups but also provides





The past two decades of the chemotherapeutic era have been
dominated as much by transferable drug resistance as by the
introduction of new and potent drugs or combinations such as
trimethoprim/sulphamethoxazole (cotrimoxazole, Bactrim, Septrin,
Septra). Both trimethoprim and sulphonamides are inhibitors of
bacterial folic acid metabolism.
Tetrahydrofolate derivatives of the vitamin folic acid are of
paramount importance in both mammalian and bacterial cells, serving
as essential cofactors in the biosynthesis of several amino acids,
purines and pyrimidines (Blakely, 1969). Folic acid itself is a
widely distributed group B vitamin. It was first isolated in
crystalline form frcm liver by Pfiffner et al. (1943) and its
structure established and confirmed by total chemical synthesis as
ptercylglutamic acid (Angier et al., 1946).
The biochemical pathway for folate biosynthesis was worked out
with extracts of Escherichia coli by Brcwn (1971) (Figure 3). The
first step involves the formation of dihydrcpteroate by the
condensation of dihydropteridines with p-amino benzoic acid (Brown et
al., 1961), catalysed by the enzyme dihydrcpteroate synthetase
(Vfeisman and Brown, 1964). One or more glutamic acid residues are
then added to dihydropteroate, in the presence of a condensing
enzyme, dihydrofolate synthetase (Griffin and Brown, 1964), to form
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dihydrofolate (DHF) (Brown et al., 1961). These two enzymic
reactions are absent in mammalian cells which in contrast utilize
pre-formed folates, obtained as the vitamin folic acid, frcm the
diet. This ability to use exogenous folates is confined to higher
species and a few unusual bacteria such as Streptococcus faecalis and
Lactobacillus casei, which possess an active transport system for the
uptake of folic and folinic acid which is dependent on glucose (Wood
and Hitchings, 1959a). However, with the exception of seme
Streptococci these unusual bacteria are not generally pathogens. It
is these two essential differences, the absence of the initial step
in folate biosynthesis in mammalian cells and the inability of
bacterial cells to utilize exogenous folates, that have been
exploited with the sulphonamide group of drugs. As structural
analogues of p-amino benzoic acid, the sulphonamides ccmpetitively
inhibit dihydropteroate synthetase (Brown, 1962).
Reduction of dihydrofolate to its active form tetrahydrofolate
(THF) by the enzyme dihydrofolate reductase (5,6,7,8-tetra-
hydrofolate: NAD+ oxidoreductase EC.1.5.1.3.) occurs in both
mammalian and bacterial cells. Tetrahydrofolate serves as a carrier
of one carbon units (Rabinowitz and Himes, 1960) by the formation of
a number of cofactors, each one of which is formed enzymatically from
a suitable one-carbon donor and tetrahydrofolate. Each substituted
THF is a cofactor in a specific reaction (Figure 4). After reaction
with a suitable precursor, again catalysed by a specific enzyme, a
new product and unsubstituted THF are formed. In most reactions THF
is just a carrier and the result of the reaction is the release of
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Figure The interconversion of tetrahydrofolate intermediates
and their relationship with purine and protein synthesis

















free THF. Thymidylate synthetase (EC.2.1.1.b.) however, requires two
atoms of hydrogen, in addition to the methylene group of
deoxythymidylate. These are taken from the THF carrier itself,
producing dihydrofolate. Thus dihydrofolate reductase (DHFR) is
again required, to regenerate the system by returning the folate to
the tetrahydrofolate state.
The enzyme DHFR therefore plays a key role in folate metabolism
and subsequent biosynthetic reactions. Partial purification of a
chicken liver DHFR enzyme was the first to be achieved (Futterman
1957, Futterman and Silverman 1957) following observations by
Greenberg (1954) that reduction of DHF to THF in chicken liver
required NADH. This system performed both a NADPH-dependent
reduction of folate to DHF and a NADH- or NADPH-reduction of DHF to
THF. The direct reduction of DHF by pyridine nucleotides was
established by Osborn and Huennekens (1958) following their partial
purification of a NADPH-linked DHFR from acetone powder extracts of
chicken liver. Similar systems were soon found in S. faecalis
(Blakely and McDougal, 1961) and E. coli B (Mathews and Sutherland,
1965). Like the avian liver enzymes, these bacterial DHFRs ware
specific for NADPH and DHF but in contrast showed no reaction with
folate. More sophisticated purification procedures subsequently led
to the establishment of the molecular waight of both the avian liver
and bacterial enzymes as about 20,000 (Kaufman and Gardiner, 1966,
Mathews and Sutherland, 1965). Since then this enzyme has been shown
to be widely present, both in microbial and mammalian systems.
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ANTIFOLATE DRUGS
The earliest reported small molecule 'antifolates' were the
2,4-diaminopteridines of Daniel and Norris (1947) (Daniel et al.,
1947). They had been synthesised to simulate the pteridine portion
of the folate molecule, and the authors were puzzled to find that the
2,4-diamino derivatives w^re much more potent inhibitors of lactic
acid bacteria than the chemically more nearly related
2-amino-4-hydroxy-pteridines.• Similarly, Hitchings et al. in 1945
started investigations with 2,4-diamino-5-methylpyrimidine followed
by a family of inhibitors which evolved through elaboration of the
5-methyl group. By 1948 (Hitchings et al.) it was asserted that all
derivatives of 2,4-diaminopyrimidine are antagonists of folic acid,
and shortly a variety of substances of this general structure were in
hand as a result of a program directed toward antimalarials (Falco et
al., 1951).
The more these small molecule antifolates were studied, the more
varied and selective their acitvities appeared to be. There was no
reason to doubt, however, that although these compounds were
originally designated antithymine compounds their principal mode of
action was as anitfolates. The inhibitory effects could be overcome
in vivo by leucovorin indicating a blockage in folate reduction (Wood
and Hitchings, 1959b; Wood et al., 1960) similar to the mechanism
which had been shown by Nichol and Vfelch (1950) for the large
molecule inhibitor aminopterin, in rat liver slices and intact
animals. In 1965, Hitchings and Burchall confirmed that the target
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site of 2,4-diaminopyrimidines was indeed the oxidoreductase enzyme
dihydrofolate reductase.
The effort to optimise the selective nature of these compounds
resulted in the development of the antibacterial drug trimethoprim
(2,4-diamino-5-(3'4,5,-trimethoxybenzyl)pyrimidine) (Figure 5) (Hitch-
ings and Roth, 1959; Hitchings and Bushby, 1961; Roth et al., 1962)
which was shown to exhibit a tremendous specificity for bacterial
dihydrofolate reductases over the mammalian enzyme (Burchall and
Hitchings, 1965). The selectivity of the small molecule inhibitors
of DHFR is the basis for their chonotherapeutic utility and extensive
studies of both mammalian and bacterial DHFRs have ensued in an
effort to determine the mechanism of this specificity. Studies of pH
profiles, molecular weight estimations, isoelectric points and the
enzyme kinetics all fail to reveal a significant difference between
DHFRs from mammalian and bacterial sources although these
characteristics do show that variations occur confirming that each
species has one (or more) type of reductase that is unique (Hitchings
and Smith, 1980). Inhibitor binding analysis, on the other hand,
reveals that trimethoprim (Tp) binds very much more tightly to the
bacterial DHFR than the mammalian enzyme (Burchall and Hitchings,
1965), but the difference between host and parasite enzymes that give
rise to these selective effects are still being determined.
Burchall (1969, 1971), in an attempt to explain the differential
binding of trimethoprim, suggested that the bacterial and animal
DHFRs have evolved independently. Thus the more sophisticated
39.
Figure 5* The structure of trimethoprim.
TRIMETHOPRIM
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mammalian enzyme is able to distinguish between the pteridine
substrate and the small molecule inhibitors (2,4-diamincpyrimidines).
On the other hand, the large molecule inhibitors (2,4
diamincpteridines) are bound to both DHFRs at their pteridine binding
site. Thus the 2,4-diamincpyrimidines are the more selective drugs
against micro-organisms.
It is now widely accepted that all diaminopteridine and
diamincpyrimidine derivatives, from methotrexate to trimethoprim,
have the same mode and locus of binding of the 2,4-diaminopyrimidine
moiety. For this reason Hitchings and Smith (1980) speculate that
the special affinity of Tp for bacterial DHFRs must be the result of
the conformation of the molecule and the fit of the trimethoxybenzyl
moiety into some hydrophobic pocket. Perkins and Bertino (1966)
suggested that some inhibitors may bind more tightly in the ternary
complex than to the enzyme alone. The structure of the ternary
complex of E. coli DHFR with the co-enzyme NADPH and an inhibitor is
not as yet known. However, the structure of the ternary complex of
L. casei DHFR with NADPH and methotrexate was described in 1978
(Mathews et al.). These authors have compared the L. casei DHFR
ternary complex with methotrexate to the E. coli DHFR binary
structure. They suggest that the large cooperative effect in the
binding of methotrexate and analogues to the ternary, as opposed to
the binary complex of DHFR enzymes, which has been observed in
several laboratories (Williams et al., 1973; Birdshall et al., 1980)
is caused by conformational changes in the DHFR which occur on
binding of the NADPH co-factor.
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A recent study (Baccanari et al., 1982) of Tp, its parent
benzylpyrimidine and the monomethoxy and dimsthoxy analog in
interaction with DHFR from E. coli and mouse lymphoma showed there to
be an increasing cooperativity in binding in the ternary complex, as
well as an increased specificity in binding to the bacterial enzyme
on increasing the meta- or para-methoxylation ie. monomethoxy
derivatives were about ten fold more active than the unsubstituted
benzylpyrimidine, the dimethyl analogues another ten fold more active
and Tp roughly six fold more active again. These authors conclude
that cooperativity in binding with the ternary complex is largely
responsible for the high affinity of Tp for E. coli DHFR as
cooperativity is not as prominent with DHFR of mouse lymphoma.
Studies by Stuart et al. (1983) involving nolecular models of
newly developed ortho-substituted derivatives of the 2,4-diamino-5-
benzylpyrimidines in the active site of dihydrofolate reductase, has
provided a rational explanation for their activities, relative to Tp.
So far all the new analogues developed have exhibited lcwer
antibacterial activity than Tp and, in most cases, very much reduced
specificity. It is interesting, however, that the new dihydro-
benzofuran derivative, compound 46, developed by Burroughs Wellcome
(Stuart et al., 1983) shows relatively good activity against the
gonococcal enzyme, compared to Tp. The inher/ent resistance to Tp of
the Neisseriaceae is known to be the result of a decreased affinity
of their DHFR for the drug (Then, 1979). This is a similar, if
somewhat less pronounced, mechanisn to R-plasmid determined
resistance (Amyes and Smith, 1974a; Skold and Widh, 1974).
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ANTIFOLATE CHEMOTHERAPY - ONE DRUG OR TWD?
Trimethoprim has been used widely since 1969 in the UK,
initially in combination with sulphamethoxazole (Sx) as
co-trimoxazole ard, since 1979, also as a single agent. Its main
uses are in the treatment of urinary tract and lower respiratory
tract infections. When co-trimoxazole was introduced in 1969, the
two components ware thought to present a unique combination for three
principal reasons: (i) remarkable synergy between them, (ii) the
ability to suppress the development of resistance and (iii) the
bactericidal effect of the combination in contrast to the individual
bacteriostasis observed with each drug individually (Bushfcy and
Kitchings, 1968). Thus although Tp was known to possess potent
antibacterial activity in its own right (Hitchings, 1969) it was
considered a sulphonamide potentiator (Bushby and Hitchings, 1968;
Hitchings, 1970) and there was little evaluation of its use
clinically as a single substance. Since its introduction, however,
there have been many reports questioning these claims, and much
evidence to suggest that Tp alone may be as clinically effective and
as safe as the combination.
The demonstration of synergy between Tp and Sx has often been
reported _in vitro (Darrell et al., 1968; Bushby, 1969, 1973) but has
never been shown in vivo. Two different mechanisms have been
suggested to explain the _in vitro synergy which occurs. As a
structural analogue of the pteridine portion of DHF, Tp serves as a
competitive inhibitor in the reduction of DHF to THF thus depleting
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the cells concentration of THF (Burchall, 1969, 1979). This
biological effect can be minimised by inclusion of a sulphonamide
which blocks the synthesis of DHF, and it is this sequential blockade
which is thought to result in potentiation of the combination of Tp
and Sx over the action of each component alone (synergy) (Darrell et
al., 1968). On the other hand, Poe (1977) has suggested that synergy
results from the simultaneous binding of Tp and Sx to DHFR, when the
drugs are present in sub-inhibitory concentrations.
However, whilst synergy between Tp and Sx readily occurs in
vitro, this does not seem to be a requirement for success in treating
many acute infections. Models of urinary tract infections (UTI)
using concentrations of each agent that occur during therapy have
shown that the activity of Tp is so dominant over the Sx that the
potential for synergy between them does not occur (Anderson et al.,
1974; Greenwood ard O'Grady, 1976; Greenwood, 1979; Lacey et al.,
1980b). In addition the concentration of Tp in the body during
therapy is sufficient to inhibit most of the pathogens in question
(Hansen et al., 1973, Wikinson and Reeves, 1979). Clinical trials
have indeed shown that Tp alone is as effective as the combination in
treating acute urinary tract and acute respiratory tract infections
(Brumfitt and Pursell, 1972; Koch et al., 1973, Kasanen et al., 1978,
Lacey et al., 1980a, Mabek ard Vejlsgaard, 1980).
The claim that the administration of a sulphonamide
simultaneously with Tp would prevent bacteria from acquiring
resistance to Tp has been more difficult to prove. Darrell et al.
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(1968) studied serial transfers of four cultures of the
Enterobacteriaceae on ditch plates containing lew concentrations of
Tp. After 25 subcultures of a heavy inoculum each culture yielded
resistant variants. These variants wsre not, however, detected if a
light inoculum was used. When a sulphonamide was incorporated into
the medium in addition to Tp, the development of this resistance was
inhibited (Darrell et al., 1968; Grunberg and Beskid, 1977).
However, these manipulations may not represent events within patients
treated with Tp and the nature of Tp resistance found in clinical
isolates may differ frcm that in cultures exposed to Tp ^n vitro.
Bacteria _in vivo are not exposed to gradually increasing
concentrations of Tp over weeks and moreover, if Tp is added in
therapeutic concentrations to E. coli suspended in serum, urine or
nutrient broth, resistant variants of E. coli do not emerge (Lacey et
al., 1980b).
Several studies have been carried out comparing the use of Tp
with Tp/Sx in patients with acute, recurrent or chronic urinary
infections and more recently, in the treatment of patients with chest
infections (Lacey, 1982). If the use of Tp alone is particularly
liable to select resistance in vivo trials, where it was prescribed
as a single agent, should show evidence of this. However, in each of
the studies there was no report of a higher incidence of Tp
resistance after the use of Tp alone compared with Tp/Sx.
A recent survey, concluding in October in 1982, of Tp resistance
in Gram negative urinary pathogens isolated from hospital and general
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practitioner patients, indicates a sudden rise, during 1982, in the
percentage of organisms resistant to Tp but sensitive to Sx (Maskell,
1983). It is suggested that the use of Tp alone has promoted this
increase in the level of resistance from 12% to 19%. These results,
however, are not comparable with those published by Lacey (1982) who
reported no change in the level of resistance of E. coli to Tp in the
hospitals of King's Lynn Health District, where co-trimoxazole was
completely replaced by Tp in 1980. His study concluded in January
1982 and did not include Gram negative pathogens other than E. coli.
Nevertheless, if the use of Tp alone is now resulting in increased
resistance it is important that this should be recognised.
Two surveys have shown that Tp resistance is rare in Haemophilus
influenzae and has not increased during 1974-1978 (Williams and
Andrews, 1974; Howard et al., 1978). This is significant since
during therapy with co-trimoxazole, the sulphonamide concentration in
lung tissue and sputum may be too low to inhibit the grcwth of
Haemophilus (Wilkinson and Reeves, 1979). In effect, therefore, this
organism may have been exposed to Tp alone. If Tp did have a
particular predilection to select resistance during clinical use, the
incidence of Tp resistant Haemophilus influenzae would be expected to
be much higher than has been reported.
Finally a comparison of the levels of Tp resistance in countries
such as Finland, where Tp has been used extensively without Sx, shows
that the incidence of Tp resistance among enterobacteria is no higher
than in other countries, where only the combination has been given
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(Kasanen et al., 1978; Hamilton-Miller, 1979; Amyes et al., 1981).
The third reason for issuing the combination was based on the
observation that individually the drugs are bacteriostatic, whereas
in combination they are bactericidal (Bushby and Hitchings, 1968).
In minimal medium the effect of Tp on the bacterial cell is indeed
bacteriostatic. However, if methionine, glycine and a purine are
present in the medium the organisms die rapidly and Tp is
bactericidal (Amyes and Smith, 1974b). In complex media, and in the
urine, these metabolites are usually present and have the effect of
overcoming the inhibitory action of Tp on protein synthesis. This
results in sustained protein synthesis, which has been shown to be
essential for a maximal bactericidal response (Angehern and Then,
1973), and produces an effect similar to "thymineless death" (Amyes
and Smith, 1974b). The bactericidal action of Tp can, however, be
reversed completely if both thymine and lysine are present in the
medium (Amyes and Smith, 1974b). In addition thymidine has been
shown to antagonise the antibacterial action of Tp (Miovic and Pizer,
1971) and thus media lacking these compounds should be employed for
accurate Tp sensitivity testing (Amyes and Smith, 1974b).
At low concentrations of Tp (less than 0.2mgL~l) in the presence
of methionine, glycine and adenine, Tp is either bacteriostatic or
has no effect on viability of sensitive organisms. Addition of Sx,
however, produces a bactericidal response even when the individual
drugs used alone are bacteriostatic (Amyes, 1982). Since the
presence of methionine, glycine and adenine has no rapid effect on Sx
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action, the bactericidal effect is presumed to result frcm
potentiation of Tp activity by Sx. This Sx enhanced Tp bactericidal
activity has also been observed _xn_ vitro with E. coli strains
carrying the Sx R-plasmid R1 and strains carrying the Tp R-plasmids
R483 and R751. But the ability of Sx to promote Tp activity only
occurs at Tp concentrations less than 0.2mgL~l and is therefore not
applicable to the clinical situation where the expected level of Tp,
in the urinary tract, after normal dosage, is between 30 and 150
mgL.""l (Brumfitt and Pursell, 1973).
Taken together, these findings concerning the reported synergy
between Tp and Sx and the emergence of Tp resistant strains would
suggest that Tp is probably as active and as safe as the combination
in the treatment of acute infections. Nevertheless, resistance to Tp
is still a major problem and, as with all antibacterial agents,
resistance is likely to be most effectively minimised by prescribing
Tp only for those patients for whom it is indicated.
CHRCMOSCMAL RESISTANCE TO TRIMETHOPRIM
Resistance to trimethoprim is defined as a minimum inhibitory
concentration (MIC) greater than 2mgL~l (Grey et al., 1979).
Acquired resistance to Tp can be related to chromosome mutations or
to the acquisition of Tp resistance plasmids. Since the action of Tp
is to cause a metabolic block by competitive inhibition with the
substrate dihydrofolate for reaction with the enzyme dihydrofolate
reductase (DHFR), resistance may be achieved by one or a combination
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of three mechanisns. First, the nature of the inhibited enzyme ie.
DHFR, can be changed qualitatively, so that the affinity of the
inhibitor is decreased. Second, a greater amount of DHFR may be
produced resulting in greater overall activity of the blocked system
without changing the percentage inhibition. Thirdly, resistance may
be achieved by some unusual bacteria by their ability, under certain
circumstances, to use exogenous folates, thus by-passing the
inhibited pathway, eg. Streptococcus faecalis (Bushby and Hitchings,
1968).
Chromosomal resistance is generally due to mutations in the
structural or regulating genes for dihydrofolate reductase resulting
in decreased susceptibility and/or overproduction of the enzyme
(conditions one and twa above).
Although much of the work done on mechanisms of resistance to
antifolate agents in bacteria has involved methotrexate resistance,
such mutants serve to illustrate the range of changes possible in
DHFR. Hyperproduction of chromosomal DHFR, between 3-80 fold, has
been reported in pneumococci (Sirotnak, 1971; 1973; McCuen and
Sirotnak, 1974) and in E. coli K-12 (Burchall and Hitchings, 1968;
Breeze et al., 1975). The enzyme is still susceptible to Tp, but the
amount of Tp necessary to inhibit the increased amount is much
higher. In seme strains of E. coli or Klebsiella, resistance has
been shown to be due to production of an altered DHFR enzyme with
decreased affinity for Tp (Poe et al., 1972; Grey et al., 1979;
Sheldon, 1977). The fol mutant of E.coli studied by Sheldon (1977)
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was also hyperproduced (10 fold). The combination of these two
mutations, therefore, explain the unusually high level of resistance
(MIC >lOOOmgL-1) observed in these strains.
For many chromosomally resistant strains, which have been
selected in the laboratory by passage of heavy inocula of bacteria in
media containing increasing concentrations of Tp, the biochemical
mechanism for their resistance remains unknown (Darrell et al., 1968;
Freisheim et al., 1972). However the clinical significance of these
mutants seems to be minimal now since the discovery of Tp R-plasmids
(Lacey et al., 1972; Fruensgaard and Kcmer, 1974; Grey et al., 1979).
An infrequent (less than 1% of Tp resistant isolates) but,
nonetheless, important type of resistance is the example of
thymidine-dependent organisms. Thymineless (thy") mutants, lack the
enzyme thymidylate synthetase required for the synthesis of thymidine
(Barner and Cohen, 1959). To overcome this defect, these organisms
have developed a mechanism by which they are able to utilize
exogenous thymine or thymidine. These thymineless strains are thus
highly resistant to Tp, providing ample thymidine is available, since
the site of action to Tp is by-passed by the direct incorporation of
thymidine by the bacteria (Stacey and Simson, 1965; Amyes and Smith,
1975).
Intrinsic resistance to Tp exhibited by certain species has been
explained in two ways. In Pseudomonas aeruginosa, which has MICs for
Tp in the range 100-200mgL~l (Grey and Hamilton-Miller, 1977),
insensitivity may relate to a relative permeability block to the drug
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which cannot penetrate the bacterial cell to vork (Hitchings, 1973).
On the other hard, sane resistant species (Neisseria meningiditis,
Clostridium perfringens and Bacteroides fragilis) have DHFR which is
100-1000 times less susceptible to inhibition by Tp than
corresponding enzymes from sensitive species (Burchall, 1971; Then
and Angehern, 1978). These DHFPs are not, however, as insusceptible
as the R-plasmid mediated DHFR which in general confer a high degree
of resistance to Tp (MIC >1000mgL~l).
THE EMERGENCE OF TRIMETHOPRIM R-PLASMIDS
The introduction of each new group of anitbiotics used on the
Enterobacteria has led to the emergence of R-plasnids conferring
resistance to these drugs (Anderson, 1968). When co-trimoxazole was
introduced there was already a high percentage of bacteria harbouring
R-plasmids within the clinical population. Most of these R-plasmids
contained determinants for sulphonamide resistance (Datta, 1969).
The initial resistance to the combination remained low, although
Tp resistant bacteria especially Klebsiella, had already been
isolated long before 1969 (Hamilton-Miller and Grey, 1975). Twa
years after the introduction of co-trimoxazole the percentage of E.
coli isolated from urinary tract infections, that were resistant to
the combination, remained less than 3% (Gruneberg, 1976). The only
organisms, isolated from the urinary tract, which were consistently
resistant at that time were the Pseudomonas species (Amyes, 1974).
However, in 1972, only three years after its introduction, bacteria
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harbouring R-plamsids conferring Tp resistance, were isolated in
London (Fleming et al., 1972).
This R-plasmid mediated resistance had two important distinctive
features. Firstly, the level of Tp resistance conferred by the
plasmids was extremely high, resistant bacteria had a minimum
inhibitory concentration greater than lOOOmgL-!. Secondly, the
resistance was able to transfer between bacterial strains.
Following the initial discovery of Tp R-plasmids, Datta and
Hedges (1972) began an examination of trimethoprim resistant
Enterobacteria isolated frcm hospitals around the UK. A total of 50
bacteria were isolated which conferred resistance to Tp at a
concentration of 8mgL~l or more. Transfer of Tp resistance to E.
coli K-12 was obtained with 19 of these 50 bacteria and the presence
of R-plasmids inferred. All 19 bacteria had been isolated frcm three
hospitals in a small area of North London. None of the bacteria
isolated from hospitals in West London, Bristol or Glasgow possessed
Tp R-plasmids.
Already a pattern was beginning to emerge that has, in general,
All
remained with Tp R-plasmids ever since. Each bacteria harbouring the
plasmid had an MIC of greater than lOOQmgL"! Tp. In most cases the
bacteria that did not show transferable Tp resistance possessed a far
lcwer MIC. Recent reports, however, indicate that Tp R-plasmids are
not always associated with high levels of resistance (Amyes et al.,
1982). Strains of Proteus harbouring Tp R-plasmids have been
isolated in which the MIC of the host organism is only lOOmgL-!. The
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R-plasraids, however, when transferred to E. coli K-12 confer the
usual high level of Tp resistance on this host (MIC >1000mgL~l).
Each of these early Tp R-plasmids conferred the same pattern of
resistance to Tp and sulphamethoxazole (Sx) and, in addition, each
was shown to belong to the W incompatibility group (Datta and Hedges,
1972) suggesting that they were all related to one another. It
appeared, therefore, that the emergence and spread of one type of Tp
R-plasmid resistance was being observed within these three North
London Hospitals. Extensive examination of mainly urine samples in
Bristol (Lacey et al., 1972) and faecal samples in Dublin, Eire
(Moorhouse and Farrell, 1972) revealed no emergence of Tp R-plasmids
during the same period although seme Tp resistance, mediated by the
bacterial chromosome, was emerging.
Jobanputra and Datta (1974), extending the survey to include
more hospitals in the London area, went on to shew that Tp resistance
was not restricted to plasmids of the W inc group, but was also
present on plasmids belonging to incompatibility groups I and P.
Further clinical surveys carried out at the Whittington Hospital,
London, between 1975 and 1977 by Amyes et al. (1978) showed that
R-plasmid resistance was increasing rapidly in London. A similar
explosive increase in Tp resistance was also being observed in areas
as far removed from the south east of England as Italy (Romero and
Perduca, 1977) and France (Acar et al., 1977). The character of the
resistant population was also changing. The Tp resistance due to
R-plasmids was increasing at a greater rate than Tp resistance as a
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whole. The increase in the number of R-plasmids was accompanied by a
diversification of their incompatibility groups and by 1975 many more
incompatibility groups were represented including N, M, N-M, S and
Fjj (Romero and Perduca, 1977).
Most of the early reports on Tp resistance concern enteric Gram
negative bacteria. However, over the last few years Tp resistant
strains of Haemophilus have been reported (Comere and Menzies, 1974;
Howard et al., 1978; Kirven and Thornsberry, 1978). The level of Tp
resistance in these strains, however, has never been greater than
64mgL~l suggesting the resistance is not plasnid mediated. Recently
the methods of sensitivity testing of Haemophilus have been
questioned. The fastidious growth requirements of the organisms and
the subsequent variation in sensitivity test medium employed is
thought to be responsible for many inaccurate reports of Tp
resistance within this species (Philpott-Howard et al., 1983). The
validity of recorded levels and incidence of Tp resistance within the
H. influenzae are, therefore often questionable.
Trimethoprim resistant Gram negative bacteria have been isolated
not only from humans but also from animals. As transmission of
R-plasmids from animals to humans has been demonstrated or strongly
suggested (Anderson et al., 1975; Amyes, 1983) it is important to
keep track of the Tp resistant strains wherever they occur.
Before 1977 there were only two reports of Tp resistant strains
isolated fran animal sources (Fleming, 1973; Gooke, 1976). Isolation
of Tp resistant strains in faecal specimens from pigs has increased
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very sharply since their initial isolation in 1977. Ninety-five
percent of the resistant strains had plasmid mediated Tp resistance
and at least 12 different resistance patterns have been isolated,
suggesting that resistance, in this survey, was not related to the
spread of one plasmid (Smith, 1980).
In Melbourne, Australia, E. coli harbouring Tp R-plasmids have
been isolated from frozen chicken carcasses. The plasmids belonged
to the incompatibility group Fj, not described anywhere else in
association with Tp (Caudry and Stanisich, 1979). Multi-resistant
strains of Salmonella typhimurium appeared in calves and then in
cattle in 1977 in Great Britian. The Tp resistance in these strains
was also plasmid mediated; four different plasmids harbouring the Tp
resistance marker could be identified belonging to incompatibility
groups Ij, 12/ and H2 (Threlfall et al., 1980).
The results of these studies show clearly that, since its
introduction, the levels of trinethoprim resistance have gradually
increased. Initially Tp resistance was of a low level and, in
general, chromosome determined. From 1972, an explosive increase in
the numbers of Tp resistant organisms was observed, accompanied by
raised MICs to the drug. This spread of resistance was being
manifested by resistance plasnids carrying the Tp resistance
determinant. During the last three years the percentage of resistant
organisms has remained fairly stable. However, the nature of the
resistant population is again changing - frcrm a population in which
the level of resistance was high and transferable to one in which the
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level of resistance remains high but is no longer transferable. This
phenomenon has largely been explained by the identification of
transposable elements carrying the Tp resistance determinant.
THE PROMISCUITY OF THE TRIMETHOPRIM RESISTANCE GENES
The diversity of the Tp resistance gene among plasmids of many
different incompatibility groups, suggested a similarity to the
promiscuous nature of the TEM ^-lactamase gene carried by the
transposon Tn3. It was not therefore unexpected when a similar
genetic element carrying resistance to Tp and Sm was identified
(Barth et al., 1976). This transposon, Tn7, was first detected in
the plasmid R483 when a piece of DNA of about 9 Megadaltons (Mdal),
carrying genes conferring resistance to streptomycin (Sm) and Tp was
found to transpose from R483 to other replicons, including the
bacterial chromosome, frcm where further migration could then occur.
As with other transposons, the attachment of Tn7 is site specific and
occurs independent of the recA gene product.
Since its discovery Tn7 has been found to be widespread among
R-plasmids isolated from both human infections and animal sources
(Richards et al., 1978; Richards and Datta, 1981). -The location of
Th7 has not, however, been restricted to R-plasmids. Increased
incidence of this transposon in the chromosome of clinical strains
and strains from animals is now being reported (Towner, 1981; Amyes
et al., 1982; Towner et al., 1982; Amyes, 1983). Recent reports
indicate that Th7 is unusual, among transposable elements, in that it
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inserts into a particular site of the E. coli chromosome with high
efficiency (Barth et al., 1976; Lichtenstein and Brenner, 1981), the
specificity of attachment being determined by specific DNA sequences
and possibly by the involvement of secondary structures (Lichtenstein
and Brenner, 1982). This would account for the change in recent
years to bacteria possessing high level non-transferable Tp
resistance.
Datta et al. (1979) reported the spread of Tp resistance in
bacteria, isolated during an outbreak of hospital infection, to be
mediated by the spread of TpSm resistance transposons
indistinguishable frcm Tn7. During this survey, these authors
identified another transposon, Tn78, which conferred resistance to Tp
alone. This transposon, however, had a MW of about 9Mdal, similar to
Tn7. Mutation back to 9m resistance was not possible, but
restriction enzyme analysis revealed no difference between this
transposon and Tn7. By these criteria it was concluded that Tn7, by
means of a small deletion, had given rise to the new transposon Tn78.
Tbwner et al. (1982) have since suggested the presence of similar
transposons in the chromosomes of clinical isolates of E. coli.
Shapiro and Sporn (1977) reported the presence of a 5Mdal
transposon, Tn402, which confers sole resistance to Tp, in the
plasmid R751. However, this transposon has only been shown to
integrate at low frequency into the bacteriophage lambda genome, and
together with the knowledge that the Tp resistant dihydrofolate
reductase of R751 is as yet, unique to this plasmid, it seems
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unlikely that transposition of Tn402 occurs in the clinical
situation.
PLASMID DETERMINED TRIMETHOPRIM RESISTANCE MECHANISMS
The mechanism of R-plasmid determined resistance to trimethoprim
remained obscure for some years. Extensive investigations with
bacteria harbouring Tp R-plasmids failed to reveal an inactivation
enzyme or a permeability barrier to the drug (Amyes, 1974).
Trimethoprim resistant strains of E. coli had however, been isolated
which owed their resistance to a chromosomal mutation resulting in an
alteration of the target enzyme, dihydrofolate reductase (Poe et al.,
1972). For this reason, E. coli 114, harbouring the first Tp
R-plasmid, R388 (Datta and Hedges, 1972), was investigated for an
alteration in DHFR activity (Amyes, 1974).
Gel filtration of cell extracts of the R-plasmid containing
strain, when assayed in the presence and absence of 4 x 10~% Tp,
revealed a Tp resistant enzyme. Repetition of the gel filtration in
the presence of standard marker proteins showed that the plasmid
enzyme has a molecular weight of 35000, compared with the E. coli
chromosomal enzyme of MW 21000. In addition, the resistant enzyme
was found to be 20,000 times more resistant to Tp than the sensitive
enzyme (Amyes and Smith, 1974a).
This was the first example of an R-plasmid encoding the
synthesis of an additional insusceptible target site enzyme that
by-passed an inhibited step in the bacterium. It has since been
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shown that some R-plasmid sulphamethoxazole resistance employs this
type of mechanism (Wise and Abou-Donia, 1975).
Subsequent to the discovery of the DHFR of R388, another plasmid
conferring Tp resistance, R483, was also shown to mediate the
synthesis of an additional Tp resistant DHFR (Skold and Widh, 1974).
This enzyme, like the R388 DHFR, has a MW of 35000, but in contrast
is produced in far greater quantities, the specific activity of the
plasmid containing strain being about ten times greater than that of
the strain lacking the plasmid. In addition, the R483 enzyme was
shown to be very sensitive to heat, again in contrast to the R388
encoded enzyme.
A distinguishing feature of the plasmid mediated enzymes was
their inability to utilize NADH as a hydrogen donor whilst the
sensitive enzyme could utilize this co-enzyme at 16% of the
efficiency of NADPH. In addition, unlike both the mammalian and
sensitive bacterial DHFRs, the plasmid encoded enzymes are resistant
bo the 2,4-diamincpteridine, methotrexate (Amyes and Smith, 1976).
This would suggest that the R-plasmid enzymes have evolved
differently frcm both the mammalian and bacterial DHFRs developing
the ability to differentiate between the substrate, dihydrofolate,
and its closest structural analogue.
PROPERTIES OF PLASMID DIHYDROFOLATE REDUCTASES
Since the initial discoveries of the R388 and R483 enzymes, many
plasmid encoded Tp resistant DHFRs have been isolated. Initially the
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properties of the enzymes from different plasmids seemed to be
similar; for example their MW, molecular charges and resistance
profiles revealed few differences (Amyes and Smith, 1978). However,
the yields of enzyme associated with the different plasmids varied
considerably and, in 1977, Pattishall et al. proposed the division of
R-plasmid DHFRs into two groups, Type I and Type II. Those of Type I
(exemplified by the DHFR from R483) are produced in large quantities,
are heat sensitive and are 10,000 times less susceptible to Tp than
the chromosomal enzyme. In contrast, those of the Type II enzyme
group, (exemplified by R67 (Pattishall et al., 1977)) are produced in
low quantities, are heat resistant and are virtually insusceptible to
Tp.
However, sane of the enzymes did not conform strictly to one
group or the other. Re-examination of the properties of DHFRs
encoded by three plasmids, R751, R388 and R483, by polyacrylamide gel
electrophoresis showed each enzyme had slightly different migratory
properties (Tennhammar-Ekman and Skold, 1979). These authors
concluded that the three enzymes were distinct from one another.
By 1980, it had been shown that the Type I and Type II DHFRs
have different subunit structures. Zolg et al. (1978), by excision
of the Type II, R388 DHFR gene by restriction endonuclease digestion,
and subsequent integration of the DNA fragment in a multiple copy
derivative of plasmid GolEl, showed that the size of the DNA fragment
encoding the R388 DHFR was 1770 bp. This fragment, at most, could
encode for a protein of 13000 daltons whereas the MW estimation of
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the plasmid enzyme was 35000 when estimated by gel filtration. This
R-piasmid DHFR must therefore be comprised of subunits which were
later snown to be four identical of MW 8300 (Zolg and Hanggi, 1981).
Other Tp resistant DHFRs related to the R388 have also been shown to
be tetrameric (Smith et al., 1979; Fling and Elwell, 1980). In
contrast, the Type I enzyme from R483 is not tetrameric, but consists
of two identical subunits of MW 18000 (Fling and Elwell, 1980).
The different subunit structures of the enzymes appeared to
clarify the distinction between Type I and Type II DHFRs.
Nevertheless, confusion persisted with respect to the other
biochemical properties of the enzymes. Classification of these
plasmid determined DHFRs therefore required a more exacting
technique. Broad and Smith (1982) examined DHFRs of Type I and Type
II as well as those from R388 and R751, by isoelectric focussing
(IEF). Ey this method three different groups could be distinguished.
Type I enzymes were found to exhibit isoelectric points of 6.4 while
Type II enzymes ware of pi 5.5. The DHFR of R388 also exhibited a pi
of 5.5 and was therefore clearly identified as a Type II enzyme. The
enzyme mediated by R751, however, was found to exhibit a unique
isoelectric point (pi 7.2) and hence constituted a third group.
Nevertheless, as the enzymes of R751 and R388 are known to be
serologically related (Fling and Elwell, 1980), it is suggested that
the R751 enzyme should perhaps be regarded as a sub-group of Type II
enzymes rather than being of a completely separate type.
In November 1982, a new type of plasmid mediated DHFR was
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detected in a non-self-transmissable plasnid (p669) which conferred
resistance to modest levels of Tp (64mgL~l) (Fling et al., 1982).
This enzyme differs markedly from both Type I and Type II DHFRs. The
concentration of Tp required to give 50% inhibition (ID50) of the
enzyme was only 1.5pi compared with 60|i4 for Type I enzymes and
70000^4 for Type II enzymes. In addition the MW of the p669 enzyme
was unusually low for a resistant DHFR at only 16000-18000. A
resistant DHFR of similar MW has previously been reported by Poe et
al. (1979). However, unlike the DHFR of Fling et al. this enzyme was
chromosomally mediated.
THE EVOLUTION OF THE TRIMETHOPRIM RESISTANCE GENE
Since their discovery, the origins of the resistance
determinants of R-plasmids have been a topic of much speculation.
Despite many years of research and profound advances in DNA
technology, very little conclusive evidence of their origin has been
forthcoming. Several lines of investigation have been pursued the
most lucrative being an examination of soil bacteria for antibiotic
inactivating enzymes. Benveniste and Davies (1973), with the
knowledge that most antibiotics are produced by soil bacteria,
reasoned that synthesis of antibiotic inactivating enzymes by species
of actinomycetes might be advantageous in protecting the organism
against anitbiotics produced by itself or by a competitor in the soil
environment. In their search for such enzymes they succeeded in
finding a kanamycin-acetylating enzyme in Streptomyces kanamvceticus
which produces kanamycins, and a gentamicin acetyltransferase in S.
62.
spectabilis which produces spectinomycin. More recently, the amino
acid sequence of the aph gene (aminoglycoside 3'-phosphotransferase)
of S. fradiae has been determined, (Thomson and Grey, 1983) and its
comparison with the phosphotransferases encoded by two transposons
Tn5 and Tn903, show all three enzymes to share 36-40% homology. The
three enzymes exhibit an area of high conservation at the carboxy
terminus which may be involved with the binding of one of the two
substrates (aminoglycoside antibiotic or ATP). The level of homology
observed between the enzymes is significant according to Doolittle
(1981) suggesting that the aph genes of antibiotic producing bacteria
and R-plasmids may share a common ancestor.
Amino acid and nucleotide sequence studies of plasmid-specified
penicillinases expressed in E. coli show these enzymes to share
marked sequence homology with the chromosomal enzymes of a number of
Gram positive organisms, indicating a common evolutionary origin
(Ambler and Scott, 1978; Sutcliffe, 1978). The SHV-1 ^-lactamase
found on seme plasmids is indistinguishable by kinetic analysis and
IEF from a chromosomal ^-lactamase found in many isolates of K.
pneumoniae. Nugent and Hedges (1979) suggest that the SHV-1
^-lactamase gene evolved as a chromosomal gene in Klebsiella and was
later incorporated into a plasmid.
Unlike the aminoglycosides and penicillins, trimethoprim is a
chemically synthesised antibacterial substance, which inhibits the
activity of the enzyme dihydrofolate reductase (DHFR). Since no
naturally occurring substance has yet been discovered that mimics
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this action it seems unlikely that a resistance mechanism to
trimethoprim evolved specifically in the past. It is more probable
that trimethoprim resistance has developed during the clinical use of
this drug. In addition, the introduction of trimethoprim has
followed the discovery of R-plasmids and hence a unique opportunity
exists to investigate the de novo pathway of drug resistance
evolution.
High level resistance to trimethoprim is achieved by the
production of plasmid determined Tp resistant DHFRs which provide an
additional insusceptible target site thus by-passing the inhibited
target site of the host. Dihydrofolate reductases are ccmmon to all
living cells. It is therefore thought, that the plasmid enzymes may
have arisen either by mobilization of a DHFR gene frcm elsewhere or
alternatively by mutation of a sensitive enzyme.
As previously indicated, plasmid-determined DHFRs may be
classified into at least two different groups - Type I and lype II.
The enzymes of both groups have molecular weights (MW) of 35000 but
have different sub-unit composition, Type I enzymes consisting of 2
sub-units MW 18000 and Type II enzymes consisting of 4 sub-units MW
8500. The amino acid sequences of the R67 and R388 lype II enzymes
and the R483 Type I enzyme have been determined and compared. The
R67 and R388 enzymes are closely homologous (Swift et al. , 1981) but
show little homology with other prokaryotic and eukaryotic DHFRs
(Smith et al., 1979; Zolg and Hanggi, 1981). This has led to the
suggestion that these plasmid DHFRs are not 'classical' reductases
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but may have evolved from non-reductase proteins which happen to have
reductase activities (Smith and Burchall, 1980; Zolg and Hanggi,
1981). In contrast the R483 Type I enzyme shares 22-29% homology
with sensitive bacterial and eukaryotic DHFRs (Fling and Richards,
1983; Simonsen et al., 1983), indicating a genuine relationship
(Doolittle, 1981). Seventy percent of this homology occurs in the
hydrophobic binding site of the enzyme. This sequence appears to
have been conserved in DHFRs isolated from many bacterial strains
(Bitar et al., 1977).
Dihvdrofolate reductases frcm many different sources have been
extensively investigated and compared with those from R-plasmids.
Studies on inherently resistant organisms such as Neisseria,
Clostridium and Bacteroides have indicated that resistance is due
principly to production of altered, less sensitive DHFRs (Then, 1979;
Then and Angehern, 1979). Amethopterin and trimethoprim resistant
mutants of S. faecium (Gleisner et al., 1974), L. casei (Bately and
Morris, 1977) and E. coli B strain (MB1428) (Bennett et al., 1978)
have also been examined and the mutant DHFRs produced by them
compared. In all cases there appears to be a significant region of
homology at the amino terminal although each enzyme remains distinct
from the plasmid resistance enzymes.
An examination of DHFRs produced by the T-even bacteriophages
has led many authors to speculate about their relationship to the
R-plasmid enzymes (Mosher et al., 1977; Pattishall et al., 1977;
Purohit et al., 1981). Varying reports concerning the MW of the
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phage DHFR have resulted in seme confusion. Erickson and Mathews
(1971, 1973) reported the DHFR of bacteriophage T4 to be a single
polypeptide with a MW of 29000, determined by SDS-PAGE. Mosher and
Mathews (1979) subsequently published the MW to be 22800. However,
recently Purohit et al. (1981) found that the T4 phage coded DHFR is
in fact a dimer ccmprised of two subunits of about 23000 daltons
each. In any event, it is evident that phage DHFRs are quite
distinct from other bacterial DHFRs (MW 18000) and are perhaps more
similar in MW to the plasmid enzymes.
In addition to being a larger MW, the T-even DHFRs are
moderately resistant to trimethoprim (Purohit et al., 1981), heat
sensitive (Mathews and Sutherland, 1965; Purohit et al., 1981) and
exhibit a definite pH optimum at about pH7.0. These properties are
very different from E. coli chromosomal DHFRs but reveal a distinct
similarity to the Type I plasmid enzymes. The phage and plasmid
enzymes are however, distinct. Precipitation of the phage enzyme by
ammonium sulphate occurs at 0-40% saturation (Mathews and Sutherland,
1965), in contrast to the plasmid enzymes which are precipitated at
50-80% saturation (Amyes and Smith, 1978). In addition the phage
enzyme is as sensitive to amincpterin as the chromosomal enzyme
(Mathews, 1967) and has been shown to be immunologically distinct
from the plasmid DHFRs (Mosher et al., 1977). Nevertheless, the
similarities plus the probable ecological juxtaposition of phage and
plasmids would seem to justify further comparisons at the level of
primary structure of the enzymes and/or their controlling genes.
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Detailed analysis of DHFRs from mammalian sources show strong
homology bet\%een the enzymes isolated frcm mice, chicken, cattle and
man (Kumar et al., 1980; Masters and Attardi, 1983). This strong
homology is not observed when comparisons are made with enzymes from
bacterial sources (Then and Riggenbach, 1978; Stone et al., 1979;
Kumar et al., 1980). Thus although mammalian and type I plasmid
DHFRs have similar affinities for trimethoprim, their lack of
sequence homology (Stone and Smith, 1979; Kumar et al., 1980; Novak
et al., 1983) coupled with their different triazine sensitivities
(Hitchings and Burchall, 1965) would suggest distinct evolutionary
origins.
Two recent reports have identified the existence of Tp
R-plasmids pUN212, isolated from E. coli (Towner and Pinn, 1981), and
p699, isolated frcm Salmonella typhimurium (Fling et al., 1982) which
confer only moderate levels of resistance to trimethoprim (MICs of
256mgL~l and 64mgL~l respectively) compared with the level of
resistance usually associated with R-plaanids (MIC >lOOQmgL-!).
Towner and Pinn (1981) speculate that the R-plasmid pUN212 specifies
an 'intermediate' type of DHFR more sensitive to Tp than the 'normal'
plasmid-encoded reductases. However, this enzyme has not yet been
characterised. On the other hand, Fling et al. (1982) isolated and
partially characterised the DHFR of plasmid p699. The reductase was
found to differ significantly from other plasmid DHFRs. It has a MW
of only 16-18000, is methotrexate sensitive and is inhibited by 50%
with a concentration of trimethoprim of 1.5pM. In addition it is
antigenically distinct from the DHFRs specified by plasmids R67 and
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R483 and from the chromosomal DHFR of E. coli RT500 (Baccanari et
al., 1975; Fling et al., 1982). This enzyme would therefore not
appear to be a precursor of the more usual plasmid DHFRs.
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2. MATERIALS AND METHODS
A. Bacterial Strains, Plasmids and Phage
The bacteria, plasmids and phage used are listed in table 1.
All bacterial strains ware stored at -70°C in nutrient broth
containing 10% (v/v) sterile glycerol.
B. Media
Complex media
The complex media used were Nutrient Broth No. 2 (CM67),
Diagnostic Sensitivity Test Agar (CM216), Columbia agar base (CM331)
and MacConkey agar (CM7b), (Oxoid, Basingstoke, Hants).
Minimal medium
Double strength minimal salts medium (DM) was made up as
described by Davis and Mingioli (1950) (table 2). Single strength
minimal medium EM base was prepared by diluting double strength DM
base with an equal volume of distilled water prior to autoclaving.
For the preparation of diluents single strength EM base was
distributed in 9.9 ml and 4.5 ml aliquots which were autoclaved at 15
psi for 15 minutes.
Supplement solutions for incorporation into minimal medium were as
shown in Table 3.
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coli pro~his-trp-lac~RifR Bachmann (1972)
Escherichia
K-12 J53
coli pro_met~ Bachmann (1972)
Klebsiella sp.
D770*
ApR Datta and Hedges (1972)
Plasmids
R6K incX ApRSmR Kontamichalou et al.(1970)
RP4 incP ApRKmRTcR Eatta et al. (1971)
R15 incN SmRSuR Eatta and Hedges (1971)
Sa incW CmRKmRSmRSuR Watanabe et al. (1968)
Rl incFji ApRCmRKmRSmRSuR Meynell and Datta (1966)
R389 incW CmRSmRSuRTcRTpR Datta and Hedges (1972)
RlE incFjj CmR This plasmid was kindly
supplied by Prof. J. T. Smith
Phage
PR4 Specific for
inc P, N and W
Stanisich (1974)
* This strain is MR+ VP+- malonate-ve ie. is not K. aerogenes or
K. pneumoniae.
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These ingredients were dissolved in a litre of distilled
water in the order given. 50ml quantities vere distributed
and autoclaved at 15 psi for 15 minutes.
Table 3 Supplement Solutions
Solution Source Strength Final Mode of
Prepared Concentration Sterilization
D-glucose B.D.H. 20Qmg/ml 2.8mg/ml Autoclaving
L-proline B.D.H. 5mg/ml 50pg/ml Steaming
L-methionine Sigma 5mg/ml 50pg/ml Steaming
L-histidine B.D.H. 5mg/ml 50pg/ml Steaming
L-trytophan B.D.H. 2mg/ml 50pg/ml Steaming
Autoclaving was performed for 15 minutes at 15 psi.
Steaming was for 30 minutes.
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Preparation of plates
All laboratory media were made up according to the
manufacturer's instructions and were autoclaved at 15 psi for 15
minutes. The plates were poured while the agar was still molten,
each containing approximately 15 ml. After setting, the plates were
dried, inverted at 50°C for 20 - 30 minutes.
Preparation of CM medium plates
The supplements were added aseptically to 50 ml double-strength
DM base as shown in table 3. Antibiotic and chemotherapeutic drug
solutions were added aseptically to give the requisite concentration.
1.4 ml of a 20% glucose solution was then added and the volume made
up to 60 ml by the addition of sterile distilled water. This was
mixed and added to 40 ml water containing 1.5g bacteriological agar
(Oxoid) which was previously autoclaved at 15 psi for 15 minutes.
After rolling gently to mix and avoid frothing, the plates were
poured. They were allowed to set and dried as above. The plates
were freshly made and used within one v^ek of manufacture.
C. Materials
Chemotherapeutic drugs
The chemotherapeutic drugs used are listed in table 4. They
were kindly donated by each of the suppliers listed. All were
supplied sterile and were prepared aseptically with sterile distilled
water.
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Table 4 Chemotherapeutic Drugs
Chemotherapeutic drug Supplier
Trimethoprim lactate* Wellcome Foundation Ltd., Beckenham, Kent
Sulphamethoxazole+ Wellcome Foundation Ltd., Beckenham, Kent
Streptomycin sulphate Glaxo Ltd., Greenford, Middlesex
Oxytetracycline
hydrochloride
Glaxo Ltd., Greenford, Middlesex
Spectinomycin Upjohn Ltd., Crawley, Sussex
Rifampicin** Le petite, Milan, Italy
Kanamycin Bristol Laboratories, Slough, Middlesex
Ampicillin Beechams Ltd., Brentford, Middlesex
Cephradine E. R. Squibb and Sons Ltd., Hounslow,
Middlesex
Chloramphenicol** Parke Davis, Pontypool, Gwent
Gentamicin Roussel Laboratories Ltd., Wembley,
Middlesex
Methotrexate"1" Lederle Laboratories, Gosport, Hants
* 1.3g of Trimethoprim lactate is equivalent to l.Og of trimethoprim
base and all results are expressed in terms of the base.
+ These drugs were dissolved with the aid of N/10 NaOH.
** These drugs vrere dissolved with the aid of absolute alcohol.
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Reagents
NADPH tetrasodium salt and NADH disodium salt viere purchased
from Sigma Chemical Company. Both compounds were stored desiccated
at -20°C and solutions were freshly prepared on the day of use.
Dihydrofolic acid (DHF), from the Sigma Chemical Company, was
prepared by dissolving 25mg of DHF in 0.05M sodium phosphate buffer
pH 7.4 containing 0.05M />-mercaptoethanol. This solution was
distributed into aliquots which were stored in total darkness at
-20°C. No aliquot was refrozen after thawing.
Lysozyme (stored desiccated at -20°C) and fl-mercaptoethanol were
also purchased from the Sigma Chemical Company.
Triton X-100 and agarose 15 'Electron' were obtained from BDH
Chemicals Ltd., Boole and caesium chloride and restriction
endonucleases from the Boehringer Corporation (London) Ltd.
Buffers
Sodium phosphate, sodium acetate, Tris-HCl and Tris-glycine
buffers were made according to the Data for Biochemical Research,
(Oxford University Press). Restriction endonuclease digestion




Serial dilutions were made using 1 in 10 and 1 in 100 dilutions
in EM base - that is 0.5 ml of culture and 4.5 ml diluent or 0.1 ml
culture and 9.9 ml diluent, respectively. Suspensions, appropriately
diluted, were mixed on a Rotamixer (Hook and Tucker Ltd.) and 0.1 ml
amounts spread with a sterile glass spreader onto solid medium. The
spread plates were incubated, inverted, at 37°C. Incubation for all
plates, except EM medium, was 18 hours and those of DM medium were
incubated for 66 hours.
Minimum inhibitory concentration (MIC) determinations on solid media
4.5 ml amounts of Oxoid No. 2 nutrient broth were seeded with an
inoculum from a fresh nutrient agar plate, and grown overnight at
37°C. A 1 in 10^ dilution was prepared by serial dilution in EM base
lacking glucose. A drop of this suspension (2pl) was spotted onto
media containing varying concentrations of the drug (Miles and Misra,
1938). All plates, except EM medium, were incubated, inverted, for
18 hours while EM medium plates were incubated for 66 hours.
Gontrols were suitably supplemented media lacking any drug.
Concentrations of the drug were usually increased by a factor of two
and the MIC was expressed as the first concentration permitting no
visible growth.
Sensitivity testing against chemotherapeutic agents
Overnight cultures vere grown in Oxoid No. 2 nutrient broth as
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above. A 1 in 10^ dilution was prepared by serial dilution in EM
base lacking glucose. Erops of this suspension were placed on
Diagnos/tic Sensitivity Test Agar (ESTA) plates containing various
drugs at a concentration of 10 mgL-1 with the exception of Sx and Sp
which ware at a concentration of 100 mgL-l. A Eenley multipoint
inoculator A400 was used for delivering approximately 2jfL. The
plates were incubated, inverted, for 18 hours at 37°C. Growth at the
spot of application on the plates containing drugs, indicated
resistance.
Replica Plating
Overnight cultures were grcwn in nutrient broth as above. A 1
in 10*7 dilution was prepared by serial dilution in base lacking
glucose. 0.1 ml aliquots of this suspension were spread on nutrient
agar plates using a sterile glass spreader and the plates were
incubated inverted for 12 hours at 37°C. The initial plates, bearing
between 100 - 150 colonies, were then replica plated by the methods
of Lederberg and Lederberg (1952). The plates were inverted over a
square of sterile velvet, placed pile upwards on a cylindrical rubber
block of diameter 8 cm, the material being held in position by a
perspex collar. The agar surface was pressed gently against the pile
and the plate was then carefully removed. Replica plates, marked
with a reference point for subsequent orientation, were then inverted
in turn over the fabric, pressed gently against it so as to pick up a
sample of the bacteria adhering to the pile, and then removed and
incubated, inverted, at 37°C for 12 hours.
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Transfer of R-plasmids
Overnight cultures were grown at 37°C in nutrient broth from a
fresh plate inoculum. After a viable count of a 10~6 dilution on
MacConkey agar was performed, 0.1 ml of the donor culture was mixed
with 1.0 ml of the recipient culture in 4.5 ml prewarmed broth. The
resultant mating mixture was incubated at 37°C for the time specified
in the results. 19.8 ml of prewarmed DM base was added to the mating
mixture - a process equivalent to washing, to remove excess broth -
and the suspension was mixed and then spun for 20 minutes at 4000 rpm
on a Heraeus Christ Bactifuge at room temperature. The supernatant
was decanted and the pellet was resuspended in a volume of prewarmed
DM base equal to that of the original mating mixture, which was 5.6
ml. After mixing thoroughly to resuspend, the "washed" mating
mixture was diluted serially to 10-4, as described for viable counts,
and 0.1ml of each dilution was plated on EM medium plates
supplemented only for the recipients, and containing antibiotic at a
concentration or concentrations which allowed only those recipients
containing the R-plasmid to grew. MacConkey plates vere incubated,
for 18 hours at 37°C and DM medium plates for 66 hours at 37°C, all
plates being inverted. Isolates were purified by streaking out for
single colonies on identical DM selective plates.
Enzyme assays
DHF reductase (by the method of Osborn and Huennekens, 1958).
Stock solutions: DHF was made up to ImM and stored as described in
the Materials. NADFH was made up to ImM in distilled water and used
that day only.
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Method 1; The assays were performed in a Pye Unicam Sp8000
spectrophotometer, at 30 °C. 1 ml quartz cuvettes were used and
contained the following reagents
40 mM buffer (usually sodium phosphate pH 6.0) o -t+^<L ioc^m
10 mM 5-mercaptoethanol ^ icc^H
0.08 mM NADPH UM NiAbPH
enzyme
distilled water to a volume of 0.95 ml
The blank cuvette contained all these constituents except NADPH.
Both cuvettes were placed in the spectrophotometer for four minutes
to allow for temperature equilibration. TP start the reaction 0.05
ml of 1 mM DHF was added to both the blank and the test cuvettes and
the decrease in absorbancy at 340 nm followed for 10 minutes. When a
decrease in absorbance occurred before the addition of DHF to the
test cuvette, this was taken to be due to a DHF-independent NADPH
oxidase. This rate was subtracted form the total rate observed in
the presence of DHF, to give the level of DHFR activity. The
decrease in absorbance at 340 nm is due to reduced absorbancy both by
oxidation of NADPH to NADP and by the reduction of DHF to THF. 52%
of the combined decrease in absorbance is due to DHF to THF, when
both substrates are being consumed stoichiometrically (Mathews et
al., 1963), and hence, with this proviso, the rate of enzymic
activity was expressed in malar terms of DHF being converted to THF.
Controls were performed routinely in the absence of any enzyme to
ensure that the addition of the two substrates together did not
result in a change of absorbance.
Method 2a: The DHF-independent NADFH oxidase activity was so
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high in some crude extracts that it was found necessary to assay
enzymic activities by placing all the reagents including DHF, but
excluding the enzyme, in the test cuvette for temperature
equilibration. The blank cuvette contained all the constituents
except NADPH and the enzyme. The reaction was then started by the
addition of the enzyme to both the test and blank cuvettes and the
initial rate was taken. When method 2a was used a separate assay was
performed to estimate the NADPH oxidase activity.
Method 2b; In this, the test cuvette was set up to contain
buffer, yS-irercaptoethanol, NADPH and water. The blank cuvette
contained all these reagents, but lacked NADPH and the enzyme. The
reaction was started by the addition of the enzyme to both the test
and blank cuvettes. The NADPH oxidase rate so found, was subtracted
from the total rate determined in the assay containing DHF (2a), to
give the rate of DHFR activity.
Note: It is uncommon to assay enzymes spectrophotometrically
with the enzyme in the blank cuvette as a routine. However, DHFR is
a special case because some strains of E. coli can exhibit an NADPH-
independent DHF nonooxygenase activity (Poe, 1973), which is
corrected for by the methods used.
Che unit of DHFR activity was taken as the amount of enzyme
vv\.ir\ule_
causing the conversion of 1 n mole of DHF to THF^using the assunption
of Mathews et al., (1963).
Preparation of cell extracts for enzyme estimation
100 ml of an overnight culture, in suitably supplemented EM
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medium, was subcultured into 900ml of prewarmed DM medium. The
culture was grown aerobically in a Gallenkamp rotary shaker at 37°C
to logarithmic phase. The cells were harvested by centrifugation at
4,000g for 60 minutes at 4°C in the 6 x 1L head of the MSE Mistral 6L
centrifuge. The cells were resuspended to 5ml with 50mM sodium
phosphate buffer pH 7.4 containing lOmM ^-mercaptoethanol and ImM
EDTA at 4°C. The bacteria were lysed in the French Press (Aminco) at
a pressure of 7 tons/in^ and the disrupted suspension was centrifuged
at 40,000g for 1 hour, at 4°C in a Du Pont Sorvall RC-5B. The
supernatant was decanted and used as the crude extract for the
determination of enzymic activities.
Preparation of cell extracts for enzyme purification
One litre of an overnight culture grown in suitably supplemented
DM medium at 37°C was inoculated into 9 litres of DM medium. The
culture was grown aerobically to logarithmic phase by shaking in the
rotary shaker at 37°C. The cells vere harvested by centrifugation at
4,000g for 60 minutes at 4°C as before. The pellet was resuspended
in about 20ml of 50mM sodium phosphate buffer pH 7.4 containing lOmM
^-mercaptoethanol and ImM EOTA (buffer A) at 4°C. All subsequent
operations were performed at 4°C. The bacteria were lysed with the
French Press (Aminco) at a pressure of 7 tons/in^ and the disrupted
suspension centrifuged at 40,000g for 1 hour in the 8 x 25ml head of
a Sorval RC-5B centrifuge. The supernatant fluid was carefully
decanted and stored at 4°C for further purification.
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Purification of dihvdrofolate reductase
The crude enzyme preparation, prepared from a 10 litre culture,
as described above, was further purified by a modification of the
method of Amyes and Smith (1974a). Nucleic acids ware precipitated
by the gradual addition of 0.1 volume 10% streptomycin sulphate. The
precipitate was removed by centrifugation at 12,000g for 30 minutes
in a Sorvall RC-5B centrifuge. The supernatant was collected and
dialysed against a 50% saturated solution of ammonium sulphate (made
up in buffer A) for four hours. Following centrifugation at 12,000g
for 30 minutes the pellet was discarded and the resulting supernatant
was then dialysed against an 80% saturated solution of ammonium
sulphate, again made up in buffer A, for a further four hours. The
pellet was collected by centrifugation at 12,000g for 30 minutes,
resuspended in a minimum volume (about 2 ml) of buffer A, and stored
frozen at -20°C for further purification.
Gel filtration
After being allowed to swell for 3 hours at 100°C in 50 mM
sodium phosphate buffer pH 7.4 containing 10 mM ^-mercaptoethanol and
1 mM EDTA (buffer A), a sufficient quantity of Sephadex G-75
superfine (Pharmacia, Uppsala, Sweden) was shaken and allowed to
settle overnight in a flask. The "fines" were carefully decanted
off, then more buffer A added and the process repeated.
The Sephadex slurry was poured carefully into a Wright acrylic
column (2 cm^ x 90 cm) which was maintained at 4°C in an LKB minicold
lab. Vhen the column was full, the top was connected and the flow
changed to an upward direction using an LKB peristaltic pump.
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The flow rate was adjusted to between 6 and 8 ml per hour and the
column washed continually with buffer A for 48 hours before use.
The samples for separation, usually 2-3 ml, were applied slowly
at the bottom of the column by syringe and eluted with buffer A. 2 ml
fractions were collected and maintained at 4°C using an LKB ultrorac
fraction collector. Elution was continued until a volume of buffer
A, equivalent to the total volume (180 ml) of the column, had passed
through. The column was washed for twelve hours between each run
with buffer A.
Enzyme molecular weight determinations
(by the method of Andrews, 1964)
Chymotrypsinogen, ovalbumin and cytochrome c were dissolved in
the sample to be tested, which was applied to the Sephadex G-75
superfine column as before. The DHFR activities were determined as
described earlier. The position of the peaks of the three additional
protein markers were found by a protein estimation of each fraction
by the method of Waddell (1956). The position of the cytochrome c
peak vas confirmed by measuring the absorbance at 410 nm.
Protein estimations
All protein estimations were performed by the method of Waddell
(1956). A standard curve was prepared using bovine serum albumin
dissolved in 20 mM sodium phosphate buffer pH 7.4. The absorbance of
various dilutions of this protein was estimated at 215 nm and 225 nm
on a Pye Unicam SP6-550 UV/VIS spectrophotometer. The difference
between the two values was plotted against protein concentration to
82.
construct the standard curve.
All samples to be tested were suitably diluted in 50 mM sodium
phosphate buffer pH 7.4 and estimated in the same manner as the
standard protein, bovine serum albumin. The protein concentrations
of the test samples were read off the standard curve.
This method has been shown to be as precise and more sensitive
than the protein estimation of Lowry et al. (1951), (Hesslewood,
1973). It has the additional advantage that it may be employed in
the presence of ammonium sulphate, whereas the Lowry method cannot.
Rolvacrylamide gel electrophoresis
The stock solutions were made up according to the method of
Davis (1964). The tubes for running the gel were sealed at one end
and placed in a vertical stand. The polymerization mixture for the
"small pore" running gel was aided to within 2 cm of the top of the
tube. A layer of distilled water was very carefully placed on the
gel to prevent the formation of a meniscus. The gel was allowed to
polymerize for 45-60 minutes, after which tine the top water layer
was tipped off and the polymerization mixture for the "large pore"
gel added to within 1cm of the top of the tube. A water layer was
carefully placed on the top of this gel and photopolymerization
continued for 45-60 minutes. The water layer was tipped off and the
sample, mixed with an equal volume of 80% sucrose solution, was added
to the top of the tube.
The seals at the bottom of the tubes were removed and the tubes
were placed in a vertical Shandon disc electrophoresis apparatus.
Tris-glycine buffer pH 8.6 was added to the lower reservoir, care
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being taken to ensure that no air bubbles lodged at the bottom of the
gels. The sane buffer was added to the upper reservoir, but in
addition it contained 1 ml of 0.001% brcmophenol blue. The anode was
connected to the lover reservoir and the cathode to the upper. The
current was switched on and maintained at 5mA per tube throughout the
run.
When the brcmophenol blue band had nearly reached the bottom of
the tubes the current was switched off and the tubes disconnected.
The gels were removed by "teasing" them out with water fran a syringe
and needle. DHFR activity was detected by either zymographic
staining or by elution of the enzyme activity frcm segments of the
gel and the subsequent assay of the eluate by the method of Osborn
and Huennekens (1958).
Zymography
Bands of DHFR activity were located on polyacrylamide gels using
the zymographic stain described by Tennhammar-Ekman and Skold (1979).
The tetrazolium salt MTT is reduced by tetrahydrofolic acid (which is
produced by DHFR from the substrate dihydrofolic acid) to form an
insoluble blue precipitate at the site of DHFR activity.
Immediately after the electrophoretic run, the gels were
transferred into glass tubes containing 40 mM sodium phosphate buffer
pH 6.0, 1.2 nM NADPH and 0.8 irM dihydrofolic acid. After 5 minutes
of incubation at 37°C, 0.6 mM tetrazolium salt was added. The gels
vvere incubated in the dark for another 30-45 minutes at 37°C and
/vioiA
finally washed in 40 mM sodium phosphate buffer, pH 6.0. fMspecific
reduction of the tetrazolium salt was identified on control gels,
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stained as described, but in the absence of dihydrofolic acid.
Preparation of ENA for agarose gel electrophoresis
Plasmid and chromosomal DNA were isolated from bacteria
employing a modification of the method of Meyers et al. (1976). 10 ml
of an overnight culture grown in Oxoid nutrient broth No. 2 at 37°C
was inoculated into 1 litre of nutrient broth. The culture was grown
aerobically in a Gallenkamp rotary shaker at 37°C overnight. The
cells were harvested by centrifugation at 4,000g for 60 minutes at
4°C and the pellet resuspended in 2.0 ml of 25% sucrose in 0.034 Tris-
HC1 (pH 8.0). Gentle lysis of the cells was begun by adding 0.3 ml
of lysozyme (5Qmg/ml in water) and mixing gently at 37°C for 5
minutes. This was followed by the addition of 2 ml of 0.234 EDTA (pH
8.0) and the mixture was shaken gently on ice for 5 minutes. Finally
3.0 ml of Triton mixture (2% Triton X-100 in 0.05M Tris-HCl (pH 8.0)
containing 0.0625M NagEETA) was added and the mixture kept at room
temperature, swirling occasionally, until viscous. The pellet was
removed by centrifugation at 40,000g for 1 hour in a Sorvall RC-5B
centrifuge. The supernatant was carefully decanted and retained.
Proteins and seme carbohydrates were then removed by extraction with
phenol. An equal volume of distilled phenol equilibrated against TES
buffer (lQmM Tris, lOmM NaCl, 0.0316irM EDTA) was added to the cleared
lysate and the two phases mixed gently. The phenol and aqueous
phases were then separated by centrifugation at 4,000rpm for 15
minutes in a Heraeus Christ Bactifuge. The upper aqueous phase was
removed using a wide bore pasteur pipette and retained. Following a
second phenol extraction, DNA was precipitated frcm the aqueous
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phase, by the addition of two volumes of cold absolute ethanol, the
tube being kept at -70°C for 30 minutes. The precipitated DNA was
recovered by centrifugation at 2,500rpn for 5 minutes and resuspended
in 0.5 ml TES buffer. The DNA sample was then analysed immediately
by agarose gel electrophoresis or stored at 4°C until ready for use.
DNA preparations of standard molecular weight plasmids were freshly
made and stored at 4°C for no longer than 1 week.
Agarose gel electrophoresis
Horizontal slab gel electrophoresis was performed by the method
of Meyers et al. (1976). Dor analysis of plasmid DNA 0.5% or 0.4%
agarose gels, of dimension 14cm x 25cm x 0.5cm, were made in a
Tris-borate buffer containing 89 mM Tris base, 2.5 mM disodium EDTA
and 89 mM boric acid (pH 8.2). The agarose was dissolved in the Tris-
borate buffer by steaming for 20 minutes and then cooled to 50°C
before pouring. Sample veils were made by use of a perspex slot
former with thirteen teeth, each 5 mm wide and spaced by 3 mm.
lOyal of a dye solution consisting of 0.025% bramophenol blue and
50% glycerol in water was mixed with 30pl of ethanol precipitated DNA
obtained from cleared lysates. The samples (total volume 40pl) were
loaded into the wells using a Gilson automatic pipettman (P200).
Electrophoresis was carried out in a plastic trough, of dimension
43cm x 25cm x 7cm. Tris-borate running buffer pH 8.2 was carefully
poured into the trough until both ends of the agarose gel were in
contact with the buffer being careful not to submerge the gel. The
samples were run from cathode bo anode. An initial voltage of 200V
was applied for 15 minutes to allow the DNA to enter the gel. The
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power was then switched off and enough running buffer was added to
completely cover the gel. The apparatus was then maintained at 4°C
and a voltage of 80V applied for 16 hours. Power was supplied by a
Vokam 500-150 power pack.
Follcwing electrophoresis the gel was carefully removed, placed
on a glass sheet, and immersed in distilled water containing ethidium
bromide at a concentration of 0.5 ^jgml""l for 30 minutes. The gel was
then counterstained in pure distilled water for 30 minutes, placed on
a long-wave UV light source (model Blak-Ray C-62, UV Products Ltd.)
and examined in the dark for fluorescence. The distance travelled by
the DNA through the gel is inversely proportional to the logarithm of
its molecular weight and plasmid molecular weights were calculated
accordingly.
Ethidium brcmide/caesium chloride density centrifugation
(by the method of Heffron et al., 1975)
3.64g of caesium chloride was dissolved in 3 ml sterile
distilled water containing 0.5 rngml-! ethidium bromide. Alcohol
precipitated DNA, dissolved in 0.5 ml TES buffer, was mixed with the
CsCl solution. The refractive index of the resulting solution was
measured using a refractometer (Bellingham and Stanley Ltd.) and
adjusted to 1.391 by the addition of sterile distilled water. The
gradient was formed by centrifugation in a Beckman ultracentrifuge at
96,000g for 65 hours at 18°C. After centrifugation, the tubes were
placed on a long wave UV light source and examined in the dark for
fluoresence.
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Preparation of DNA for restriction endonuclease digestion
Plasmid DNA for restriction endonuclease digestion was extracted
from bacteria by the method of Holmes and Quigley (1981). 4.5 ml of
nutrient broth was inoculated with a single bacterial colony taken
frcm a fresh agar plate. The culture was grown aerobically with
vigorous agitation in a Gallenkamp rotary shaker at 37°C overnight.
1.5ml of this overnight broth culture was poured into an Eppendorf
tube and centrifuged for 1 minute at 11,500g in an MSE Micro Centaur.
The remainder of the overnight culture was stored at 4°C. Following
centrifugation, the medium was removed with a pasteur pipjztette,
leaving the bacterial pellet as dry as possible. The cell pellet was
then resuspended in 0.35 ml of 8% sucrose in lOmM Tris-HCl (pH 8.0)
containing 50mM EDTA and 0.5% Triton X-100. 25pl of a freshly
prepared solution of lysozyme (lOmg/ml in lOmM Tris-HCl pH 8.0) was
added and the mixture vortexed for 3 seconds. The tube was then
placed in a boiling water bath for 40 seconds, to remove chromosomal
DNA, and immediately centrifuged at ll,500g for 10 minutes at roam
temperature in an MSE [Micro Centaur. Following centrifugation the
pellet was removed from the Eppendorf tube with a toothpick and
discarded. 40^ul of 2.5M sodium acetate and 0.42 ml of isopropanol
were then added to the supernatant. The resulting solution was mixed
by vortexing and stored for 15 minutes at -70°C. The precipitated
nucleic acids were then collected by centrifugation at ll,500g for 15
minutes at 4°C in an MSE Micro Centaur. The supernatant was
discarded and the pellet resuspended in 50pl of TE buffer (10 mM
Tris, 1 mM EDTA pH 8.0) containing DNase-free RNase (50 ugrnl-!)
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(Sigma Chemical Co.). The tube was then incubated for 10 minutes at
37°C to allow the RNase to act, resulting in the elimination of RNA
that can mask small fragments of DNA in agarose gels. This mini-
preparation containing 2-3 jxj of plasmid DMA. was stored at -20°C
until ready for use.
Restriction endonuclease cleavage of ENA
Twenty microlitres of the plasmid mini-preparation was removed
to a sterile Eppendorf tube. To this tube was added 2.2jil of the
appropriate enzyme buffer and 2 units of the desired restriction
enzyme. The tube was incubated for 1 hour at 37°C. Following
incubation the reaction was terminated by cooling to 4°C and the
addition of 15pl of a solution containing urea, 50% (w/v) sucrose,
50rtM EDTA and 0.1% bromcphenol blue (pH 7.0). The mixture was then
analysed on an agarose gel using as molecular weight markers, A ENA
treated vrLth Hind III (Murray and Murray, 1975).
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3. RESULTS
A. Investigations into the source of the Tp resistance gene
1. The role of the genus Klebsiella
Prior to the isolation of Tp R-plasnids, a significant number of
Klebsiella species were isolated which were resistant to lew levels
of Tp (Fruensgaard and Komer, 1974; Jobanputra and Datta, 1974;
Hamilton-Miller and Grey, 1975). In addition, a high proportion of
the first organisms isolated which harboured Tp R-plasmids were
Klebsiella spp. (Datta and Hedges, 1974), suggesting that this genus
might provide the origin of the plasmid Tp resistance gene and a
suitable environment for its evolution.
In order to test this hypothesis, the dihydrofolate reductase
(DHFR) produced by the original plasmid-containing Klebsiella strain
was investigated. As the original strain without a plasmid was never
found, the Klebsiella strain D770 containing the Tp R-plasmid, R389,
was studied. This strain was isolated in 1971, from a patient in the
St. Pancras Branch of University College Hospital, London (Fleming et
al., 1972) and was kindly supplied by Professor N. Datta. In
addition to Tp resistance, strain D770 possesses transferable
resistance to streptomycin (Sm), chloramphenicol (Cm), tetracycline
(Tc) and sulphamethoxazole (Sx), and non-transferable resistance to
ampicillin (Tip) (Datta and Hedges, 1972).
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(i) Elimination of plasmid R389 frcm Klebsiella sp. D770
In order to investigate the host dihydrofolate reductase, it was
first necessary to remove the Tp R-plasmid. Datta and Hedges (1972)
reported that the introduction of the inc W group R-plasmid, Sa, into
Tp resistant E. coli J62-2 transconjugant strains, harbouring plasnid
R389, resulted in the simultaneous loss of resistance to Tp, Sm, Sx
and Cm, while resistance to Tc was retained. Therefore R389 was
classified as an inc W group plasmid carrying resistance determinants
to Tp, Sx, Sn and Cm. Elimination of R389 from the original plasmid-
bearing Klebsiella sp. D770, designated Strain A, was attempted by
replica plating to select for colonies which had spontaneously lost
Cm resistance, and therefore, by definition, resistance to Tp. Tri¬
methoprim resistance was not used initially to test for the loss of
the plasmid as the prevalence of this resistance gene on a transposon
might result in just the loss of the transposon.
Strain A was grown overnight at 37°C in nutrient broth and
diluted 1 in 10^. 0.1 ml aliquots of the diluted culture were spread
on nutrient agar plates which were subsequently incubated overnight
to obtain single colonies. The single colonies were then replica
plated by the method of Lederberg and Lederberg (1952) onto
Diagnostic Sensitivity Test Agar (DSTA) plates and DSTA plates
containing Cm at a concentration of 10 mgL~l. Following overnight
incubation at 37°C the plates were examined for colonies which had
lost their resistance to Cm. Loss of Cm resistance occurred at the
very high frequency of 1 x 10~2 per cell, suggesting the spontaneous
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loss of an R-plasraid. Following purification on nutrient agar, the
Cm sensitive derivatives (D770Qns) were tested for simultaneous loss
of Tp resistance by streaking for single colonies on ESTA plates
containing Tp at a concentration of 1000 mgL~l. The results showed,
hcwever, that all of the D770Cms derivatives had retained high level
resistance to Tp.
(ii) The plasmid profile of Klebsiella sp. D770
Since Cm resistance was lost at high frequency from Strain A
without the simultaneous loss of Tp resistance, the possibility
exists that these resistance determinants are not present on the same
replicon within the original Strain A.
This theory was tested by conjugating Strain A for five hours
with the rifampicin resistant E. coli strain J62-2, selection being
made for the transfer of On and Tp resistance genes both separately
and together.
Table 5 Transfer of Tp and Cm resistance determinants from Strain A
(Klebsiella sp. D770(R389)) into E. coli J62-2
Conor Recipient Selection Transfer
frequency/
donor cell
Strain A J62-2 Tp 3.74 x 10-4
Cm 3.28 x 10-1
TpCm 1.95 x 10-4
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The results (table 5) show that the Cm resistance determinant
transfers at a much greater frequency than the Tp resistance
determinant, but that the Tp resistance gene is always accompanied by
the transfer of the On resistance gene. This would support the Datta
and Hedges (1972) hypothesis that R389 is a non-self-transferable Tp
R-plasmid which is mobilised by a second plasmid, shown here to carry
the Cm resistance determinant.
In order to confirm that two R-plasmids are present within the
original aonor (Strain A) and the Tp resistant transconjugants, the
DNA of these strains was extracted and analysed by agarose gel
electrophoresis by the method of Meyers et al. (1976). One litre
stationary phase cultures wsre harvested and lysed gently by
treatment with lysozyme, EDTA and Triton X-100. Proteins and some
carbohydrates were removed by phenol extraction of the cleared
lysates and alcohol precipitated DNA was then separated by
electrophoresis in 0.4% agarose. The results (figure 6) show that
both the donor and recipient strains possess several plasmids of
various molecular weights (MW). Unfortunately the plasmid bands
obtained for the original Klebsiella D770 strain (figure 6, track 5)
are not as clear as those obtained for the E. coli J62-2 recipient
(figure 6, track 6). This is a result of the mucoid nature of D770
and the inherent problems often encountered during lysis of this
organism. However, both strains can be seen to possess a plasmid of
30 Mdal (plasmid 1). Strain A also appears to possess two more
plasmids of 37 and 42 Mdal (plasmids 2 and 3). An additional faint
band of DNA at 33 Mdal is also present in this strain and represents
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Figure 6. Agarose gel electrophoresis of plasmids extracted from
Strain A (Klebsiella sr. D770(R389)) and E. coli J62-2
transconjugants selected on Tp containing plates.
Track 1, Rl; track 2, R15; track 3» KP^; track R6K;
track 5, plasmid profile of Strain A; track 6, plasmid
profile of J62-2 transconjugant strains.
Electrophoresis was in 0M% agarose at 80V for 16 hours.
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open circular forms of plasmid 1. The transconjugant E. coli J62-2
on the other hand, possesses a single very large plasmid of
approximately 70 Mdal in size. The size of this plasmid could only
be estimated approximately because of the inaccuracies which occur at
molecular weights greater than 60 million.
Determination of the resistance pattern of the Tp resistant
transconjugant revealed that Tc, 9m, Sx and Cm resistance genes had
also been transferred, suggesting that the 70 Mdal plasmid present
within this strain has probably resulted from recombination between
plasmids 2 arvd 3, present within the original host.
(iii) Physical analysis of the Qm sensitive derivative of Klebsiella
sp. D770
The high frequency of loss of Cm resistance from strain D770
suggests that loss of this resistance determinant may be due to
either the spontaneous loss of an R-plasmid, or the loss of a
resistance transposon. This was investigated by an examination of
the ENA of a purified D770Qns derivative. Cellular DMA. was extracted
and analysed by agarose gel electrophoresis as before. The results
(figure 7, track 5) show that the bands of DNA corresponding to
plasmids 1 and 2 are still present in this strain. However, no band
was observed corresponding to the 42 Mdal plasmid 3. The less well
defined open-circular form of plasmid 1 is again present. Loss of Cm
resistance appears, therefore, to be due to the spontaneous loss of
the 42 Mdal plasmid 3.
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Figure 7. Agarose gel electrophoresis of plasmids extracted from
Cm sensitive derivatives of Strain A (Klebsiella sp. D770Cms)
and E. coli J62-2 transconjugants selected on Tp
containing plates.
Track 1, Rl; track 2, R15; track 3. RF^; track 4, R6K;
track 5, plasmid profile of Klebsiella sr. D770CmS;
track 6, plasmid profile of J62-2 transconjugant strains.
Electrophoresis was in O.^f-% agarose at 80V for 16 hours.
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In order to determine whether plasmid 3 encodes any of the other
D770 resistances, On sensitive derivatives of D770 were tested for
resistance to Srn, Sx, Tp and Tc by streaking onto DSTA plates
containing these drugs. The results indicated that Tc resistance was
the only other resistance determinant carried by this plasnid since
all On sensitive derivatives vere new Tc sensitive but had retained
their resistances to Tp, Sm and Sx.
Since the Tp R-plasmid had been shown previously to be mobilised
by the Cm R-plasmid, the Cm sensitive derivative (D770Cms) was tested
for its ability to transfer Tp resistance. Fbllowing 18 hours
incubation of the D770Cms donor with an E. coli J62-2 recipient
transfer of the Tp resistance determinant was measured and shown to
occur at a frequency of 2.6 x 10~4 per donor cell. Thus it would
appear that the Cm R-plasmid is not an absolute requirement for the
mobilisation of R389, although in its presence the transfer frequency
Ji
of the Tp resistance determinant is seen to increase IO fold to 2.96
per donor cell, during an 18 hour mating.
Analysis of the DNA of this J62-2 Tp resistant, Cm sensitive
transconjugant by agarose gel electrophoresis revealed the presence
of only two DNA bands corresponding to the covalently closed circular
plasmids 1 and 2 (figure 7, track 6). Comparison of these results
with those previously obtained for the E. coli Tp resistant, Cm
resistant transconjugant indicate that the large MW plasmid observed
in the On resistant strain is no longer present when Cm resistance
and the 42 Mdal plasmid (plasmid 3) are lost. Hence, it is likely
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that this large plasmid is indeed formed as a result of recombination
between plasmids 2 and 3.
(iv) Selection of Tp sensitive derivatives of Klebsiella sp» D770
A 10~6 dilution of an overnight broth culture of Klebsiella
strain D770Cm^ was spread on nutrient agar plates as described
previously. Single colonies were subsequently replica plated onto
DSTA plates and DSTA plates containing Tp at a concentration of 1000
mgL~l. Loss of Tp resistance new occurred at a frequency of 3 x 10~3
per cell which was similar to the spontaneous loss of a plasmid.
Following purification on DSTA, three of the spontaneous Tp sensitive
derivatives were tested for the simultaneous loss of resistance to Sm
and Sx. In addition, the minimum inhibitory concentration (MIC) of
Tp was determined as described in the Materials and Methods. The
results showed that all three Tp sensitive derivatives had retained
resistance to both Sm and Sx but had reduced their MIC of Tp to 1
mgL~l.
The transfer frequencies of the Sm and Sx resistance deter¬
minants were calculated following an 18 hour mating of the Tp
sensitive D770 derivative with E. coli J62-2. Tne transfer
frequencies at 4.2 x 10~4 per donor cell for the Sm resistance gene
and 3.7 x 10-^ per donor cell for the Sx resistance gene were similar
to those obtained for the Tp resistance determinant of R389 when the
D770Cm^ derivative was used as a donor in a similar mating.
Since Sm and Sx resistances had been retained and were still
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transferable the DNA of the Tp sensitive derivatives was analysed by
the method of Meyers et al. (1976) in order to determine the plasmid
content of the cell. After separation of the cellular DNA by
electrophoresis in 0.4% agarose two bands of plasmid ENA were found
to be present corresponding to MWs of 30 million (plasmid 1) and 32
million (figure 8, track 5). These results suggest therefore, that
loss of Tp resistance has resulted in the loss of a 5 Mdal fragment
of DNA from the original 37 Mdal of plasmid 2. The high frequency of
loss of Tp resistance coupled with the reduction in MW of plasmid 2
suggests that resistance to Tp may have been lost frcm this strain as
a result of the spontaneous loss of a Tp resistance transposon,
confirming the original uncertainty about the use of Tp resistance
loss as a marker for the loss of the plasmid.
Therefore, a Tp sensitive derivative of Klebsiella strain D770
had now been prepared and was taken to represent the original strain
lacking the Tp resistance determinant. This strain, designated
Strain B, was employed in further investigations.
(v) Mutation to Tp resistance of the Tp sensitive derivative of
Klebsiella sp. D770
In order to determine whether the Klebsiella D770 chromosomal
DHFR is a precursor of the Tp R-plasmid DHFR it was necessary to
mutate the Tp sensitive derivative, Strain B, to high level Tp
resistance. An overnight culture of Strain B, grown in nutrient
broth, was harvested and resuspended in 0.1 volume of EM base. 0.1
ml of this ten times suspension was then spread onto EM plates
99-
Figure 8. Agarose gel electrophoresis of plasmids extracted from
Cm sensitive, Tp sensitive derivatives of Strain A
(Klebsiella su. D7?0CmsTpS).
Track 1, Rl; track 2, R15; track 3» R?^; track 4, R6K;
track 5, plasmid profile of Klebsiella sp. D770CmsTpS.





containing Tp at a concentration of 100 mgL~l. However, no Tp
resistant colonies ware found on any of the plates, even after
incubation at 37°C for three days.
Since mutation to high level Tp resistance could not be
demonstrated in Strain B, there remained the possibility that the
acquisition of Tp resistance required the presence of an additional
factor. In view of the fact that most of the early lp R-plasmids
isolated belonged to incompatibility group W, it is conceivable that
the presence of an incompatibility W group plasmid within strain B
may provide the additional information required to promote mutation
of this strain to Tp resistance. The inc W plasnid Sa, which does
not carry the Tp resistance gene but possesses resistance to an, Sx,
On and kanamycin (Km), was therefore, chosen as a suitable candidate
to test as the promoter of mutation to Tp resistance.
Plasmid Sa was introduced into Strain B by mating with E. coli
J53(Sa). The transfer frequency was 2.9 x 10~7 per donor cell in an
18 hour mating. This frequency was lew so the identity of the
recipient was checked thoroughly by purifying on EM plates devoid of
added amino acids but containing either Cm or Km, resistance to both
of which are carried by Sa but were not present in Strain B. The
recipients grew well on these plates whereas no growth of the E. coli
J53(Sa) donor strain was observed. In addition, the physical
presence of Sa was confirmed by extracting the DNA from the trans-
conjugant and subsequently analysing it on a 0.4% agarose gel by
electrophoresis. Tne results (figure 9, track 5) show the presence
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Figure 9- Agarose gel electrophoresis of plasmids extracted from
Strain B (Klebsiella sr. D770(Sa)TpS).
Track 1, Rl; track 2, R15; track 3> RP4-; track 4-, R6K;
track 5, plasmid profile of Strain B.










of an additional plasmid band in this strain corresponding to a MW of
23 million, similar to that reported for Sa (Gorai et al. 1979).
Tp resistant mutants of Strain B, harbouring Sa, were again
selected for on EM plates containing Tp at concentrations of 100
mgL~l and 1000 mgL~l as described previously. Ibis time colonies
resistant to 100 mgL-1 Tp were detected. The mutation frequency was
calculated by dividing the viable count obtained from an overnight
broth culture on MacConkey medium by the number of resistant colonies
which grew on EM medium containing Tp, and found to be 1.56 x 10~8.
However, no resistant colonies grew on plates containing 1000 mgL"l
Tp. Bellowing purification of the Tp resistant colonies on EM plates
containing Tp at 100 mgL-1, a further selection was made for mutation
to 1000 mgL~"l Tp resistance. Mutation to this level of Tp occurred
at a very low frequency of 7.07 x 10~H. These high-level Tp
resistant mutants (Strain C) were then purified and tested for their
ability to transfer Tp resistance.
Strain C was employed as a donor in an 18 hour mating with
E ■ coli strain J62-2. Selection was made for the transfer of Km and
Tp resistance determinants both separately and together in order to
determine whether the mutation to Tp resistance had occurred on
plasmid Sa. The Km resistance gene was found to transfer at a
frequency of 2.8 x 10"^ per donor cell. However, no transfer of the
Tp resistance determinant was detected suggesting that plasmid Sa had
promoted a chromosomal mutation to high-level Tp resistance.
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(vi) Isolation and purification of Klebsiella EHFRs
In order to determine whether mutation of the Tp sensitive
Klebsiella, Strain B, to Tp resistance was due to the production of a
'new' dihydrofolate reductase (DHFR), the enzyme frcm the resistant
mutant, Strain C, was isolated and purified by a modified method of
Amyes and Smith (1974a) as described in the Materials and Methods.
The DHFRs from the original Tp R-plasmid containing strain, Strain A,
and the Tp sensitive derivative Strain B were also isolated and
purified, in order that the DHFR of Strain C could be compared with
both the R-plasmid enzyme (ie. Strain A enzyme) and the original
chromosomal enzyme (ie. Strain B enzyme).
Ten litre exponential phase cultures of each organism, grown in
EM minimal medium, were harvested by centrifugation and lysed at 4°C
in the French Press. Nucleic acids were removed by precipitation
with streptomycin sulphate. NADPH oxidase activity was then
precipitated by dialysis against a 50% saturated solution of ammonium
sulphate. The pellet was removed by centrifugation. DHFR activity
was then precipitated by further dialysis against an 80% saturated
solution of ammonium sulphate. Following centrifugation, the
supernatant was discarded. The pellet containing the DHFR activity
was then resuspended in a minimum volume of 50 itM sodium phosphate
buffer (pH 7.4) containing 1 rrM EETA and 10 mM /5-mercaptoethanol
(buffer A). Further purification of the DHFRs was then achieved by
Sephadex exclusion chromatography by the method of Pattishall et al.
(1977).
1C&.
The 50-80% pellet, resuspended in buffer A, was applied to a
Sephadex G-75 superfine column (2 cm2 x 90 cm). Sephadex G-75 super¬
fine was employed, as opposed to ordinary Sephadex, to obtain better
separation of the resistant and sensitive enzyme peaks. In contrast
to the observations of Amyes and Smith (1976), Pattishall et al.
(1977) reported the complete separation of R-plasmid and chromosomal
encoded enzymes by gel filtration on Sephadex G-75. This was
achieved by reducing the flow rate of the column buffer frcm 30 mlh~l
to less than 5 mlh~l. The flow rate of the'Sephadex G-75 superfine
column was therefore adjusted to between 6 and 8 mlh~l. DHFR
activity was eluted with buffer A at 4°C. 2 ml fractions ware
collected and then assayed for DHFR activity by the method of Osborn
and Huennekens (1958), in the presence and absence of 4 x 10"% Tp, a
concentration sufficient to abolish the activity of the chromosomal
enzyme. This allowed the identification of peaks of Tp-resistant and
Tp-sensitive DHFR.
DHFR activities and protein concentrations were assayed through¬
out the purification procedure. The purification tables for each
enzyme show that about ten times more DHFR was recovered from both
the Tp R-plasmid containing Strain A (Table 6) and the Tp resistant
mutant Strain C (Table 8) than with the Tp sensitive Strain B (Table
7) following gel filtration. In addition the level of purification
of the DHFR from Strain B was about 5 times lower than that achieved
for the other tvro enzymes.
The enzyme profiles, obtained following gel filtration, for the
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DHFRs encoded by each of the three Klebsiella strains (figure 10)
show marked differences. The Tp R-plasmid containing Strain A was
found to produce two separate enzyme peaks eluting at fractions 43
and 51 (figure 10a). When assayed in the presence of 4 x 10"^4 Tp
the peak eluting at fraction 43 was found to be resistant and thus
represents the plasmid encoded enzyme. On the other hand, the enzyme
eluting at fraction 51 was abolished at this concentration of Tp and
must therefore represent the Tp sensitive chromosomal DHFR. In
addition the enzyme profiles indicate that the chromosomal determined
enzyme of Strain A is produced at two-thirds of the level of the R-
plasmid mediated enzyme. The Tp sensitive derivative, Strain B, on
the other hand, showed a single peak of DHFR activity eluting at
fraction 52 (figure 10b). This peak represents the Tp sensitive
chrcmosomally mediated enzyme of this strain since DHFR activity was
completely abolished when assayed in the presence of 4 x 10~^1 Tp.
Analysis of the enzyme profile of Strain C again shows marked
differences to the Strain A and Strain B enzymes. A large prominant
peak of Tp sensitive activity was found to elute at fraction 49
(figure 10c). In addition a slight shoulder of Tp sensitive activity
was also observed at fraction 51. The relative quantities of Tp
sensitive DHFR, represented by the areas under each enzyme curve,
reveals that Strain C produces approximately twD and a half times
more Tp sensitive DHFR than Strain A, which in turn produces about
ten times more than Strain B.
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Figure 10. Elution of DHFR activities of Klebsiella Strains A, B
and C on Sephadex G-75 superfine gel filtration.
a = Strain A (Klebsiella sr. D770(R*389) ); b = Strain B
(Klebsiella sr. D770(Sa)Tp ); c = Strain C (Klebsiella sr.
D770(Sa)TpR).
Total DHFR activity, O; DHFR activity in the presence of




(vii) Molecular Weight of DHFR coded by Klebsiella spp.
The molecular weight (MW) of each enzyme was estimated by
repetition of Sephadex gel filtration in the presence of standard MW
marker proteins. Crude enzyme preparations were prepared as before.
The 50-80% ammonium sulphate pellet was resuspended in buffer A and
mixed with 50 mg quantities of cytochrome c, chymotrypsinogen and
ovalbumin, before applying to the Sephadex G-75 superfine column.
The logarithm of the MW is proportional to the ratio of the elution
volume (Ve) to the void volums (Vo) ie. Ve/Vo (Andrews, 1964). The
ratio was found for each of the three molecular weight marker
proteins ard this value was plotted against the logarithm of the MW.
The results (figure 11) show that each strain produces a chromosomal,
Tp sensitive DHFR of slightly varied MW. The chromosomal enzymes
frcm Strains A ard B have MWs of 21400 ard 20000 respectively. These
MWs agree, within experimental error, with those found previously for
E. coli chromosomal DHFRs (Amyes and Smith, 1976). On the other
hand, the enzyme produced by Strain C has a MW of 24300. This value
is somewhat higher than those previously reported for chromosomal
DHFRs produced by bacteria. However, the enzyme profile of Strain C
also showed a slight shoulder of activity which corresponds to a MW
of 21300, a similar value to that obtained for Strain A. It is
therefore possible that Strain C may be producing a second DHFR of
24300 daltons in addition to the normal host DHFR of 21300 daltons.
The Tp resistant enzyme of Strain A, eluting at fraction 43,
corresponds to a MW of 35500 which agrees well with previous reports
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Figure 11. The molecular weight of DHFR as measured by gel
filtration on Sephadex G-75 superfine.
Strain A = Klebsiella sr. D770(R389); Strain B = Klebsiella
sr.D770(Sa)Tp^; Strain C = Klebsiella sp. D770(Sa)Tp^.
LOGARITHM MOLECULAR WEIGHT
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for the Type I and Type II R-plasmid determined enzymes (Amyes and
Smith, 1976; Pattishall et al., 1977).
(viii) Inhibition of DHFR activity by trimethoprim
The most distinguishing feature between the chromosomally
mediated DHFRs and the Type I and Type II R-plasmid enzymes is their
susceptibility to Tp. The concentration of Tp required to achieve
50% inhibition of the activity (ID5Q) of the R-plasmid encoded enzyme
of Strain A and the two chromosomal enzymes of Strains B and C was
measured. Partially purified enzyme preparations obtained from gel
filtration vrere assayed for DHFR activity in the presence of
increasing concentrations of Tp. The results (figure 12) show that
the enzyme encoded by R389 (ie. plasmid 2 of Strain A) is highly
resistant to Tp with an ID50 of 80,000^ (obtained by extrapolation).
This value is similar to those previously reported for Type II DHFRs
(Pattishall et al., 1977). Thus R389 appears to encode a Type II
DHFR.
The drug-sensitive chromosomal enzyme of Strain B is inhibited
by 50% in the presence of 0.02)-M Tp. Again this result is in
agreement with the published values for Tp sensitive E. coli
chromosomal enzymes (Broad and Smith, 1982). However, the enzyme
produced by Strain C has an ID50 for Tp of 0. . This enzyme is
hence 25 times more resistant to Tp than the original host
chromosomal enzyme of Strain B.
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Figure 12. Trimethoprim inhibition of partially purified DHFR from
Klebsiella Strains A, B and C.
Strain A (Klebsiella sr. D770(R389)). • ; Strain B
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(ix) Inhibition of DHFR activity at 45°C
Although the relative insusceptibility to Tp of the R389
mediated enzyme indicates that it should be classified as a Type II
enzyme, the level of production of this enzyme suggests a similarity
to Type I DHFRs (Pattishall et al., 1977). In order to distinguish
the R389 encoded enzyme further, its heat sensitivity was measured.
The partially purified enzyme preparation, described earlier, was
maintained at 45°C. At various tine intervals samples were withdrawn
and assayed for DHFR activity as described. The temperature
inactivation curve (figure 13) shows that the R389 enzyme retains
100% of its activity after 4 minutes of incubation at 45°C. This
result is in agreement with those obtained previously for Type II
enzymes (Tennhammar-Ekman and Skold, 1979; Broad and Smith, 1982).
Similar heat inactivation curves were plotted for the enzymes
produced by Strains B and C. The chromosomal enzyme of Strain B was
also found to be heat stable, a characteristic also associated with
E. coli Tp sensitive, chromosomal enzymes (Amyes and Smith, 1976;
Itennhammar-Ekman and Skold, 1979; Broad and Smith, 1982). However a
significant difference in the behaviour of the chromosomal enzyme of
Strain C was observed. In contrast to previous reports for bacterial
DHFRs, the activity of this enzyme was increased over three fold on
heating at 45°C. Thus, the mutant chromosomal DHFR appears not only
to be heat stable but in addition is activated by heating at 45°C.
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Figure 13. Heat sensitivity of partially purified. DHFR from
Klebsiella Strains A, B and C.
Strain A (Klebsiella sp. D770(H389))» • ; Strain B
(Klebsiella sr. D770( Sa)TrS), O ; Strain C (Klebsiella
sp. D770(Sa)TpR), ■
3-0-1




2. The role of Escherichia coli and incompatibility W group plasmids
The inc W group plasmid R388 was the first R-plasmid found to
confer Tp resistance. It was detected in a pathogenic E. coli strain
isolated from a patient in St. Pancras Branch, University College
Hospital, London (Fleming et al., 1972). Prior to the isolation of
R388, only two other widely used inc W plasmids had been isolated, Sa
conferring resistance to Cm, Sm, Sx and Km (Watanbe et al., 1968) and
R7K conferring resistance to Sm and Ap (Coetzee et al., 1972).
Electron microscope heteroduplex studies (Gorai et al., 1979) and
physical and genetic analysis (Ward and Grinsted, 1982) of these
three inc W plasmids have shown them to exhibit a high degree of
genetic conservation in their replication and transfer regions, while
their antibiotic resistance genes appear to have been acquired either
by transposition or by sane other mechanism. However, restriction
enzyme maps of Sa and R388 (Ward and Grinsted, 1982) show that these
two plasmids share some degree of horology within their resistance
genes. Therefore, the relationship between Sa and R388 was examined
to determine vhether R388 is directly derived from Sa.
(i) Purification of DHFR frcm E. coli J53(Sa)
The enzyme dihydrofolate reductase (DHFR) indirectly plays an
important role in many biosynthetic pathways including the synthesis
of nucleic acids. Since plasmids are autonomously replicating DNA
molecules it seems possible that even those not carrying Tp
resistance determinants may encode the production of DHFRs.
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Therefore, plasmid Sa was investigated for its ability to produce a
DHFR which may be related, in some way, to the Tp resistant R388
encoded enzyme.
E. coli strain J53(Sa) was grcwn in 10 litres of EM medium to
logarithmic phase. Enzyme extracts were prepared, in buffer A, as
described in the Materials and Methods. Partial purification of the
enzyme was performed by a modification of the method of Amyes and
Smith (1974a) as described previously. Further purification was
achieved by Sephadex exclusion chromatography by the nethod of
Pattishall et al, (1977). Fractions were collected and assayed both
in the presence and absence of 4 x 10"% Tp to determine whether an
additional Tp resistant DHFR had been produced. DHFR activities and
protein concentrations were assayed throughout the purification
procedure. Following gel filtration 8.7% of the enzyme was recovered
and the level of purification was 30.95 (Table 9). These values are
similar to those obtained by Amyes and Smith (1976) for the E. coli
114 enzyme.
The enzyme profile following gel filtration (figure 14) shows
that a single peak of DHFR activity eluted which was completely
abolished when assayed in the presence of Tp. The molecular weight
of this enzyme was determined by repetition of gel filtration in the
presence of the standard molecular weight markers, cytochrome c,
chymotrypsinogen and ovalbumin. The size of the DHFR was then
estimated and found to be 23400 daltons. This value of 23400 daltons
is slightly greater than those previously reported for Tp sensitive
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Figure 14. Elution of DHFR activity of E. coli J53(Sa) on Sephadex
G-75 superfine gel filtration.
Total DHFR activity, o ; DHFR activity in the presence
-6




E. coli chromosomal enzymes (Amyes and Smith, 1978). However, this
discrepancy may be due to the use of Sephadex G-75 superfine which
permits a finer resolution of proteins compared with ordinary
Sephadex G-75.
In order to confirm that this 23400 dalton DHFR is indeed the
chromosomally encoded enzyme of strain J53 the enzyme from an E. coli
J53 strain devoid of plasmid Sa was similarly purified and applied to
Sephadex G-75 superfine along with standard molecular weight marker
proteins. Again a single peak of Tp sensitive DHFR activity was
found to elute (figure 15) corresponding to a MW of 22400. Strain
J53 therefore encodes a DHFR of MW approximately 23000.
The results, so far, suggest that plasmid Sa does not encode its
own DHFR. However, it is still possible that an enzyme of similar MW
to the chromosomal enzyme may be being produced in very low amounts,
its presence remaining undetected due to the presence of the
chromosomal enzyme. A second attempt was therefore made to detect a
plasmid encoded enzyire by mutating the J53(Sa) strain to Tp
resistance in the hope of inducing the production of a Tp resistant,
Sa encoded, DHFR.
(ii) Mutation to Tp resistance of E. coli J53(Sa)
Before mutation of strain J53(Sa) to Tp resistance was attempted
the minimum inhibitory concentration (MIC) of Tp on EM medium for
this strain was determined and found to be 0.1 mgL~l. Mutation of
J53(Sa) to high level Tp resistance was then achieved by sequential
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Figure 15. Elution of DHFR activity of E. coli J53 on Sephaaex
G-75 superfine gel filtration.
Total DHFR activity, O ; DHFR activity in the presence





subcultures of J53(Sa) on EM plates containing increasing concen¬
trations of Tp.
Strain J53(Sa) was grcwn to stationary phase at 37°C in nutrient
broth. The cells vere harvested, washed in EM base and resuspended
in the same volume of EM base. 0.1 ml amounts of the undiluted
culture vrere then spread on suitably supplemented EM plates
containing Tp at a concentration of 1.0, 5.0 and 10.0 mgL~l. A
viable count of the overnight broth culture was also made on
MacGonkey agar so that the mutation frequency to Tp resistance could
be determined. The results (table 10) show that mutation to 5.0
mgL~l Tp resistance occurred at a frequency of 5.4 x 10-10.
Table 10 Tp resistance mutation frequency by E. coli J53(Sa)
The mutation frequency shown is the viable count obtained from an
overnight culture on MacGonkey agar divided by that obtained on EM
medium containing Tp at the concentrations listed.












Mutant colonies were purified on EM plates containing 5.0 mgL~l Tp.
These mutants (J53(Sa)Tp5R) were then grown as before in nutrient
broth, harvested, washed and resuspended in EM base. 0.1 ml amounts
of the undiluted culture were spread on EM plates containing Tp at
concentrations of 10, 20, 40 and 100 mgL~l. Colonies resistant to 40
mgL~l Tp occurred at a frequency of 7.23 x 10~9 (table 10), but no
colonies grew on the Tp 100 mgL~l plate. Following purification, the
J53(Sa)Tp40R mutants were further subcultured as before onto EM
plates containing Tp at concentrations of 100, 200, 400, 600, 800 and
1000 mgirl. Mutation to Tp 1000 mgL~l was found to occur at a
frequency of 2.91 x 10~9 (table 10). Thus J53(Sa) appears to mutate
easily to high level Tp resistance (ie. MIC >1000 mgL~l), the
mutations occurring during three sequential subcultures.
The final mutant, designated J53(Sa)TplKR, was then checked both
for the continued presence of plasmid Sa, and for its auxotrophic
requirements. A 1 in 10^ dilution of an overnight culture was used
to inoculate ESTA plates containing 9m, Cm, Sx and Km (the four
resistance determinants carried by Sa) and EM plates lacking either
proline or methionine (the two J53 auxotrophic requirements). Good
growth occurred on plates containing each of the drugs listed but no
growth was observed on plates lacking either of the two amino acids.
Thus J53(Sa)TplKR has retained both Sa and its requirements for
proline and methionine.
In order to determine whether the mutation to Tp resistance has
occurred on plasmid Sa or within the bacterial chromosome, strain
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J53(Sa)TplKR was conjugated with E. coli strain J62 for five hours
and selection was made for the transfer of Tp and Qn resistance
determinants both separately and together. The results showed that
Cm resistance transferred at a frequency of 1.13 x 10~2 per donor
cell but that Tp resistance was non-transferable. Thus the mutation
to Tp resistance appears to have occurred within the chromosome of
J53.
(iii) Mutation to Tp resistance of E. coli J53
The results of the experiments with Klebsiella sp. D770 suggest
that the presence of Sa within this strain promotes a chromosomal
mutation to high level Tp resistance. In order to determine whether
Sa is promoting a similar mutation in E. coli J53 the above mutation
procedure was repeated with a J53 strain devoid of plasmid Sa.
The MIC of Tp on EM medium for E. coli J53 was determined
initially and found to be 0.1 mgL-l, a value similar to that obtained
for J53(Sa). E. coli J53 was then subcultured in the same way as
strain J53(Sa), on suitably supplemented EM plates containing
increasing concentrations of Tp. The results (table 11) show that
like J53(Sa) strain J53 also mutates to high level Tp resistance in
three sequential steps. In addition the mutation frequencies at each
stage are similar to those obtained with the plasmid containing
strain. Therefore, the presence of plasnid Sa in strain J53 does not
appear to be a prerequisite for the mutation of this strain to Tp
resistance.
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Table 11 Tp resistance mutation frequency by E. coli J53
Hie mutation frequency shown is the viable count obtained from an
overnight culture on MacConkey agar divided by that obtained on EM
medium containing Tp at the concentrations listed.
Bacterial Strain Cone. Tp Mutational frequency
mgL~l
J53 5 6.00 x 10-10
J53Tp5R 40 8.26 x 10"9
J53Tp40R 1000 9.71 x 10~9
(iv) Mutation to Tp resistance of B. coli J62 and E. coli J62(Sa)
The results of the previous two sections indicate that E. coli
J53 is able to mutate easily to high-level Tp resistance. In order
to determine whether this phenomenon is unique to strain J53 or is
applicable bo other E. coli K-12 strains, the ability of strain J62
to mutate to Tp resistance was investigated. In addition a J62
strain containing plasmid Sa was also examined. The MIC of Tp on EM
medium for both the original J62 strain and a plasmid containing
transconjugant was determined as before and found to be 0.8 mgL~l,
slightly higher than the J53 strains. Each J62 strain was then grown
in nutrient broth, harvested, washed and spread on suitably
supplemented EM plates containing increasing concentrations of Tp.
However, no growth occurred on plates containing Tp at concentrations
greater than 0.4 mgL~l, the mutation frequency of both strains to Tp
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5.0 mgL 1 resistance being less than 10 Thus the ease with which
J53 is able to mutate to Tp resistance is associated with this strain
only and is not a property of E. coli K-12 strains in general.
(v) The resistance mechanism of E. coli J53TplKR and E. coli
J53(Sa)TplKR
Previous reports of chromosomal mutations to Tp resistance in E.
coli strains have indicated that the most common mechanism involves
the over-production of the normal Tp sensitive DHFR (Burchall and
Hitchings, 1968; Breeze et al., 1975; Sheldon and Brenner, 1976).
However, several reports have suggested that some Tp resistant
mutants of E. coli K-12 may cwe their resistance to the production of
a mutant DHFR vdiich has a slightly decreased affinity for Tp
(Sheldon, 1977; Poe et al., 1979). In order to determine which
mechanism was responsible for the high levels of resistance observed
here, the DHFRs frcm both the J53 Tp resistant mutants (J53TplKR and
J53(Sa)TplKR) and the original Tp sensitive strain, J53(Sa), were
isolated and characterised.
Ten litre exponential phase cultures of each organism, grown in
EM medium, were harvested and lysed in the French Press. The lysate
was cleared by high speed centrifugation and the specific activity of
DHFR in all three extracts measured in sodium phosphate buffer pH
6.0. The results (table 12) show that the DHFR of both the Tp
resistant mutants is produced in much greater quantity, approximately
ten times the amount, than the original Tp sensitive DHFR. However,
despite the increased production of DHFR in these mutant strains, the
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level of enzyme produced is not sufficient to explain the increase in
MIC of Tp of the organism from 0.1 mgL"~l to greater than 1000 mgL~l.
Table 12 The specific activity of EHFR in crude extracts of E. coli
J53(Sa), E. coli J53(Sa)TplKR and E. coli J53 TplKR
The specific activity is expressed in nmoles dihydrofolate being con¬
verted per minute per mg protein in a 1.0 ml volume assay.




In order to characterise the DHFRs produced by the resistant
mutants, partially purified enzyme preparations were made by the
modified method of Amyes and Smith (1974a). Further purification was
achieved by sephadex gel filtration on Sephadex G-75 superfine by the
method of Pattishall et al. (1977). The purification tables for each
enzyme (tables 13 and 14) show that the levels of recovery and
purification of these resistant DHFRs were slightly lower than those
obtained for the original J53(Sa) chromosomal enzyme (table 9).
Following elution of the enzymes with buffer A, fractions were
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assayed for DHFR activity both in the presence and absence of 4 x
10~% Tp. Both strains showed the presence of a single enzyme peak
(figure 16). However, in contrast to the original J53 Tp sensitive
enzyme, the enzymes produced by J53TplKR and J53(Sa)TplKR were
resistant to 4 x 10~%1 Tp and showed maximum activity when assayed in
its presence (figure 16). The enzyme from J53TplKR also showed an
additional shoulder of activity eluting in fraction 65 (figure 16b).
(vi) Molecular weight of CHER coded by E. coli J53TplKR and E. coli
J53(Sa)TplKR
The molecular weights of the two resistant enzymes were then
estimated. Further ten litre exponential cultures of the resistant
strains wsre prepared as before. Partially purified samples were
then mixed with standard molecular wsight marker proteins and applied
to a Sephadex G-75 superfine column as before. The molecular weights
of the "Ip resistant DHFRs were then estimated and found to be 22400
for the J53TplKR enzyme and 22600 for the J53(Sa)TplKR enzyme. These
values are similar to those obtained for the original Tp sensitive
chromosomal enzymes of strains J53 and J53(Sa). The additional
shoulder of Tp resistant DHFR activity from strain J53TplKR was
present again and corresponds to a MW of 16000.
Thus it would appear that both J53TplKR and J53(Sa)TplKR owe
their resistance to the over production of a DHFR encoded by the




Figure 16. Elution of DHFR activities of E. coli J53(Sa)TplK and
p
E. coli J53TplK on Sephadex G-75 superfine gel filtration.
a = E, coli J53(Sa)TplKR; b = E. coli J53TplKR.
Total DHFR activity, O ; DHFR activity in the presence




(vii) Inhibition of DHFR activity by trimethoprim
In order to characterise and compare the resistant and sensitive
enzymes further, the extent of their resistance to Tp was determined.
The enzyme produced by strain J53(Sa) was taken to represent the Tp
sensitive chromosomal mediated DHFR of E. coli J53 and was used for
further characterisation. This enzyme will be referred to as the
J53(Sa)Tps enzyme.
FoHewing sephadex gel filtration, fractions containing DHFR
activity vere pooled. The pooled fractions were than assayed in
increasing concentrations of Tp at pH 6.0 and the concentration
required to give 50% inhibition (ID^q) of each enzyme was determined.
The inhibitor profiles of the two Tp resistant mutant enzymes were
almost identical (figure 17), the activity being directly
proportional to the logarithm of the Tp concentration. The ID5Q for
the J53TplKR DHFR was 89 and for the J53(Sa)TplKR enzyme 63 jiA.
These values are similar to those reported by Pattishall et al.,
(1977) for the Type I plasmid encoded DHFRs. The Tp sensitive
chromosomal enzyme on the other hand has an ID50 of 0.08 juM. This
value is similar to those obtained by Amyes and Smith (1978) for E.
coli K-12 chromosomal enzymes. Thus it would appear that the mutant
enzymes are 1000 times more resistant to Tp compared with the
original J53 enzyme.
Since the enzymes from both resistant mutants appear to be
produced in similar amounts and are equally resistant to Tp it was
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Figure 17. Trimethoprim inhibition of partially purified DHFR from
E. coli J53(Sa), E. coli J53TplKR and E. coli J53(Sa)TplKR.
E. coli J53(Sa), O ; E. coli J53TplKR, • ;
E. coli J53(Sa)TplKR, □ .
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assumed that the resistance mechanism of both mutants was similar.
Therefore, further characterisation of only one of the resistant
enzymes was performed, namely the DHFR produced by strain J53TplKR.
(viii) Inhibition of DHFR activity by methotrexate
The activity of the J53(Sa)Tps and J53TplKR DHFRs was reassayed
in the presence of increasing concentrations of methotrexate. This
was done to determine whether the mutation in strain J53TplKR to
resistance to Tp - a 2,4-diaminopyrimidine - also manifested
resistance to 2,4-diaminopteridine derivatives. The inhibition of
both the Tp sensitive and Tp resistant enzymes by methotrexate gave
linear responses when activity was plotted against the logarithm of
methotrexate concentration (figure 18). The ID50 °f the Tp sensitive
enzyme with methotrexate was 6.6 rM which is in good agreement with
the published values for E. coli chromosomal enzymes (Amyes and
Smith, 1976, 1978; Pattishall et al., 1977). The ID50 °t
methotrexate with the Tp resistant enzyme of J53TplKR on the other
hand was 71 nM indicating that this enzyme is about ten times less
susceptible to the 2,4-diaminopteridine. Therefore, the mutation in
the DHFR gene has resulted not only in a greatly decreased affinity
of the enzyme for Tp, but also a slight decrease in its affinity for
msthotrexate.
(ix) Michaelis-Menten kinetics of DHFRs
Previous reports have shown that Tp R-plasmid determined DHFRs
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Figure 18. Methotrexate inhibition of partially purified DHFR from
E. coli J53(Sa) and E. coli J53TplKR.
E. ccli J53(Sa) TpS DHFR, O ; E. coli J53TplKR DHFR, •
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have a slightly higher affinity for the primary substrate
(hihydrofolate) than E. coli Tp sensitive, chromosomally encoded
enzymes (Amyes and Smith, 1976, 1978). Fran the ID50 experiments the
Tp resistant enzyme of mutant J53TplKR appears to be behaving in a
similar way to Type I R-plasmid determined enzymes. Therefore, this
enzyme was examined to determine if it, too, showed a similar higher
affinity for dihydrofolate (DHF).
The partially purified J53TplKR and J53(Sa)Tps enzymes were
reassayed under conditions of partial saturation with DHF and the
results analysed by the method of Lineweaver and Burk (1934) to
determine the Km valves.
The results (figure 19) show that, in the absence of Tp, a
linear response was obtained by plotting the reciprocal of the
substrate concentration (1/s) against the reciprocal of the rate of
the enzymic reaction (1/v) and hence the enzymes obey
Michaelis-Menten kinetics at pH 6.0 and 30°C. The intercept on the
abscissa gives the negative of the reciprocal of the Michaelis
constant (Km), the Km value being the substrate concentration at
which half the maximal velocity occurs (Dixon and Vfebb, 1958). The
Km values for the two enzymes ware determined and found to be 1.3 x
10~^1 with DHF for the Tp sensitive J53 enzyme and 3.0 x 10~% with
DHF for the Tp resistant J53TplKR enzyme. Thus the Tp resistant
enzyma does have a slightly higher affinity for DHF than the Tp
sensitive enzyme.
So far the most striking difference between these two enzymes
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Figure 19* Lineweaver-Burk plots of the Tp and. Tp DHFRs from
E. coli J53(Sa) and E. coll J53TplKR.
The reciprocal of the substrate concentration (DHF)(l/s)
is plotted against the reciprocal of the DHFR activity
(1/v). Tp concentrations: No Tn, • ; 4 x 10"^ M Tp,A ;
A- x 10*8M Tp, ■ ; 2 x 10"5M Tp, A ; 4 x lO'^M Tp, □ .
1/s (x104M)"1
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appears to be in their affinity for trimethoprim. This would
suggest, therefore, that the inhibitor constants (Ki) of the enzymes
should differ substantially. Hence, the activity of the Tp sensitive
DHFR was assayed as before in the presence of 4 x 10~% and 4 x 10~%1
Tp, to determine the kinetic effects of the drug. The double
reciprocal plots of 1/v against 1/s, in the presence of Tp, both
intercept the ordinate at the same position (figure 19a). This
intercept was also that obtained in the absence of Tp. This
indicates that Tp inhibition of this enzyme is competitive with
respect to DHF as the maximum rate is unaffected. However, the plots
in the presence of Tp intercept the abscissa nearer the origin than
the uninhibited slope. If the distance to the origin from the
intercept is - 1/Kp:
Km
where i is the concentration of the inhibitor (Dixon and Webb, 1958).
The Ki values obtained for the two Tp concentrations used were 1.05 x
10~% and 2.3 x 10~%1 with a mean value of 6.4 x 10~%, indicating
that the inhibitor bound firmly to the enzyme.
The purified Tp resistant J53TplKR DHFR was also assayed at
various limiting DHF concentrations with two relatively high
concentrations of Tp. The results (figure 19b) show that a linear
response was obtained and these intercepted the ordinate at the same
position observed in the absence of Tp. Thus this enzyme, though
resistant to Tp, is also inhibited competitively by the drug. The Ki
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values at 2.0 x 10""% and 4.0 x 10~% Tp wore calculated as before
and values of 1.13 x lO'^M and 6.32 x 10~% were obtained
respectively. The mean Ki value of Tp was hence 8.81 x 10~® for the
J53TplKR Tp resistant enzyme. Thus this enzyme has a very low
affinity for Tp with a mean Ki value approximately 1000 times greater
than the Tp sensitive J53 enzyme. This matches the difference
between the respective ID50S for Tp.
(x) pH profile of DHFRs .
Pattishall et al. (1977) and Amyes and Smith (1978) have shown
that there are significant differences between the pH profiles of E.
coli chromosomal DHFRs and the Type I and Type II R-plasmid encoded
enzymes. VJiereas the R-plasmid Tp resistant enzymes exhibit distinct
peaks of activity between pH 5.5 and 6.5, the Tp sensitive DHFRs show
a broad spectrum of activity over almost the complete pH range of 5.0
to 9.0.
The pH profiles of both the Tp sensitive and Tp resistant J53
enzymes were determined. The pooled fractions of each enzyme after
gel filtration were assayed at pH values between 5.0 and 9.0. Sodium
acetate buffer was employed for pH's from 5.0 to 5.5, sodium
phosphate buffer for pH's from 6.0 to 8.0 and Tris-HCl buffer for
pH's 7.5 to 9.0. Controls were performed at each pH value tested to
correct for decreases in the absence of the enzyme. The results
(figure 20) show that the two enzymes differ significantly in their
pH profiles. The Tp sensitive enzyme exhibits a broad range of
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Figure 20. The pH activity curve for the Tp and Tp DHFRs from
E. coli J53(Sa) and E. coli J53TplKR.
The activity of DHFR is expressed as a percentage of the
maximum activity at pH 6.0.
The buffers employed were sodium acetate,# ; sodium
phosphate, O ; Tris-HCl, ■ .
pH
141.
activity over the complete pH range tested (figure 20a). When
assayed in the presence of sodium phosphate buffer there appear to be
two small peaks of enzyme activity at pH 6.0 and 7.5. However, the
percentage activity over the entire pH range remained above 65% which
is similar to the profiles obtained for other chromosomal DHFRs
(Baccanari et al., 1975; Pattishall et al., 1977; Amyes and Smith,
1978).
Tne pH profile of the Tp resistant J53 DHFR, on the other hand,
was very different. A sharp peak of activity was observed at pH 6.0
(figure 20b) which is characteristic of the Type II plasmid encoded
enzymes (Pattishall et al. , 1977). However, an anomalously high
result was obtained when this enzyme was assayed in sodium acetate
buffer pH 5.0. Over three times the activity was recorded at this pH
compared with pH 6.0. Nevertheless, with the exception of this
anomaly, the pH profile of this Tp resistant enzyme bears
considerable resemblance to those previously reported for plasmid
encoded DHFRs.
(xi) Substrate profile of DHFRs
The natural substrates for E. coli DHFR have been reported to be
NADPH and DHF (Burchall and Hitchings, 1965). However, these authors
also showed that NADH was about 25% as efficient as NADPH, as the
reductant for DHF. They found that folic acid could not, however, be
substituted for DHF, in the presence of either NADH or NADPH.
Subsequently Amyes and Smith (1978) showed that R-plasmid mediated
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enzymes exhibit no detectable activity when NADH is substituted for
NADPH, or when folic acid is substituted for DHF.
The two DHFRs from E. coli J53 were therefore, assayed using
NAM instead of NADPH and substituting folic acid for DHF. The
enzyme preparations used were the partially purified DHFRs following
gel filtration. Unlike the previous reports, no DHFR activity could
be detected when NADH or folic acid were substituted for the natural
substrates. Hence, both the Tp resistant and Tp sensitive enzymes of
J53 appear to be specific for the substrates DHF and NADPH.
(xii) Inhibition of DHFR activity at 45°C
The temperature sensitivity of each of the partially purified
enzyme preparations was measured. Each preparation was maintained at
45°C. At various time intervals samples were withdrawn and assayed
for DHFR activity as described. Both enzymes were found to be
relatively stable on heating at 45°C, each retaining 60% of its
activity following 4 minutes of incubation at this temperature.
These results are typical of both the Type II R-plasmid encoded
enzymes and the Tp sensitive chromosomally mediated DHFRs of E. coli
strains (Amyes and Smith, 1978; Tennhammar-Ekman and Skold, 1979;
Broad and Smith, 1982).
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B. The continuing evolution of the Tp resistance gene
During routine isolation of strains from the Orthopaedic Unit of
Edenhall Hospital, near Edinburgh, it was revealed that a surge of Tp
resistance was occurring within the Gram negative rods isolated from
urine specimens. This highly resistant bacterial population, when
further investigated, was shown to consist of both strains which
possessed R-plasmids and were able to transfer their Tp resistance
and strains which appeared to be devoid of R-plasmids and were unable
to transfer their resistance (Amyes et al., 1982). The diversity of
Tp resistance exhibited by this bacterial population suggested that a
detailed examination of these isolates might serve to illustrate the
spread and evolution of the Tp resistance gene, both on R-plasmids
and on resistance transposons, within clinical isolates.
1. Genetical Analysis
(i) Tp resistance within clinical isolates
Clinical strains isolated from urinary tract infections were
kindly supplied by the Central Microbiology Laboratories, Edinburgh,
on MacConkey agar plates. Each strain was cultured overnight in
Oxoid No. 2 broth. The cultures were diluted 1 in 10^ in EM base and
spotted, as described in the Materials and Methods, onto DSTA plates
containir*g Tp at 0, 10, 100 and 1000 mgL~l. The results (table 15)
show that an unprecedented 64% of the isolates were insusceptible to
Tp at a concentration of 10 mgL~l and of these 39.8% were resistant
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to 1000 mgL~l Tp. A relatively low percentage (45%) of the resistant
isolates vere'E. coli and subsequently a much larger proportion were
Klebsiella, Proteus and Pseudomonas species.
i
Table 15 Percentage of isolates resistant to trimethoprim
Species MIC of Tp (rngL-1)
10 100 1000 >1000
E. coli 18.0 6.5 7.0 13.5
Klebsiella spp. 12.5 4.5 8.5 4.5
Proteus spp. 5.5 5.0 3.0 4.0
Pseudomonas spp. 0.0 0.0 3.5 3.5
Aercmonas spp. 0.0 0.5 0.0 0.0
A representative sample of those organisns with minimum
inhibitory concentrations (MIC) of Tp of 100 mgL~l or more were
examined in detail for the presence of Tp R-plasmids. Each strain
was grcwn in nutrient broth and conjugated for 5 hours with the
rifampicin resistant E ■ coli K-12 strain J62-2. Trimethoprim
resistant recipients ware selected on suitably supplemented EM plates
containing rifampicin and trimethoprim. If no transfer occurred, the
mating incubation was increased to 18 hours. A total of 15 strains
were shown to transfer Tp resistance (table 16).
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Table 16 Number of strains resistant to high levels of trimethoprim
Species MIC of Tp (mgir^)
100-1000 >1000
tra- tra+ tra- tra+
E. coli 40 34
Klebsiella spp. 50 33
Proteus spp. 14 24
Pseudcmonas spp. 50 40
tra = non-transferable
tra+ = self-transferable
Eleven of these strains had characteristic MICs of Tp greater than
1000 mgL-l. However, the other four strains, all of which were
identified as Proteus spp., had MICs of Tp of only 100 mgL-l.
Although the level of Tp resistance in these Proteus isolates was
low, transfer of the R-plasanids to the standard E. coli J62-2 strain
was accompanied by an increase in the level of Tp resistance, to
greater than 1000 mgL~l in the transconjugant strain.
In addition to those strains exhibiting self-transferable Tp
resistance, a large number of organisms were found to possess high-
level (MIC >1000 mgirl)r non-transferable Tp resistance. These
isolates v&re subsequently investigated for the presence of trans-
posons in the chromosome.
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(ii) Characterisation of R-plamsids
The resistance patterns were determined for each of the Tp
R-plasmids isolated. The Tp resistant transconjugant strains were
grown in nutrient broth and diluted 1 in 10^ in EM base. The diluted
cultures were then inoculated onto D5TA plates containing various
drugs at the concentrations listed in the Materials and Methods. The
plates were incubated overnight at 37°C. The results (table 17) show
that five different resistance patterns were exhibited by the
R-plasmids.
Table 17 Characterisation of Trimethoprim R-plasmids









In addition, the molecular weights of the R-plasmids were determined.
R-plasmid DNA was extracted from each of the E. coli transconjugant
strains by the method of Meyers et al. (1976) as described in the
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Materials and Methods. Alcohol precipitated DNA was then analysed by
agarose gel electrophoresis. The results (table 17) show that there
was a minimum of seven different plasmid types present within the
Gram negative rods isolated from these urine specimens, because some
plasmids of the same resistance pattern were of different sizes.
(iii) Extraction of Tp resistance transposons from clinical
R-plasmids
The diversity of R-plasmids indicates that the spread of Tp
resistance was not manifested by a single R-plasmid. Thus a
representative sample of six R-plaanids were subsequently
investigated for the presence of transposons carrying Tp resistance.
The conjugation experiments involved in the detection of two
transposons are summarised in table 18. The kanamycin (Km) resistant
inc P group plasmid, RP4, was employed as a vector for the
identification of Tp resistance transposons that may be present in
the Tp R-plasmids.
RP4 was introduced into standard E. coli J62-2 strains, each
harbouring a different R-plasmid, during a 5 hour rating as described
sVe.<ps
in the Materials and Methods (table 18^). Selection was made on
suitably supplemented EM plates for J62-2 recipients of plasmid RP4.
The transconjugants were purified on the same medium and were then
subcultured twice in nutrient broth in the absence of antibiotic
selection pressures, to allcw any transposition events to take place.
The purified J62-2 transconjugants wsre then used as donors in a
subsequent mating with E. coli strain J53. Tne mating was for 5





















































































hours and selection was made for the transfer of Tp and Km resistance
determinants both separately and together. The transfer frequencies
for the individual Tp and Km resistance genes differed from those
obtained when selection was made for the two resistances together
Step3 fc>
(table 18A) • This indicates that the Tp and Km resistance
determinants are transferring independently of each other. However,
a single colony, isolated from the Tp/Km plate and purified on the
sane medium, was subsequently used as a donor in a further one hour
mating with strain J62. The transfer frequencies of the Tp and Km
resistance genes ware again measured, both separately and together.
steps c
The results (table 18^) showed that the transfer frequency of each
resistance determinant was new similar to that obtained vhen
selection was made for the two resistance genes together. This
indicates that the Tp resistance determinant is now transferring with
the Km resistance gene and hence suggests that the Tp resistance gene
has transposed into RP4.
In order to confirm that the plasmid RP4 is indeed present in
these transconjugants, purified Tp/Km resistant J62 strains were
tested for their sensitivity to phage PR4 which is specific for
plasmids of inc groups P, N and W. Each organism was taken from a EM
plate containing Tp and Km and streaked onto a nutrient agar plate.
A concentrated preparation of phage PR4 was spotted onto each plate
and these were then incubated overnight at 37°C. The presence of RP4
was confirmed if a clear zone of bacterial lysis had occurred at the
area of inoculation with PR4. In each case lysis was observed.
Strains of J62-2 containing the original clinical plasmids were also
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tested and showed no lysis with phage PR4 indicating that none of the
original plasraids belong to inc groups P, N or W.
Each Tp/Km resistant transconjugant was also tested for the
simultaneous acquisition of the To and Ap resistance determinants
that are also determined by KP4. Each strain was grcwn in nutrient
broth and diluted 1 in 104 in EM base. The diluted cultures were
then inoculated onto DSTA plates containing the appropriate
antibiotics, at a concentration of 10 mgL~l, with a multiple
inoculator. In every case, all three RP4 resistances were present in
addition to Tp.
Finally, the Tp resistant transconjugants were examined for the
physical presence of plasmid DNA. DNA was extracted from the cells
by the method of Meyers et al. (1976) and analysed by electrophoresis
in 0.5% agarose gels. In each case only one covalently closed super-
coiled band of plasnid DNA was detected, indicating the sole presence
of plasmid RP4.
Tp resistance transposons were extracted frcm each of the six
clinical plasmids investigated. These transposons were originally
given the designations TnGB4-TnGB9 but have now been re-classified as
Tn4129-Tn4134 (table 19).
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Table 19 Clinical plasmids and their transnosons
Clinical plaanid Transposon
No. Resistance Size No. Former
(Mdal) Designation
PUK179 TpApSm/SpSxCeTc 39.8 Tn4129 TnGB4
PUK217 TpApSx 28.8 Tn4130 TnGB5
pUK218 TpApSx 28.8 Tn4131 TnGB6
pUK163 TpApSx 38.9 Tn4132 TnGB7
ptJKl73 TpAp 25.0 Tn4133 TnGB8
PUK176 TpApSm/SpSx 40.1 Tn4134 TnGB9
(iv) Extraction of Tp resistance transposons from the chromosome of
clinical strains
Organisms with high level (MIC >1000 mgL~l), non-transferable Tp
resistance viere investigated for the presence of transposons located
in the chromosome. Preliminary experiments revealed that 8 of the 11
strains were resistant to a wide variety of antimicrobials including
those carried by plasmid RP4. It was thus impossible to use RP4, or
other commonly-used standard plasmids as vectors for any transposons
present. Hence, only three organisms, E. coli strains E7 and E27 and
Proteus sp. E16, were further investigated.
Each of the three clinical isolates was examined initially for
the presence of plasmid DNA. DMA was extracted by the method of
Meyers et al. (1976) and separated by electrophoresis in 0.5% agarose
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gels. However, no plasmid DNA could be detected by this procedure.
The Tp resistance gene was then extracted from the chromosome of
each of these organisms employing KP4 as the plasmid vector. The
conjugation experiments and results for the clinical isolate E. coli
strain E27 are shown in table 20. Plasmid RP4 was introduced into
the clinical strains during an 18 hour mating (table 20a) and similar
conjugation experiments were performed as before. After the
introduction of RP4 into the clinical strains, the transconjugants
were purified and then subcultured twice in nutrient broth in the
absence of antimicrobial drugs to allow transposition to occur.
Plasmid RP4 was then transferred into the rifampicin resistant E.
coli strain J62-2 during a 5 hour mating, and selection was made for
the transfer of the Tp and Km resistance determinants. Tp resistance
now appeared to transfer but at a lower frequency than the Km
resistance determinant of RP4 (table 20b). This suggests that the Tp
resistance gene in some of the donor cells has been mobilised by
plasmid RP4.
A transconjugant taken from a Tp containing selection plate was
purified on the same medium and then used as a donor in a further 5
hour mating with strain J53. Selection was again made for the
transfer of Tp and Km resistance genes. The results (table 20c)
showed that the transfer frequencies of both resistance determinants
were now identical indicating that transposition of the Tp resistance
gene into RP4 had taken place.
Table20Extractionofthpresis ancegenfromchro somef.liE27 STEPDONORRECIPIENTTRANSCDNJUGANTS L CTIONRANSFER
FREQUENCY/ DONORCELL
aJ53(RP4)E.coli27 bE.coli27(RP4)J62-2 cJ62-2(RP4::Tn4126)53
E.coli27(RP4)Km1.3x0-2 J62-2(RP4::Tn4126)Tp1.8x0-6 Km4.1x10-3 J53(RP4::Tn4126)Tp4.x10-3 Km3.2x10-3
15+.
This transposition event was confirmed using the same criteria
as before. Each purified Tp resistant transconjugant was shown to be
sensitive to phage PR4, resistant to both Tc and Ap in addition to Tp
and Km and gave a single plasmid band when analysed by agarose gel
electrophoresis.
Tp resistance transposons were extracted from the chromosome of
each of the clinical isolates examined, and vore designated Tn4126,
Tn4127 and Tn4128 (former designations: TnGBl, TnGB2 and TnGB3
respectively).
(v) Characterisation of the Tp resistance transposons
Characterisation of the Edenhall transposons reported here
initially involved the determination of their resistance pattern. E.
coli J62 strains harbouring plasmid RP4 containing the transposons
were grown aerobically in nutrient broth for 5 hours. Each culture
was then diluted 1 in 10^ in EM base and inoculated onto DSTA plates
containing a range of antibacterial drugs. E. coli strain J62 with
and without the original plasmid vector RP4 was used as a control.
The results showed that the only resistances present in addition to
those carried by RP4, were Tp resistance and in some strains Sm and
Sp resistance. The MICs of these three drugs were then determined
for each strain. The results (table 21) suggest the presence of two
different transposons within this bacterial population. The three
transposons Tn4126, Tn4127 and Tn4128 extracted from the chromosome
of strains E27, E7 and E16 respectively, confer resistance to both Tp
155.
Table 21 Antibacterial resistance levels conferred by transposons
Organism Minimum inhibitory concentration
(mgL~l)
Hp Sm Sp
J62 1 4 10
J62(RP4) 1 4 10
J62(RP4::Tn4126) >1000 40 200
J62(RP4::Tn4127) >1000 40 200
J62(RP4::Tn4128) >1000 40 200
J62(RP4::Tn4129) >1000 40 200
J62(RP4::Tn4130) >1000 40 200
J62(RP4::Tn4131) >1000 40 200
J62(RP4::Tn4132) >1000 8 20
J62(RP4::Tn4133) >1000 8 20
J62(RP4::Tn4134) >1000 8 20
156.
ana Sm/Sp. Similarly transposons Tn4129, Tn4130 and Tn4131 extracted
from plasmids pUKl79, pUK217 and pUK218 also carried resistance to
Sm/Sp in addition to Tp. However, the three transposons Tn4132,
Tn4133 and Tn4134, extracted from plasmids pUK163, pUK173 and pUK176
were shown to possess resistance to Tp alone, with MICs of Sm and Sp
of 8 mgL~l and 20 mgL-^- respectively.
(vi) Molecular characterisation of the transposons
In order to determine the size of the transposons, the molecular
weight (MW) of plasmid RP4 was measured by agarose gel electro¬
phoresis, both before and after transposition of Tp resistance genes
into the plasmid had taken place. Plasmid DMA was prepared by the
method of Meyers et al. (1976) and separated by electrophoresis in
0.5% agarose gels. The position of the plasmids was compared with
those of the standard plasmids, Sa (23 Mdal), R6K (26 Mdal), R15 (40
Mdal) and R1 (62 Mdal), which wsre run concurrently (figures 21a, b).
The MW of plasmid RP4 and RP4 transposon containing derivatives were
then estimated (Table 22). The increase in MW of KP4 represents the
size of the Tp resistance transposons.
The three chromosomal transposons, Tn4126, Tn4127 and Tn4128
each measured 9 Mdal in size (figure 21a, tracks 5, 6, 7). Similar
sizes of 8 Mdal were calculated for Tn4129, Tn4130 and Tn4131 (figure
21b, tracks 9, 10, 11). These six transposons each carry a
resistance determinant to Sm/Sp in addition to Tp and would therefore
appear to be similar to the veil characterised TpSn/'Sp resistance
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Figure 21a. Agarose gel electrophoresis of RB^ derivatives containing
transposons extracted from the chromosome of clinical
strains.
Track 1, Sa and Rl; track 2, Sa; track 3» R15>
track 4, RP^; track 5f RP^: 11^126; track 6, RF4:: Tn4l27;
track 7, RP^::Tn^l28.
Electrophoresis was in Q.tfo agarose at 80V for 16 hours.
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Figure 21b. Agarose gel electrophoresis of RP4 derivatives containing
transposons extracted from clinical R-plasmids.
Track 1, RP4-: :Tn4l32; track 2, RP4-:: Tn4l33; track 3,
R3?4::Tn4l34; track If, R15; track 5» Rl; track 6, Sa;
track 7, R6K; track 8, RPA-; track 9. RP^: :Tn4l29;
track 10, RP4: :Tn^l30; track 11, RF4: :Tn4l31.
Electrophoresis was in 0.5fo agarose at 80V for l6 hours.
SIZE
(Mdal)
1 2 3 4 5 6 7 8 9 10 11
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transposon Tn7 (Barth et al., 1976).














Transposons Tn4132, Tn4133 and Tn4134, however, carry the single
resistance determinant to Tp and, when present in plasmid RP4, give
quite different results from those obtained for the other six
transposons (figure 21b, tracks 1, 2, 3). Plasmid RP4 harbouring
Tn4134 showed only a small increase in the MW of RP4 (figure 21b,
track 3), the size of the insertion being calculated as 2 Mdal. In
contrast, RP4::Tn4133 derivatives showed a similar decrease of about
2 Mdal in the size of RP4 (figure 21b, track 2). RP4::Tn4132
derivatives, on the other hand, showed no change in the MW of RP4
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(figure 21b, track 1).
Previous reports have shown that insertion of transposons into
RP4 may cause small deletions of RP4 at the site of insertion (Barth
et al., 1978; Datta et al. , 1979; McGombie et al., 1983). This
phenomenon may therefore explain the result obtained for RP4::Tn4132
derivatives. Insertion of Tn4132 into RP4 may have resulted in a
small deletion of about 2 Mdal in the size of RP4. It is
conceivable, therefore, that Tn4132 may be of a similar size to
Tn4134. However, if the size of Tn4133 were to be explained by this
deletion event, a deletion of approximately 4 Mdal would have to have
occurred. This amount represents a relatively large proportion of
RP4 and, therefore, the similarity of these three transposons was
further investigated by restriction enzyme digestion of the RP4
transposon containing derivatives.
(vii) Restriction enzyme analysis of transposons
Plasmid DNA was prepared by the method of Holmes and Quigley
(1981). Each preparation was digested for one hour with the
restriction endonuclease Hind III, under the conditions recommended
by the Boehringer Corporation Ltd. The reaction was terminated by
cooling to 4°C and the simultaneous addition of the recommended 'stop¬
ping buffer'. Restricted fragments were then analysed immediately on
0.5% agarose gels run at 140 volts for three and a half hours.
The results (figure 22, tracks 1, 2, 3) show that the RP4
derivatives containing transposons Tn4132, Tn4133 and Tn4134 have
l6l.
Figure 22. Agarose gel electrophoresis of RP4 and RF4 transposon
containing derivatives after digestion with the
restriction endonuclease Hind III.
Track 1, RF4:: Tn^+132; track 2, RP^+: :Tn^l33; track 3,
RP^::Tn4l34; track 4, RP4: :Tn4l29; track 5, RP^f-: :Tn4l30;
track 6, RF4: :Tn4l31; track 7» RP^+j track 8, A DNA after
digestion with Hind III.
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identical restriction endonuclease digest patterns. A total of seven
fragments vere present^ in each of these plasmid derivatives. When
the original plasmid RP4 was digested with Hind III, a single band of
DNA was observed (figure 22, track 7), confirming that RP4 has only
one restriction site for this enzyme. The large number of fragments
present in the RP4 transposon derivatives suggests, therefore, that
either these transposons have several restriction sites for this
enzyme, or, more probably, that the transposons have inserted into
RP4 at multiple sites.
The sizes of the smaller fragments were estimated by comparison
with those obtained for lambda DNA following digestion with Hind III
(figure 22, track 8) (Murray and Murray, 1975). The fragment sizes
were 1.65 Mdal, 2.2 Mdal, 3.3 Mdal, 4.1 Mdal, 5.7 Mdal and 8.8 Mdal.
The MWs of some of the larger fragments suggest that some of them may
possibly have been formed as a result of oligimerisation of smaller
fragments, for example, the fragment corresponding to a MW of 3.3
million may be a result of dimerisation between two 1.65 Mdal
fragments.
In order to compare the relatedness of the small transposons
with Tn4129, Tn4130 and Tn4131, RP4 derivatives containing these
transposons were similarly digested with Hind III. The results
(figure 22, tracks 4, 5, 6) shew that each derivative gives rise to
five restriction fragments. Three of the fragments are present in
each of the three plasmid derivatives and correspond to MWs of 1.65,
2.0 and 3.3 million. The other two fragments, which are considerably
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larger, differ in size between each plasmid derivative. Digestion of
RP4 containing the 9 Mdal TpSm/Sp resistance transposon, Tn7, with
Hind III is kncwn to give rise to two small fragments and two much
larger fragments (Eatta et al., 1979). If the 3.3 Mdal fragment
present in the digests performed here is assumed to be a dimer of the
1.65 Mdal fragment, then the transposons Tn4129, Tn4130 and Tn4131
may be classified as Tn7-like Tp resistance transposons. The
different sizes of the larger fragments are due to the insertion of
each transposon into a different site on RP4.
A comparison of the digest patterns obtained for each of the six
RP4 transposon containing derivatives suggests that the smallest 1.65
Mdal fragment of Tn7 may be present in all six transposons, implying
that the large and small transposons may be related, the small
transposon comprising of only a fraction of the large transposon.
It should be noted that summation of the molecular weights of
the fragments obtained for each digestion does not correspond to the
MW of the RP4 transposon derivative. This may be explained by the
inability to measure the size of the larger fragments, since
fragilents of molecular weights of greater than about 8 million are
unable to be assigned an accurate molecular size by this method
(Grinsted et al., 1977).
(viii) Mutation to Sm/Sp resistance of the small transposons
An examination of the resistance patterns of the original
clinical R-plasmids harbouring both large and small transposons
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revealed that two of the plasmids, pUK217 and pUK218, from which
TpSm/Sp resistance transposons had been extracted, did not express
Sm/Sp resistance in the original plasmid (table 19). In addition,
plasmid pUKl76, which does express Sm/Sp resistance, possessed a
transposon conferring resistance to Tp alone (table 19). It, there¬
fore appears that under certain conditions the Sm/Sp resistance genes
of plasmids are not expressed. For this reason, the ability of the
small Tp resistant transposons to mutate to Sm/Sp resistance was
investigated in order to determine if these genes are also present
within the smaller transposons.
Overnight nutrient broth cultures of the three E. coli J62
strains possessing plasmid RP4 harbouring the transposons Tn4132,
Tn4133 and Tn4134 were harvested and resuspended in the same volume
of IM base. 0.1 ml of the washed cultures was then spread on DSTA
plates containing either Sm (20 mgL~l) or Sp (100 mgL~l). A viable
count of each culture was also made on MacConkey agar plates. In
addition, similar cultures of E. coli J62 and E. coli J62(RP4) were
treated in the same way and acted as controls. The plates were
incubated overnight at 37°C and then examined for the presence of
resistant colonies. The ratio of the viable count on MacGonkey agar
to that on plates containing either Sm or Sp vras taken as the
mutational frequency. The results (table 23) show that strains
harbouring transposons Tn4132, Tn4133 and Tn4134 mutate at a
frequency of about 4 x 10~7 to Sm/Sp resistance. This frequency of
mutation is at least 100 times greater than that observed with J62
and J62 harbouring RP4. The presence of these transposons within the
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Table 23 Sm resistance and Sp resistance mutation frequency by
strains carrying Tn4132, Tn4133 and Tn4134
The mutation frequency shown is the viable count obtained frcm an
overnight culture on MacConkey agar divided by that obtained on DSTA
plates containing 20mgL~l Sm or 100mgL-l Sp.
Bacterial Strain Mutation frequency
Sm Sp
J62 <1.0 x 10"9 <3.0 x 10~9
J62(RP4) 2.8 x 10"9 <3.0 x 10~9
J62(RP4::Tn4132) 2.5 x 10~7 8.6 x 10"7
J62(RP4::Tn4133) 4.2 x 10-7 7.4 x 10-7
J62(RP4::Tn4134) 4.8 x 10-7 1.1 x 10~7
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bacterial cell appears, therefore, to increase the frequency of
mutation to Sm/Sp resistance.
In order to determine whether this mutation had occurred on the
bacterial chromosome or on plasmid RP4, the Sm/Sp resistant mutants
were purified on D5TA containing both drugs and used as donors in a
one hour mating with E. coli strain J53. Selection was made for the
transfer of Tp, 3m and Km resistance determinants, both individually
and in combination with each other. The results (table 24b) show
that 3m resistance is transferable and hence that the mutation is not
chromosomally located. The transfer frequencies of the Tp and Sm
resistance determinants measured both separately (table 24a, b) and
together (table 24c) appear to be identical, indicating that both
these resistance determinants are being transferred together.
However, the transfer frequency of the Tp and Km resistance
determinants when measured together (table 24f) is significantly
lower than the values obtained when selection is made for the
transfer of each resistance gene separately (table 24a, d), implying
that the Tp and Km resistance determinants are no longer transferring
together. In addition, the transfer frequencies of the 9m and Km
resistance determinants, when measured both separately (table 24b, d)
and together (table 24e) differ significantly and this would suggest,
therefore, that the mutation to Sm resistance has occurred within the
Tp resistance transposon rather than on RP4. These mutated
transposons will be referred to as Tn4132*, Tn4133* and Tn4134*
throughout the remainder of this thesis.
167.
Table 24 Transfer of Tp, Sm and Km resistance determinants from the
transposon containing E. coli J62 Sm/Sp resistant mutants
to E. coli J53
Step Donor Recipient Selection Transfer frequency/
donor cell
a J62(RP4::Tn4132)* J53 Tp 5.4 X
1
o1—1
b Sin 5.0 X 10"4
c TpSm 3.6 X 10"4
d Km 3.3 X 10~3
e KmSm 4.6 X 10~5
f KmTp 3.8 X 10~5
g TpSmKm 3.2 X MO
1 Ln
a J62(RP4::Tn4133)* J53 Tp 2.8 X 10"3
b Sm 3.4 X 10-3
c TpSm 4.4 X 10~3
d Km 3.8,.X 10-3
e KmSm 5.3 X 10-5
f KmTp 4.3 X 10-5
g TpSmKm 6.5 X 10-5
a J62(RP4::Tn4134)* J53 Tp 3.1 X 10~3
b Sm 1.0 X 10~3
c TpSm 1.5 X 10~3
d Km 2.9 X 10~3
e KmSm 6.7 X 10"5
f KmTp 4.0 X 10~5
g TpSmKm 1.6 X 10"4
* represents a Sm resistant, Sp resistant derivative.
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(ix) RP4-independent transfer of the mutated transposons
The results of the transfer experiments (table 24) indicate that
following mutation of the J62(RP4) transposon containing derivatives
to Sm/Sp resistance, the Tp resistance transposons are no longer co-
transferring with the Km resistance gene on plasmid RP4. Hie
differences in transfer frequencies of these two resistance
determinants, however, may not be indicative of the independent
transfer of KP4 and the transposons. That is to say, the transposons
may still be transferring on KP4, but in some instances insertion of
the transposon into RP4 may have resulted in the 'switching off' of
some or all of the RP4 resistance determinants. Hiis hypothesis was
tested by determining the proportion of Tp resistant strains which
express the RP4 resistance determinants, ie. resistance to Ap, Tc,
and Km. Transconjugants selected on Tp containing plates were
purified. Overnight broth cultures were diluted 1 in 10® and 0.1 ml
amounts of the diluted cultures were spread on DSTA plates containing
each of the drugs at concentrations of 10 mgL~l. The results (table
25) indicate that approximately 8% of transconjugants harbouring
transposon Tn4132*, 5% harbouring Tn4133* and only 3% harbouring
Tn4134* express resistance to Tc, Ap and Km.
Those strains, which do not exhibit the RP4 determined
resistances, ware then examined physically to determine if they still
possessed RP4 even though its genes are not being expressed. The DNA
was extracted frcm the Tp resistant Km sensitive transconjugants and
analysed by the method of Meyers et al. (1976).
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Table 25 Percentage of Tp resistant transconjugants resistant to Km,
Ap and Tc
Percentage resistant strains
Strain Tp Km Ap Tc KmApTc TpKmApTc
J53(RP4::Tn4132*) 100 10.0 10.0 7.9 7.9 8.6
J53(RP4::Tn4133*) 100 6.7 6.1 5.6 5.2 4.7
J53(RP4::Tn4134*) 100 3.2 2.4 2.6 2.6 2.5
However, no plasmid DNA could be detected by this method. In
addition, each transconjugant was also tested for sensitivity to
phage PR4 as described previously. All three transposon containing
strains wsre found to be resistant to this phage. Taken together
these results suggest that the Tp resistance transposons in these
transconjugants are new present within the bacterial chromosome as
opposed to the plasmid RP4.
From these results it would appear that the transposons have
transferred on RP4, but that on entry into the recipient cell the
transposon has immediately inserted into the bacterial chromosome
with the simultaneous loss of RP4 from the majority of the
recipients. In order to confirm the presence of the transposon
within the bacterial chromosome, Tp resistant strains which had been
shown to be devoid of plasmid DNA by agarose gel electrophoresis,
were employed as donors in a one hour mating with E. coli strain J62.
Selection was made for the transfer of Tp resistance. The results
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(table 26), however, indicate that Tp resistance is still
transferable, the transfer frequency of Tp for each strain being
about 1 x 10"3 per donor cell.
Table 26 Transfer of the Tp resistance determinant from E. coli J53
strains harbouring transposons Tn4132*, Tn4133* and Tn4134
Conor Recipient Transconjugant Selection Transfer
Frequency/
Donor Cell
J53(Tn4132*) J62 J62(Tn4132*) Tp 1.1 x 10-3
J53(Tn4133*) J62 J62(Tn4133*) Tp 1.5.x 10"3
J53(Tn4134*) J62 J62(Tn4134*) Tp 8.4.x 10-4
These results suggest, therefore, that the transposons Tn4132*,
Tn4133* and Tn4134* are able to transfer independently of a plasmid
vector. However, it is possible that agarose gel electrophoresis may
not have detected the presence of an extremely large plasmid within
the donor cell and therefore, to exclude this possibility, a further
test was made to ensure that no plasmid DNA was present within the
donor strain.
A one litre stationary phase culture of the donor strain
J53(Tn4133*) was harvested and the EMA extracted as before. Alcohol
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precipitated DNA was then subjected to caesium chloride density
gradient centrifugation in the presence of ethidium bromide (EtBr).
9k,OcOg
Centrifugation was for 64 hours at 18° C and at 38,000 rpm in a
Beckman SW50 rotor. Following centrifugation the tube was examined
under the UV light for the presence of EtBr stained bands of DNA..
Twa controls, a J62 strain known to be devoid of plasmid DNA and a
J62 strain possessing the 62 Mdal plasmid Rl, were run concurrently.
Hie results (figure 23) shew that the J62 control (tube 1) possesses
one band of DNA corresponding to linear fragments of chromosomal DNA.
The J62(R1) control (tube 2), on the other hand, gave 3 bands, an
upper band consisting of linear fragments of chromosomal DNA, a
middle band representing open circular plasmid ENA and a lower band
corresponding to covalently closed circular plasmid DNA. The results
for J53(Tn4133*) (tube 3) show the presence of only one band of
linear chromosomal DNA.
Thus it would appear that the Tp resistant donor strain did not
possess any plasmid DNA and hence that the Tp resistance transposon
is now somehow able to mediate its own transfer.
(x) Transposition of the mutated transposons into plamsid R1E
The presence of the mutation to Sm resistance within the Tp
resistance transposon suggests that further transposition of Tp
resistance to another replicon should now be accompanied by the
simultaneous acquisition of resistance to Sm and Sp. In order to
test this hypothesis an attempt was made to transpose the mutated Tp
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Figure 23. Ethidium bromide/caesium chloride density gradient
centrifugation of DNA extracted from E. coli J53(.Tn4l33*) ■
Tube 1, DNA extracted from E. coli J62 control;
tube 2, DNA extracted from E, coli J62(R1) control;
tube 3, DNA extracted from E, coli J53(Tn4l33*)«







resistance transposons from RP4 into the inc Fjj, Cm resistance
plasmid RlE. The conjugation experiments involved wsre similar to
those described previously for transposition into RP4. The results
for the mutated transposon, Tn4133*, are shown in table 27. Plasmid
RlE was introduced into the J53(RP4::Tn4132*), J53(RP4::Tn4133*) and
J53(RP4::Tn4134*) transconjugants by a five hour mating (table 27a).
Following two subcultures in nutrient broth in the absence of anti¬
biotic selection pressures, RlE was transferred into J62 during a 1
hour mating and selection was made for the transfer of Tp and Cm
resistance determinants both separately and together. The results
(table 27b) show that each resistance determinant is transferring
independently of the other. A TpQm resistant transconjugant was then
purified and used as a donor in a 1 hour mating with E. coli strain
J53. Selection was again made for the transfer of Tp and Cm
resistance determinants. The results (table 27c) again suggest that
these twa resistance determinants are transferring independently.
Following purification, the TpCm resistant transconjugants were
tested for the presence of plamsid RP4 both by multiple inoculation
onto DSTA plates containing Ap, Km and Tc, each at 10 mgL~l, and by
testing their sensitivity to phage PR4. All three transposon
containing transconjugants were found to be sensitive to these drugs
but resistant to phage PR4 indicating that plasmid RP4 had been lost
from the cell. Similarly, each transconjugant was tested for
resistance to 9m and Sp. However, none expressed resistance to these
antibiotics, indicating the the Sm/Sp resistance mutation present
within the Tp resistance transposons is unstable. Thus resistance to




























































Sm/Sp is lost during subculture in the absence of selective
pressures.
Despite a further transfer of Tp and Cm resistance determinants,
similar transfer frequencies for both resistance genes could not be
demonstrated (table 27d). Nevertheless, following purification,
plasmid DNA was extracted from the final J62 TpQn resistant
transconjugants and subsequently analysed by agarose gel electro¬
phoresis as described previously. The results (figure 24) shew that
both strains harbouring Tn4132* (track 7) and Tn4133* (track 6)
possess plasmid R1E with a MW of 41 Mdal. The relatively large size
of RLE, however, renders it impossible to determine whether these
small MW transposons are present on this R-plasmid. On the other
hand, the results obtained with Tn4134* (figure 24, track 8) show
that RlE has increased in size to 49 Mdal. This result suggests,
therefore, that Tn4134* could now measure 8 Mdal as opposed to 2 Mdal
when inserted into plasmid RP4.
The transfer frequencies obtained during these conjugation
experiments with RlE showed a similarity to the results obtained when
the mutated transposons were transferred from their J62(RP4) hosts
into J53 and selection was made for the transfer of Tp and Km
resistance. Similar analysis of Tp resistant transconjugants
obtained frcm a mating between J53(R1E: :Tn4133*) and J62 showed that
only 5% of J62 transconjugants were Cm resistant. Examination of Tp
resistant, On sensitive J62 transconjugants both by agarose gel
electrophoresis (figure 24, track 5) and CsCl density gradient
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Figure 2k. Agarose gel electrophoresis of HIE and R1E transposon
containing derivatives and DNA extracted from E. coli
j62(Tn^l33*) transconjugants selected on Tp containing
plates.
Track 1, Rl; track 2, RP4; track 3. R6K; track k, R1E;
track 5, DNA extracted from j62(Tn4l33*); track 6,
RlE::Tn4l33*; track 7, R1E: :Tn^l32*; track 8, R1E: :Tn4-13^*.
SIZE
(Mdal)
1 2 3 4 5 6 7 8
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centrifugation (figure 25) failed to reveal the presence of plasmid
ENA. In addition, the J62(Tn4133*) transconjugant was shown to
transfer Tp resistance to E. coli J53 at a frequency of 6.8 x 10-^
per donor cell during a 1 hour mating. Thus transfer of this small
molecular weight transposon again appears to be occurring without the
need for a plasmid vector. These observations, may offer an
explanation for the differences in transfer frequencies obtained when
selection is made for the transfer of Qn resistance, determined by
RlE, and Tp resistance, determined by the transposons.
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Figure 25. Ethidium "bromide/caesium chloride density gradient




(i) Investigation of the DHFR coded by Tp resistance transposons
The degree of similarity between the six transposons extracted
from Tp R-plasmids was further investigated by an examination of
their gene products. E. coli J62 strains harbouring the RP4
transposon derivatives wsre used for the preparation of all six
DHFRs. A preliminary experiment was done to determine the DHFR
activities of strains containing either large or small molecular
weight transposons. The specific activities were compared with the
chromosomal DHFR activity of a Tp sensitive J62 strain. One litre
exponential cultures of E. coli J62, E. coli J62(RP4: :Tn4129) and E.
coli J62(RP4: :Tn4133), grown in EM minimal medium, were harvested by
centrifugation and resuspended in 2.0 ml of 50 irM sodium phosphate
buffer pH 7.4 containing 10 mM ^-mercaptoethanol and 1 rrM EDTA
(buffer A). Crude enzyme preparations were then made. The cells
were lysed on ice in the French Press arid the lysate cleared by high
speed centrifugation for 1 hour in a Sorvall RC-5B. The specific
activity of DHFR in all three extracts was measured in sodium
phosphate buffer pH 6.0 by the method of Osborn and Huennekens,
(1958). All assay results were corrected for the DHF-independent
NADPH oxidase activity. The results (Table 28) show that both the
transposon containing strains exhibit high levels of DHFR activity
characteristic of Type 1 DHFRs previously associated with transposon
mediated Tp resistance.
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Table 28 The specific activity of EHFR in crude extracts of E. coli
J62, E. coli J62(RP4:;Tn4129) and E. coli J62(RP4;:Tn4133)
The specific activity is expressed in nmoles dihydrofolate being
converted per minute per mg protein in a 1.0 ml volume assay.




These preliminary results suggested that the two transposons may
be encoding similar gene products. Therefore the DHFR encoded by
each of the Tp transposons was purified and characterised.
(ii) Purification of transposon encoded CHER
Ten litre amounts of J62 strains containing the transposons,
inserted into plasmid RP4, were grown to logarithmic phase in EM
medium. Enzyme extracts were prepared, in buffer A, as described in
the Materials and Methods. Partial purification of the enzymes was
performed by a modification of the method of Amyes and Smith (1974a)
as described previously. Comparison of the purification and recovery
of each of the enzymes revealed little difference between them
(Tables 29-34). Usually about 30% of DHFR activity was recovered
following dialysis against 50% ammonium sulphate with the exception
of the DHFRs from J62(RP4::Tn4129) (7.6%) and J62(RP4::Tn4131) (60%).
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The purification at this stage ranged between 0.4 and 1.5. Both the
levels of recovery and purification were much lower than those
reported by Amyes ard Smith (1976) for the R388 "iype II enzyme.
However, the R388 enzyme is known to be much more stable than the
Type I enzyme (Tennhammar-Ekman and Skold, 1979) and this may account
for the lower recovery found with the enzymes studied here.
The 50-80% precipitate, containing the DHFR activity, was
collected and further purified by sephadex exclusion chromatography
by the method of Pattishall et al. (1977). The pellet resuspended in
buffer A was applied to a Sephadex G-75 superfine column (2cm2 x
90cm) and DHFR activity was eluted with buffer A at a flow rate of
between 6 and 8 ml per hour as described previously. Two ml
fractions were collected and assayed for DHFR activity in the
presence and absence of 4 x 10~§VI Tp, a concentration sufficient to
abolish the activity of the chromosomal enzyme. This allowed the
identification of peaks of Tp-resistant and Tp-sensitive DHFR.
Elution patterns for the DHFRs encoded by transposons Tn4129
(Figure 26a) and Tn4130 (Figure 27a) were in most respects identical
and showed two clearly defined peaks of activity corresponding to the
Tp-resistant transposon encoded enzyme, which eluted at about
fraction 46 and the Tp-sensitive chromosomal encoded enzyme which
eluted between fractions 55 and 57
The enzyme profiles for the DHFRs encoded by transposons Tn4131
(Figure 28a), Tn4132 (Figure 27b), Tn4133 (Figure 26b) and Tn4134
(Figure 28b) were also identical but did, however, differ markedly
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Figure 26. Elution of DHFR activities of E. coli J62(RP4-: :Th4l29)
and E. coli J62(RP4-: :Tn^l33) on Sephadex G-75 superfine
gel filtration.
a = J62(RP4: :Tnifl29); b = J62(RP^:: Tn4l33).
Total DHFR activity, O ; DHFR activity in the presence




Figure 27- Elution of DHFR activities of E. coli J62(RP^-: :Tn^l30)
and E. coli J62(RF!+: :Tn4l32) on Sephadex G-75 superfine
gel filtration.
a = J62(RP^+: :Tn^l30); b = J62(RP^::TnA-132).
Total DHFR activity, O ; DHFR activity in the presence




Figure 28. Elution of DHFE activities of E. coli J62(RP4::Tn4l3l)
and E. coli J62(RP4::Tn4l3^) on Sephadex G-75 superfine
gel filtration.
a = J62(RF4: :Tn4l3l); b = J62(RP4-: : Tn4l3^).
Total DHFR activity, O ; DHFR activity in the presence of




from the Tn4129 and Tn4130 enzyme profiles. Each enzyme profile
shows two less veil defined peaks of activity elating at fractions 53
and 57. These peaks often merged to form a single, slightly broader
peak of activity (Figures 26b, 28b). The enzyme in fraction 53 was
resistant to Tp at a concentration of 4 x 10~%, unlike the peak at
fraction 57 and therefore represents the transposon encoded DHFR. In
addition to these enzyme peaks, a small shoulder of activity was
found to elute around fraction 66. This shoulder of Tp resistant
enzyme activity was only present in enzymes encoded by transposons
Tn4131, Tn4132, Tn4133 and Tn4134.
(iii) Molecular Weight of DHFR coded by tranposons
The different elution profiles of these enzymes suggested a
difference in their molecular weight (MW). Thus sephadex exclusion
chromatography was repeated in the presence of marker proteins of
known molecular weight in order to determine the enzyme molecular
weights. Ten litre exponential cultures of the six transposon
containing strains were prepared and treated with streptomycin
sulphate ard ammonium sulphate as described before. The 50-80%
ammonium sulphate pellet was resuspended in buffer A and mixed with
the molecular weight markers described in the Materials and Methods.
This sample was then applied to a Sephadex G-75 superfine column and
fractions were collected and assayed for Tp resistant DHFR activity.
The Ve/Vo ratio was found for each of the three molecular weight
marker proteins, as described previously, and this value was plotted
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against molecular weight on a semi-logarithmic graph scale. The
results showed that the MW of the Tp sensitive DHFR encoded by
strains harbouring Tn4129 and Tn4130 was about 21000 which agrees
well with the published value of 20500 (Amyes and Smith, 1978).
Similar MWs were obtained for the Tp sensitive enzymes from the other
four transposon containing strains.
The position of the Tp resistant DHFR encoded by Tn4129 was
canmensurate with a molecular weight of 35000 which is in full
agreement with the published value of 35000 for the Tn7 encoded DHFR
of plasmid R483 (Pattishall et al., 1977). The MW of the DHFR
encoded by transposon Tn4130 was found to be 32000 (table 35) which
is also in good agreement with the MW of Type I plasmid encoded
enzymes (Pattishall et al., 1977; Amyes and Smith, 1978).
Table 35 Molecular weights of dihydrofolate reductases










However, when the 50-80% precipitate of strain J62(RP4::Tn4133) was
eluted with marker proteins on Sephadex G-75 superfine, the Tp
resistant DHFR peak was found to correspond to a MW of 24000 (table
35). This DHFR molecular veight differs from all previously
characterised Tp resistant, plasmid encoded DHFRs. In addition a
shoulder of Tp resistant DHFR activity was found corresponding to a
MW of 10600. Similar MWs were determined for the DHFRs coded by
transposons Tn4131, Tn4132 and Tn4134 (table 35). These four
transposons, therefore produce a DHFR which is two thirds the MW of
the Type I and Type II plasmid enzymes. The presence of a second Tp
resistant shoulder of activity suggests that this enzyme may be
composed of tvo subunits with MWs between 10600 and 12400 which
possess low levels of DHFR activity.
(iv) pH profile of DHFRs
All the assays described have been performed at pH 6.0 in sodium
phosphate buffer. Previously characterised R-plasmid DHFRs have all
been shown to exhibit a sharp peak of activity at this pH (Amyes and
Smith, 1978). Trimethoprim sensitive enzymes, on the other hand,
show a broad spectrum of activity over almost the complete pH range
of 5 to 9 (Amyes and Smith, 1978). The pH profiles of all six
transposon mediated Tp resistant DHFRs were ccmpared in order to
determine if the large and small enzymes exhibit different pH optima.
Following Sephadex G-75 superfine gel filtration, fractions
containing Tp-resistant DHFR activity were pooled and assayed at pH
values between 5.0 and 9.0. Gontrols ware performed at each pH value
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tested to correct for decreases in absorbance in the absence of the
enzyme. The results (figure 29) shew that all six enzymes exhibit a
pH optimum at pH 6.0. The enzymes coded by transposons Tn4129,
Tn4131, Tn4132 and Tn4134 show a slightly broader range of activity/
with 95% of the maximum activity between pH 5.5 and 6.0 for enzymes
from Th4129 and Tn4132 and between pH 6.0 and 6.5 for enzymes from
Tn4131 and Tn4134. This slightly broader pH optimum is
characteristic of Type I DHFRs as opposed to the Type II enzymes
which sharply peak at pH 6.5 (Pattishall et al., 1977).
It should be noted however, that three of the enzymes (from
Tn4130, Tn4131 and Tn4134) showed an anomalously high level of
activity, between 90 and 100%, at pH 5.0. This result was checked
several times both by repeating the assay of each enzyme and in
addition by the preparation of new enzymes which were then assayed as
before. In each case a high level of activity was observed at pH
5.0.
However, with the exception of this anomalous result the six
enzymes show similar pH profiles 95% activity being retained over a
pH range of 5.5 to 6.5 in sodium phosphate buffer. All subsequent
assays were therefore performed in sodium phosphate buffer at pH 6.0.
(v) Substrate profile of DHFRs
A feature which distinguishes Tp resistant plasmid encoded
enzymes from the host chromosomal enzyme of E. coli is the difference
in substrate specificity profiles. With the Tp-sensitive E. coli 114
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Figure 29- The pH activity curve for the Tp DHFRs from E. coli J6Z
strains harbouring Tp resistance transposons.
The activity of DHFR is expressed as a percentage of the
maximum activity at pH 6.0.
The buffers employed were sodium acetate, • ; sodium








DHFR, about 16% of the activity seen with NADPH is observed when
NADH is substituted (Amyes and Smith, 1976). Similarly, the J62
enzyme exhibits 8.2% of the NADPH activity when NADH is used (Amyes
and Smith, 1978). However, neither of these chromosomal enzymes show
any activity when folic acid is substituted for DHF (Amyes and Smith,
1978).
Purified enzyme preparations of all six Tp-resistant DHFRs
obtained from pooled gel filtration fractions were assayed in the
presence of NADH instead of NADPH and/or folic acid substituting for
DHF. No activity could be detected when NADH was substituted for
NADPH, and none of the six enzymes exhibited any activity when folic
acid was substituted for DHF. Therefore, both the large and small
DHFRs differ frcm chromosomal DHFRs, in their response to NADH, but
have similar substrate profiles to R-plasmid determined DHFRs (Amyes
and Smith, 1978).
(vi) Inhibition of DHFR activity at 45°C
A major distinguishing feature of Type I DHFRs is their heat
sensitivity. It is well documented that the Type I enzymes are
inactivated to 50% (TD50) within two or three minutes of heating to
45°C. (Amyes and Smith, 1978; Tennhammar-Ekman and Skold, 1979; Broad
and Smith, 1982). Type II DHFRs, on the other hand, are much more
heat resistant with TD50S of greater than 15 minutes (Tennhammar-Ekman
and Skold, 1979; Broad and Smith, 1982).
The heat sensitivities of the six partially purified (gel
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filtration pooled fractions) Tp resistant enzymes were measured. The
temperature inactivation curves of both large and small MW DHFRs
showed similar linear relationships between the logarithm of the
activity and the tine that the enzyme was maintained at 45°C. All
six enzymes were found to be sensitive on heating to 45°C, each
losing 50% activity after about 2 minutes (table 36). These six
transposon mediated enzymes therefore appear to be more closely
related to the Type I DHFRs than the Type II enzymes.
Table 36 Time taken to lose 50% dihydrofolate reductase activity at
45°C







(vii) Inhibition of DHFR activity by antifolate compounds
In order to compare the transposon determined enzymes further
the extent of their resistance to trimethoprim was determined. The
enzyme preparations used were the partially purified, pooled, gel
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filtration fractions. In each case the DHFR activity was assayed in
increasing concentrations of Tp at pH 6.0, and the concentration
required to give 50% inhibition (ID50) °f each enzyme was determined.
Inhibitor profiles of both the large and small MW enzymes were very
similar and in each case the activity was directly proportional to
the logarithm of the Tp concentration. The ID5os f°r s;'LX enzymes
were similar, with values between 30 and 60 jJ4 (table 37).
Table 37 Trimethoprim and methotrexate concentrations which cause
50% inhibition of dihydrofolate reductase activities








These values are in good agreement with those found by Pattishall et
al. (1977) for Type I DHFRs. The results of Amyes and Smith (1978),
hcwever, estimate the ID50 of the Type I enzyme to be between two to
three times greater at about 150 jM. These discrepancies may be
explained by the use of pure Tp by Amyes and Smith (1978), as opposed
to Tp lactate which was employed here and by Pattishall et al.
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(1977), which may result in a greater value for the IE^q.
The activity of the six enzymes was also assayed in the presence
of increasing concentrations of methotrexate, to compare their
relative sensitivities. Inhibitor profiles of both large and small
MW enzymes were very similar, the activity again being directly
proportional to the logarithm of methotrexate concentration. The
IQ30S for methotrexate of the six enzymes ware also similar, ranging
from 2.5 to 7.1 jl\ (table 37). These values are again in good
agreement with those for Type I EHFRs (Pattishall et al., 1977; Amyes
and Smith, 1978).
The large and small MW EHFRs, therefore, exhibit inhibition
profiles similar both to each other and to Type I DHFRs.
(viii) Michaelis-Menten kinetics of EHFRs
In order to determine whether the resistant enzymes have similar
affinities for the primary substrate (dihydrofolate), the activities
of the partially purified enzymes were investigated under conditions
of partial saturation with DHF and the results analysed by the method
of Lineweaver and Burk (1934) to determine the Km values.
The results for both large and small MW enzymes showed that in
the absence of Tp straight lines were obtained by plotting the
reciprocal of the substrate concentration (1/s) against the
reciprocal of the rate of the enzyme reaction (1/v) and hence the
enzymes obey Michaelis-Menten kinetics at pH 6.0 and 30°C. The Km
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value for each of the enzymes was estimated (table 38) and found to
be about 20 with DHF. This value is similar to that obtained for
the Tp sensitive chromosomal determined DHFR (Amyes and Smith, 1978).
The Km value for Tp resistant plasmid mediated DHFRs has been
reported to vary between 4 and 10 jlM with DHF (Pattishall et al.,
1977? Amyes and Smith, 1978; Tennhammar-Ekman and Skold, 1979).
Since Km values are subject to several errors this variation is
probably not significant. Thus all six enzymes show similar
affinities for DHF to those previously reported for both chromosomal
and plasmid determined enzymes.
The results of the ID50 experiments with Tp suggested that the
inhibitor constant (Ki) of the enzymes should also be similar. In
order to confirm this the activity of the enzymes was assayed as
before at various limiting DHF concentrations in the presence of two
relatively high concentrations of Tp, to determine the kinetic
effects of the drug. In each case the double reciprocal plots of 1/v
against 1/s, in the presence of Tp both intercepted the ordinate at
the sane position. This intercept was also that obtained in the
absence of Tp, indicating that the enzymes, although resistant to Tp,
are inhibited competitively by the drug with respect to DHF, as the
maximum rate is unaffected. However, the plots in the presence of Tp
intercepted the abscissa nearer the origin than the uninhibited
slope.
The Ki values for the two Tp concentrations used were calculated
as described previously and the mean Ki value determined for each
enzyme. The mean Ki values for the six enzymes ranged between 2.1 ii4
201.
Table 38 Michaelis-Menten kinetics of dihydrofolate reductases with
dihydrofolate as substrate and trimethoprim as inhibitor
Km for Ki for









and 45 (table 38). The small variations between the inhibitor
constants of these enzymes are probably due to experimental error
arising as a result of the lew levels of activity being tested and
are therefore probably not significant. Hie results indicate,
however, that each enzyme has a very lew affinity for Tp, the mean Ki
value being approximately 10,000 times greater than that reported for
the chromosomal DHFR (Amyes and Smith, 1978). These Ki values are
also in good agreement with the published results for Type I DHFRs
(Pattishall et al., 1977; Amyes and Smith, 1978; Tennhammar-Ekman and
Skbld, 1979). Therefore, whether the transposon mediated DHFRs are
assayed for their ID50 or their Ki value a similar decrease in
affinity for Tp is obtained which agrees well with the increase in
resistance level observed with intact bacteria.
(ix) Polyacrylamide gel electrophoresis of DHFRs
Fran the previous sections it would appear that all six enzymes
are biochemically very similar. However, the results of the gel
filtration experiments suggest that the enzymes may be divided into
two groups, differing significantly in their molecular weight. Since
size appears to be the only significant difference between the
enzymes it was important to confirm that the two DHFRs were different
enzymic entities by employing another method of protein separation by
molecular size. Therefore, two of the enzymes, coded fcy Tn4129 and
Tn4133, were examined by polyacrylamide gel electrophoresis (PAGE),
which separates proteins both fcy their molecular weight and their
charge.
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Initially the method of Tennhammar-Ekman and Skold (1979) was
employed. Crude enzyme extracts from 10 litres of exponential phase
cultures of E. coli J62(RP4::Tn4129) and E. coli J62(RP4::Tn4133)
vaere prepared by the modified method of Amyes and Smith (1974a).
Following sephadex exclusion chromatography, fractions containing
DHFR activity were pooled and the enzymes re-precipitated by dialysis
against an 80% saturated solution of ammonium sulphate. The pellet
was collected by centrifugation resuspended in buffer A and then
dialysed overnight against 100 volumes of the same buffer. Between
100-200 yug of each enzyme preparation was mixed with sucrose solution
and applied directly to the separation gels. The gels were set up as
described in the Materials and Methods and the samples were run from
the cathode to the anode. Electrophoresis was conducted at 4°C and
pH 8.6 under the conditions described by Davis (1964) and until the
marker of brcmophenol blue migrated to the bottom of the gel. Bands
of DHFR were located on the gels using the zymographic staining
procedure as described in the Materials and Methods. Following
incubation of the gels with NADPH and dihydrofolate, enzymatically
formed tetrahydrofolate was detected by the addition of the
tetrazolium salt MTT which is reduced by tetrahydrofolate to give a
blue, insoluble formazan deposit. Unspecific bands of MTT reduction,
not related to tetrahydrofolate were identified by control
incubations without added dihydrofolate. To distinguish between
bands corresponding to the Tp resistant transposon encoded enzymes
and those corresponding to the host chromosomal enzyme, further
incubations were carried out in the presence of 4 x 10~§4 Tp, a
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concentration sufficient to abolish chromosomal DHFR activity. The
gels vere then examined for specific bands of Tp resistant DHFR
activity.
The results (figure 30) show, however, the presence of several
bands of MTT reduction, each band being present in both control and
test gels, making it impossible to distinguish those bands
corresponding to DHFR activity. The large number of non-specific
bands is most probably due to the low level of purification of the
DHFRs prior to electrophoresis. Fling and Elwell (1980), studying
the subunit structure of Type I and Type II DHFRs by PAGE performed
extensive purification of the enzymes through several affinity
columns before subjecting them to electrophoresis. The inability
here to distinguish between the DHFRs using zymography, together with
the fact other authors have found it necessary to use extensive
purification procedures, casts some doubt on the results of
Tennhammar-Ekman and Skold (1979) who claim to have shown differences
in the electrophoretic mobility and size of the R388, R751 and R483
encoded DHFRs by this method.
In order to overcame the problems of identification of the
enzymes in the polyacrylamide gels, the experiment was repeated
employing an alternative method for the detection of the DHFRs
following electrophoresis. Gel-chromatographed enzyme samples were
again used and applied to the separation gels as before. Following
electrophoresis the gels ware sliced into 3 mm segments using a
scalpel. Each segment was placed in 0.5 ml of buffer A and DHFR
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Figure 30. Polyacrylamide gel electrophoresis and zymographic
staining of DHFRs produced by E. coli J62(RP4: :Tn4l29)
and E. coli J62(RP4:: Tn4l33).
Columns 1-3 contained partially purified enzyme from
E. coli J62(RP4::Tn4l29) and columns 4-6 enzyme from
E. coli J62(RP4::Tn4l33).
In columns 1 and 4 the zymographic incubation took place
in the absence of dihydrofolate (-DHF) and in columns
3 and 6 in the presence of 4 x 10 Tp (+Tp).
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activity was allowed to elute overnight in the buffer at 4°C. The
following day the eluate from each slice was assayed for DHFR
activity, both in the presence and absence of 4 x 1CTH4 Tp. The
fractions ware numbered from the bromophenol blue end of the gel so
that fraction 1 contains this marker.
The results (figure 31) show that the sample from the Tn4129
containing strain exhibited two separate peaks of DHFR activity
(figure 31a). A small peak of activity was found in fraction 7,
which was completely abolished when assayed in the presence of 4 x
10~% Tp. A second, much larger peak of DHFR activity eluted from
fraction 12. This enzyme continued to display maximum activity when
assayed in the presence of 4 x 10~% Tp. The sample frcm
J62(RP4::Tn4133), on the other hand, shows a single peak of DHFR
activity (figure 31b). The maximum activity of DHFR was at fraction
8. Seventy-five percent of the DHFR activity in fraction 8 was
resistant to 4 x 10~% Tp indicating that three quarters of the
acitivity in this peak represents the Tn4133 encoded enzyme, the
remaining 25% corresponding to the host chromosomal enzyme. The
absence of a second peak of DHFR activity at fraction 12 confirms
that the two transposons, Tn4129 and Tn4133, do indeed encode DHFRs
of different nolecular weight, the enzyme produced by Tn4133 being
closer in size to the host chromosomal enzyme than the enzyme encoded
by Tn4129.
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Figure Jl. Folyacrylamide gel electrophoresis of partially
purified DHFRs from E. coli J62(RF4::Tn^l29) and
E. coli J62(RP^: :Tnifl33).
The histograms show the activity of DHFR (units/ml)
in each fraction. The shaded areas show the level of
DHFR activity in the presence of k x 10~ M Tp.
a = J62(RFif::Tn4l29); b = J62(RF^-s : Tn4l33) .




A. Origins of the Tp resistance genes
1. Klebsiella species
Recent research into the origins of plasmid borne antibiotic
resistance genes has indicated that mobilization of chromosomal genes
has probably played an important role in the evolution of certain
R-plasmids (Ambler and Scott, 1978; Sutcliffe, 1978; Nugent and
Hedges, 1979; Thomson and Grey, 1983). The initial aim of this
thesis was to investigate possible sources of the Tp resistance genes
present on R-plasmids and transposons. The ubiquitous nature of the
enzyme dihydrofolate reductase suggests that the highly resistant
enzymes encoded by Tp R-plaamids may also have arisen from the
mobilization of chromosomal genes, possibly following their mutation
to Tp resistance.
In the search for the precursor of the plasmid encoded enzymes,
the DHFR encoded by spontaneous Tp resistant mutants of Klebsiella
sp. D770 was isolated and partially characterised. This strain was
one of the first Tp R-plamsid containing organisms isolated (Fleming
et al., 1972) and was of particular interest because of its unusual
biochemical characteristics (Datta and Hedges, 1972). The failure of
the original workers to isolate Klebsiella strains similar to strain
D770 but devoid of Tp R-plasmids, rendered it necessary to perform
preliminary experiments aimed at removing the Tp R-plasmid, R389,
from strain D770 before the strain itself could be studied.
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Initial investigations revelaed that in addition to the
R-plasmid R389 (plasmid 2) which carried resistance determinants to
Tp, Sx and Sm there was also a second R-plasmid (plasmid 3) of
molecular weight 42 million present within this strain, which
conferred resistance to Tc and Cm. This plasmid, however, was
unstable and lost spontaneously at high frequency from the cell. On
the other hand subsequent efforts to remove R389 by selection for Tp
sensitive derivatives resulted, not in the loss of the whole plasmid,
but rather surprisingly, in the loss of a 5 Mdal piece of DNA from
R389. The high frequency of loss of this resistance determinant,
without the concommitant loss of the R-plasnid, suggests that the Tp
resistance determinant of R389 resides on a transposable element.
Previous reports of Tp resistance transposons have usually been
associated with the gene responsible for the production of Type I
DHFRs (Fling et al., 1982). The only exception was the discovery of
the 5 Mdal transposon, Tn402, present on plasmid R751 (Shapiro and
Spom, 1977). This transposon, which has only been shown to
transpose to bacteriophage lambda, encodes an unusual DHFR which has
recently been classified as a sub-group of the Type II DHFRs (Broad
and Smith, 1982). It has also been suggested, however, that the Tp
resistance gene of the inc W R-plasmid, R388, may also be on a
transposon (Amyes and Smith, 1977). This R-plasmid was isolated from
a patient in the St. Pancras Branch, University College Hospital,
London shortly before the isolation of R389 (Fleming et al., 1972).
However, no detailed molecular analysis of this strain has yet been
performed, so the exact nature of the 'transposon' has not been
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confirmed.
The isolation and partial characterisation of the DHFR encoded
by R389 in this thesis, indicates that it should also be classified
as a Type II DHFR. However, it is interesting to note that the R389
enzyme is synthesised in relatively large amounts; a characteristic
usually associated with the Type I plasmid mediated enzymes but not
the Type II enzymes. Since the R389 enzyme is both heat stable and
highly insensitive to Tp (both characteristics of Type II DHFRs) it
is most likely that the levels of production are under the control of
the host species. Nevertheless, although no direct evidence exists
to confirm that the high levels of synthesis of Type I DHFRs is a
result of their location within a transposon, it is conceivable that
the elevated levels of the enzyme may be related to the location of
the gene within a transposon, the transposon providing a regulatory
function controlling the level of enzyme production. The increased
synthesis of the R389 Type II enzyme may, therefore, be similarly
related to its presence within a transposon.
After production of a Tp sensitive derivative of Klebsiella sp.
D770 initial attempts to mutate this strain to high level Tp
resistance were unsuccessful. Since the original Tp R-plamsid, R389,
present within strain D770 belonged to incompatibility group W, it
was thought that perhaps the introduction of an inc W group plasmid
might provide an additional factor required for the mutational
process. Indeed Tp sensitive derivatives of Klebsiella sp. D770,
possessing the inc W R-plasmid Sa, were shown to mutate with relative
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ease to high level Tp resistance. However, an examination of the
resistance mechanism revealed that the mutation to Tp resistance did
not involve the production of either an additional large molecular
weight enzyme or a mutant chromosomal enzyme with similar resistance
levels to Tp as the plasmid mediated DHFRS. Interestingly, however,
the resistant mutant did appear to be coding for a chromosomal enzyme
of a slightly greater molecular weight. This was distinguishable
from the original chromosomal enzyme which appeared as a shoulder of
activity corresponding to a molecular weight of 21300.
The resistance mechanism employed by this mutant strain
resembles those previously reported for Tp resistant mutants of E.
coli (Breeze et al., 1975; Sheldon and Brenner, 1976; Sheldon, 1977)
and Klebsiella (Grey et al., 1979). In each case, resistance was
shown to result from either a single or successive mutations within
the DHFR gene altering both the levels of production of the enzyme
and its affinity for Tp. Similar elevated levels of synthesis of the
DHFR coupled with a decrease in the enzyme affinity for Tp were
observed for the DHFR encoded by this Klebsiella derivative.
However, it is clear that this organism is not the source of the
plasmid enzymes. The molecular weight of the mutant Klebsiella DHFR
is only 24300 as opposed to 35000 for the plasmid mediated enzymes.
In addition, the Klebsiella enzyme is at least a thousand times more
sensitive to Tp than the plasmid enzymes.
Nevertheless, the ease with which Klebsiella strains harbouring
R-plasmids were shown to mutate to Tp resistance, coupled with the
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intrinsic lew levels of Tp resistance often observed with this
species (Fruensgaard and Komer, 1974; Jobanputra and Datta, 1974;
Hamilton-Miller and Grey, 1975) may be indicative of their possible
role in providing a suitable environment for the continuing evolution
of Tp R-plasmids. Indeed the inherent resistance to a variety of
antimicrobials of many pathogenic strains of Klebsiella spp.
harbouring Tp R-plasmids, has been shown to result in their gradual
predominance over E. coli strains, during treatment of urinary tract
infections with drugs other than Tp (Gruneberg and Bendall, 1979).
Similarly strains of Proteus and Pseudcmonas species, which are also
inherently resistant to many antibacterial agents, may also provide a
'protective' background for evolving R-plasmids and resistance genes.
It is hence significant that only 45% of the highly resistant
bacterial population studied during this thesis belonged to the
species E■ coli and over 54% were Klebsiella, Pseudomonas and Proteus
species.
2. Incompatibility W group plasmids
It seemed feasible that Tp-sensitive plasmids might also be a
potential source of DHFRs that could be precursors to the Tp
resistant plasmid enzymes. It was for this reason the inc W plasmid
Sa was investigated. This plasmid was isolated in 1962 (Watanabe et
al., 1968) and has a very extensive sequence homology with the first
Tp R-plasmid, R388 (Gorai et al., 1979; Ward and Grinsted, 1982). It
seemed possible, therefore, that Sa could have been the precursor of
R388. However, no plasmid determined enzyme could be detected, as
213.
only one DHFR was ever found in Sa containing cells. Therefore, it
would appear that if Sa is indeed the immediate precursor of R388,
the Tp resistance gene present on R388 would have to have been
acquired by Sa, either by transposition, or some other recombin-
ational mechanism, from elsewhere, and was not inherent to Sa.
The essential role of the inc W plasmid Sa in the mutation to Tp
resistance of Klebsiella strains implied that this plasmid may be
providing an additional factor resulting in the increased mutation
frequency of certain genes. This hypothesis was extended to
investigate the possible role of plasmid Sa in the mutation to Tp
resistance of Escherichia coli K-12 strains. Two auxotrophic mutant
strains of E. coli K-12 were examined for their ability to mutate to
high levels of Tp resistance. Strain J62, which is auxotrophic for
the amino acids histidine, proline and tryptophan (Clowes and Rowley,
1954) showed no significant mutation to resistance to even moderate
levels of Tp. In addition, the introduction of plasnid Sa into this
strain did not alter the mutation frequency. On the other hand, when
the experiments were repeated with the auxotrophic mutant strain J53
(Bachmann, 1972), the strain mutated with relative ease to high
levels of Tp resistance. The presence of Sa within strain J53 did
not significantly increase the mutation frequency. Hence plasmid Sa
is not performing the same role when present within E. coli K-12
strains as it did in the Klebsiella sp.
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3. Escherichia coli
Mutation to high-level Tp resistance of E. coli J53 was achieved
in three sequential subcultures. The resultant mutant strain,
J53TplKR, had an MIC of Tp greater than 1000 mgL~l. Breeze et al.
(1976) also isolated mutant E. coli K-12 strains, with MICs greater
than 1000 mglT1, by serial subculture in progressively higher con¬
centrations of Tp. However, a minimum of six subcultures was
necessary to achieve this level of resistance. Therefore, strain J53
has an increased capacity to mutate to Tp resistance when selection
is made for such mutants.
The mutant J53 strains were found to mediate the production of
elevated levels of chromosomal encoded DHFRs. Interestingly the
molecular weights of the DHFRs from both the original J53 parent
strains and the J53 mutant derivatives were slightly higher than
those previoulsy reported for the E. coli J53 chromosomal DHFR
(Pattishall et al., 1977). This is most probably due to the slightly
better separation achieved here by the use of Sephadex G-75
superfine. The first publication on the purification of plasmid and
chromosomal encoded DHFRs failed to achieve separation of the tvo
enzymes by Sephadex exclusion chromatography (Amyes and Smith,
1974a). However, Pattishall et al. (1977) found that by reducing the
flow rate of the column to less than 5 ml/h, they obtained clearly
defined peaks of Tp-resistant and Tp-sensitive DHFR activity, from
cell extracts of E. coli strains harbouring Tp R-plasmids. The
results of this thesis shew that, by employing a Sephadex G-75
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superfine matrix, enzymes which differ in size by as little as 2000
daltons may be resolved. Hence it is conceivable that sane
chromosomal DHFRs, previously estimated to be of molecular weight
21000 may, by the use of Sephadex G-75 superfine, be nearer 23000
daltons in size. In addition to the increased levels of production,
the enzyme synthesised by the E. coli J53 mutant was also highly
resistant to Tp with an inhibition constant (Ki) for Tp of 8.81 x
10~%. This value is similar to those of R-plasmid specified DHFRs
(Pattishall et al., 1977; Amyes and Smith, 1978). No other mutant
chromosomal DHFRs have ever been shown to be as insensitive to Tp as
the enzyme isolated here. Sheldon and Brenner (1976), Baccanari et
al. (1977) and Poe et al. (1979) have all isolated mutant E. coli
DHFRs with slightly decreased affinities for Tp. However the Ki
value for Tp of each of the enzymes was only between 1.0 x 10~%1 and
1.0 x 10-7M. Therefore, strain J53TplKR appears to be producing a
new enzyme which is possibly more closely related to the
plasmid-mediated DHFRs than those chromosomal mutants previously
described and may be a precursor of the plasmid enzymes.
This hypothesis is reinforced by the discovery in this thesis of
a new class of transposon-mediated enzymes, which share many of the
biochemical characteristics of the Type I DHFRs but differ markedly
in their molecular weight. The size of these new transposon encoded
enzymes shows considerable resemblance to the molecular weight of the
J53 mutant enzymes. Although these mutant strains have been obtained
in vitro, the possibility that the transposon enzymes may have arisen
by the incorporation of a spontaneously derived mutant chromosomal
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enzyme in vivo into a transposable element cannot be dismissed.
In addition to the 22400 dalton enzyme encoded by J53TplKR, a
second enzyme of molecular weight 16000 was distinguished as a
shoulder of Tp resistant DHFR activity. Although this 16000 dalton
enzyme was not characterised it is evident from the DHFR elution
profile of strain J53TplKR that the shoulder of activity
corresponding to this molecular weight is resistant to at least 4 x
10~^1 Tp. Fling et al. (1982) recently detected a 'new' plasmid-
encoded enzyme of similar molecular weight to the shoulder observed
here. Preliminary characterisation of their 'new' enzyme showed it
to have an ID50 for Tp of about 10~%. The plasmid p699, encoding
the 'new' enzyme was identified as a small 8kb non-self transmissible
plasmid, thought to be mobilized by a second R-plasnid present in the
original host (Fling et al., 1982). In view of the identification of
a chromosomal determined enzyme of a similar size and resistant to
similar levels of Tp in this thesis, it is possible that Fling et al.
(1982) may in fact have been observing the mobilization of part of
the bacterial chromosome carrying a spontaneously derived mutant DHFR
gene encoding an enzyme similar to the one isolated from strain
J53TplKR. However, more detailed characterisation of both these
small molecular weight enzymes is required before a definite relation¬
ship between them can be established.
Detailed biochemical characterisation of the J53TplKR DHFR
showed that, not only is the enzyme resistant to Tp, but also that it
is slightly less sensitive to the 2,4-diaminqpteridine methotrexate
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than the J53 parent enzyme. However, the resistance to methotrexate
expressed by the J53TplKR enzyme is not as great as that exhibited by
the piasmid-mediated enzymes, the J53TplKR DHFR being about one
hundred times more susceptible to this drug than the Type I and Type
II DHFRs. Nevertheless, the slightly decreased susceptibility to
methotrexate may contribute to the theory that this mutant enzyme is
indeed a stage in the process to produce an enzyme similar to those
encoded by Tp R-plasmids.
One of the most striking differences between the J53 parent
Tp-sensitive DHFR and its Tp resistant derivative is the pH profile
of the enzymes. The parent enzyme displayed a characteristic pH
profile previously associated with Tp sensitive chromosomal enzymes,
maintaining over 60% of its activity throughout the pH range 5.0 to
9.0 (Pattishall et al., 1977; Amyes and Smith, 1978). However, the
Tp resistant derivative of strain J53 showed twu very distinct peaks
of activity at pH 5.0 and 6.0. Doe et al. (1979) studying the DHFRs
from two mutant E. coli K-12 strains have shown that differences
observed in their pH profiles are probably related to slight
differences in the local environment of histidine residues at the
active site of the enzymes. A similar modification in the local
environment may also account for the altered pH profile observed with
the J53TplKR DHFR. The results of this thesis indicate that DHFRs
encoded by Tn7-like transposons can also exhibit tvro pH optima at pH
5.0 and 6.0 as can the new transposon mediated enzyme identified
here. The differences in pH profile of the transposon mediated
enzymes do not, however, appear to reflect alterations in their
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susceptibility to antifolate inhibitors. Thus the different pH
profiles observed for the J53 and J53TplKR DHFRs are unlikely to have
resulted from the change in their respective susceptibilities to Tp.
3. Tne continuing evolution of the Tp resistance gene
Since the first report of the 9 Mdal transposon, Tn7, encoding
Tp and Sm/Sp resistances (Barth et al., 1976) the incidence of Tp
resistance within the Enterobacteriaceae has risen markedly (Amyes et
al., 1978; Eatta et al., 1980; Amyes et al., 1981; Fling et al.,
1982; Towner et al., 1982). Examination of many of these isolates
has revealed the presence of Tn7 within both the bacterial chromosome
and R-plasmids of many different incompatibility groups. This
transposon appears therefore to be playing a major role in the spread
of Tp resistance.
Investigation of Tp R-plasmids isolated during an epidemic of Tp
resistance within the Enterobacteria isolated from patients in
Edenhall Hospital revealed that the spread of the resistance gene was
again being manifested by transposons within this bacterial
population. Transposons ware extracted from six of the plasmids.
Three of the transposons, Tn4129, Tn4130 and Tn4131 were found to
carry the determinants for Sm/Sp resistance in addition to Tp
resistance. When these transposons were measured in the vector
plasmid RP4 they v^re estimated to be about 9 Mdal in size which
suggests a similarity to Tn7. Each of these transposons possess
three restriction sites for the endonuclease Hind III, showing the
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presence of two small DMA fragments characteristic of Hind III
cleavage of Tn7 (Datta et al. , 1979; Lichtenstein and Brenner, 1982;
Taylor, 1983). The three other transposons Tn4132, Tn4133 and Tn4134
also carried the gene for Tp resistance but not for Sm resistance.
They were estimated to be about 2 Mdal in size when inserted into
plasmid RP4. However, the size of the inserted DNA was not easily
determined, since transposition of these small transposons was
seme times accompanied by a decrease in the molecular weight of the
RP4 containing derivative. This phenomenon has been observed
previously with other transposons following their insertion into
plasmid RP4 (Barth et al., 1978; Eatta et al., 1979; McCombie et al.,
1983). Hence, in common with other workers, transposon sizes were
determined when an increase in the RP4 transposon containing
derivative was observed (McCombie et al., 1983). One of the
transposons, Tn4134, when inserted in the plasmid RlE showed an
increase in the molecular weight of this plaamid, of 9 million. This
suggests that Tn4134 has a molecular size of 9 Mdal. However, if
this was the case, insertion of the same transposon into plasmid RP4
would have to have been accompanied by a deletion of at least 7 Mdal,
since an increase of only 2 Mdal was calculated for RP4: :Tn4134
derviatives. Datta et al. (1979) identified a 9 Mdal transposon,
Tn78, in an inc M R-plasmid isolated form a Tp resistant strain of
Klebsiella aerogenes K-16. This transposon, like Tn4134, also
carried the single resistance determinant for Tp but caused only a
very small reduction (1 Mdal) in the molecular weight of RP4
derivatives harbouring Tn78. In addition, unlike Tn4134, no
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reversion to Sm/Sp resistance could be demonstrated for Tn78
demonstrating that Tn4134 is quite distinct from Tn78.
The deletions frequently observed following insertion of
transposons are usually thought to be a result of the spontaneous
loss of small fragments of DNA during or immediately after the
insertion process (Vfeisberg and Adhya, 1977). However, an
alternative explanation for the deletions occurring here is that
multiple insertion of the transposon into the vector plasmid may have
occurred. Tnis event would then provide two or more regions of
homologous DNA, between which recombination can occur, with the
ultimate loss of the intervening DNA. Transposon mediated deletions
of this nature have previously been proposed by Kleckner et al.
(1977). This process of multiple insertion also offers an
explanation for the observed increase in size of 9 Mdal occurring
after acquisition of Tn4134 by plasmid R1E, if recombination between
homologous DNA failed to take place.
Evidence for the multiple insertion of the transposons described
in this thesis, within plasmid RP4, is provided by the restriction
endonuclease digest patterns of the RP4 transposon containing
derivatives. Each of the RP4 small transposon derivatives showed a
similar restriction pattern. The 2.0 Mdal fragment, obtained
following restriction of Tn7 with Hind III, was absent in these
digests, confirming that these small transposons are distinct from
both Tn7 and Tn78 which in contrast give rise to such fragments
(Datta et al., 1979). However, the estimated size of the transposons
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at 2 Mdal, indicates that only the smallest fragment of molecular
weight 1.65 million could have resulted from two restriction sites in
the transposon itself. Plasmid RP4 is known to have a single
restriction site for the endonuclease Hind III (Grinsted et al.,
1977) and therefore the other fragments obtained following digestion
of RP4::Tn4132, RP4::Tn4133 and RP4::Tn4134 must be a result of the
insertion of these transposons into several sites of the RP4 genome.
Therefore this 'new' transposon, like Tn7, does not appear to exhibit
the phenomenon of cis-acting transposition immunity (Hassan and
Brevet, 1983) which has so far only been reported for Tn3-like
transposons (Robinson et al., 1977).
The presence of the smallest Hind III fragment, of molecular
weight 1.65 million, in the digests of each of the six transposons
suggests that, despite their different molecular weights, the
transposons might be related. Indeed, isolation and detailed
characterisation of the DHFR gene product of each transposon revealed
that each element encodes the synthesis of a Tp-resistant DHFR with
biochemical properties almost indistinguishable frcm each other and
from the Type I Tn7-mediated enzyme of plasnid R483 (Pattishall et
al., 1977; Amyes and Smith, 1978). Each of the enzymes is produced
in large quantity, about ten times that of the normal E. coli host
DHFR. All are heat labile, losing their activity rapidly when raised
to 45 °C, and each enzyme is inhibited by 50% by similar levels of Tp
and methotrexate with ID5qs of about 50 for Tp and 5 juM for
methotrexate. In addition, the pH and substrate profiles of the
enzymes are similar.
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The enzymes, however, are not identical as they differ
strikingly in their molecular weight. The size of the enzymes
produced by Tn4129 and Tn4130 at 35000 and 32000 daltons
respectively, is more similar to those found for Type I DHFRs
(Pattishall et al., 1977; Amyes and Smith, 1978), whereas the DHFR
encoded by each of the small transposons, Tn4132, Tn4133 and Tn4134
has a molecular weight of about 24000. Enzymes of this novel
molecular weight, ie. 24000, have never previously been associated
with plasmid or transposon mediated resistance. However, Purohit et
al. (1981) reported that the DHFR encoded by the T4 bacteriophage
comprised of two subunits of about 23000 daltons each. Although, as
dimers, the T-even DHFRs are moderately resistant to Tp and
temperature sensitive, both characteristics of the new enzymes
described in this thesis, it is unclear whether the 23000 dalton
monomer is similarly active. In spite of these similarities, the
phage enzyme is however distinct from the new transposon encoded
enzyme both by its sensitivity to 2,4-diaminopteridines (Mathews,
1967) and its precipitation by ammonium sulphate at 0-40% saturation
(Purohit et al., 1981).
The plasmid p699-determined enzyme reported by Fling et al.
(1982) is also of a lower molecular veight (between 16000 and 18000)
than the Type I and Type II enzymes. Preliminary characterisation of
this p699-mediated enzyme, however, shows it to be quite distinct
from the enzyme reported here. The level of resistance conferred by
plasmids encoding the small molecular weight DHFR isolated by Fling
et al. (1982) is only moderate, the MIC of Tp being 64 mgL~l in
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coli, compared with the high level (MIC >1000 mgL~l) of resistance
achieved in strains producing the enzyme reported here. In addition,
the Tp 50% inhibitory concentration for the p669 enzyme is
approximately 1.5 jM compared with about 50 jM for the enzyme
described here. However, more properties of the p669 enzyme require
to be studied before a true comparison between it and the new enzyme
detected here can be made.
The similarity between the two enzymes described here suggests a
common evolutionary origin. In favour of a common origin of the
transposons and the DHFR genes themselves is the observation that the
9 Mdal Tn7-like transposon Tn4131, carrying the resistance
determinants for Sm/Sp in addition to Tp, encodes a DHFR of 24500
daltons. It would therefore appear that a Tn7-like transposon is
coding for a small molecular weight enzyme.
It is known that the Tn7 determined enzyme is made up of two
identical subunits about 19000 daltons (Fling and Elwell, 1980; Novak
et al., 1983). However, these subunits are not active on their own
and therefore may not be directly related to the small molecular
weight enzyme reported here. The small transposon DHFR appears also
to be made up of subunits, as the enzyme profile shows a small peak
at between 10000 and 12000 daltons which has activity. Although the
Type II enzyme coded by the R-plasmid R388 has also been shown to
consist of subunits of about 10500 (Fling and Elwell, 1980) it is
more likely that the new enzyme is made up of part of the tvro
subunits of the Tn7 DHFR, the redundant regions of which are missing.
z?h.
A point of particular interest was the presence of TpSm/Sp
resistance transposons within clinical plasmids which did not express
resistance to either Sm or Sp. Several possible explanations for
this observation exist. It is conceivable that insertion of the
TpSm/Sp transposon within the original clinical plasmid may have
occurred adjacent to a resident IS sequence, the IS element exerting
a polar effect on the transposon and "switching off" the expression
of the Sm/Sp resistance gene (Jordan et al., 1968). Alternatively,
an IS element may have inserted into the actual transposon betvreen
the promoter and the Sm/Sp resistance gene itself. This again could
result in the "switching off" of Sm/Sp resistance gene expression.
The role of IS sequence as mobile promoters resulting in the
switching "on" or "off" of bacterial genes has been suggested
previously by Glansdorff et al. (1980). Following transposition of
the transposon to another replicon (in this case RP4) the IS element
may be spontaneously lost restoring the expression of the Sm/Sp
resistance gene. However, it is also important to consider that the
host species may be causing the observed changes in MIC of Sm/Sp.
Indeed, the Sm resistance transposon, Tn904, has been shown to
express a gene dosage effect When present in E. coli which is not
mirrored when the transposon is present within P. aeruginosa
(McCombie et al., 1983). A similar gene dosage effect has been
suggested for the f$ -lactamase specified by the plasmid R-1818 when
present in Proteus mirabilis (Smith, 1969).
The observed differences in Sm/Sp resistance gene expression of
the Tn7-like transposons Tn4130 and Tn4131 suggests that the small
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transposons may also be carrying the Sm/Sp resistance gene in a
"dormant switched off" state. Selection for spontaneous Sm/Sp
resistant mutants of E. coli J62 strains harbouring the small
transposons revealed them to mutate at a greater frequency than
strains which do not carry the transposons. The location of the
mutation was subsequently identified within the Tp resistance
transposon. However, this mutation was shown to be unstable and the
strains rapidly became sensitive to Sm/Sp again following removal of
selective pressures. This would imply that the selective pressure of
subculturing in the presence of concentrations of Sm and Sp greater
than the MIC of the organism has resulted in the selective
amplification of a Sm/Sp resistance gene, which normally exerts a
very low level of resistance on its host, with a correlated
amplification in the organisms MIC to the drugs. This selective
amplification and induced resistance mechanism has previously been
reported for several resistance genes including the Tc resistance
gene of TnlO (Spies and Laufs, 1983; Spies et al., 1983) and the
kanamycin/neomycin resistance gene of plasmid pRR983 (Peterson and
Rownd, 1983). Following removal of the selective pressure, the MIC
decreases and the gene copy number returns to normal.
After mutation of RP4 transposon containing derivatives to
Sm/Sp resistance it was found that the Km resistance determinant of
RP4, and the Tp resistance gene of each of the transposons, Tn4132,
Tn4133 and Tn4134, no longer transferred together. Further
experiments in which Tp resistant transconjugants were tested for the
presence of RP4, suggested that the transposons were probably
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transferring on this plasmid vector but that following entry into the
recipient cell the transposon was excised and inserted into the
bacterial chromosome with the subsequent loss of RP4 from the
majority of transconjugants. Gawton-Burke and Clewell (1982) have
observed that the Tc resistance transposon Tn916, when present on a
conjugative plasmid is excised at fairly high frequency when
transferred to recipient strains with between 43 and 77% of
transconjugant strains losing the transposon. It is possible that a
similar excision event is occurring here but that in this case
integration into the chromosome, of the excised transposon,
subsequently takes place. Philips and Novick (1979) have suggested
that the erythromycin transposon, Tn554, upon entry into recipient
cells, undergoes a "zygotic induction" of an integrase or transposase
which facilitates its insertion into the chromosome.
However, contrary to the expected results, the Tp resistance
gene in transconjugants which had been shown to be devoid of plasmid
ENA, was found to be transferable, suggesting that somehow the
mutated transposons were now able to mediate their own transfer. A
number of recent reports have suggested similar transfer of
resistance genes in the apparent absence of extrachrcmosomal ENA.
Franke and Clewell (1980, 1981) and Gawton-Burke and Clewell (1982)
have reported the transfer of Tn916 between strains of Streptococcus
faecalis devoid of plaamid DNA. These authors suggest that this
transposon, having an approximate size of 10 Mdal, may possess a
fertility potential capable of mobilizing determinants that reside on
it and as such Tn916 may represent a new class of genetic elements
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that could be referred to as "conjugative transposons". Smith et al.
(1981) have reported similar findings concerning transferable Tc
resistance in Clostridium difficile, and transfer of clindamycin and
Tc resistance in Bacteroides fragilis is also believed to occur by a
conjugal transfer system in the absence of plasmid DNA (Mays et al.,
1982; Smith et al., 1982).
However, in view of the size of transposons Tn4132, Tn4133 and
Tn4134 it seems unlikely that these transposons would possess the
genes required, to encode the enzymes necessary, to mediate their own
transfer. A more plausible explanation would be the integration of
RP4 into the bacterial chromosome. In favour of this hypothesis are
reports of certain R-plasnids in E. coli (Nugent, 1981) and
Haemophilus (Stuy, 1980) which prefer to be integrated in the
chromosome. However, although Watson and Scaife (1980) have shown
that insertion of RP4 derivatives containing the att region of
lambda, into the bacterial chromosome of E. coli, results in loss of
expression of their incompatibility function, it is generally
believed that integration of R-plasmids into the chromosome of E.
coli is not usually accompanied by the complete loss of expression of
plasmid function, as would appear to be the case here (Datta and
Barth, 1976; Martin et al., 1981; Nugent, 1981). Nevertheless,
several authors have indicated that formation of R' plasmids by recom¬
bination of inc P plasmids, notably R68.45, with the bacterial
chromosome, can result in structural instability of the R-plasmid
while the chromosomal markers remain stable (Haas and Hollcway, 1976,
1978). This instability is not of the type in which the whole
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plasmid is lost as a unit but instead results in a progressive loss
of plasmid markers during bacterial replication, until either the
remnant stabilizes as a more or less permanent function of the
original plasmid or the whole plasmid is lost (Godfrey et al., 1980).
It is thought that the deletions which occur are generated by
intramolecular recombination between regions of homology, possibly
generated following mobilization of the bacterial chromosome (Godfrey
et al., 1980). It is conceivable, therefore, that a similar
situation may have occurred here. Following recombination between
KP4 and the transposons, the added selective pressure of subculturing
in high concentrations of Sm/Sp may have enhanced the selective
replication of the transposon, providing additional regions of
homology and subsequently, through intramolecular recombination,
causing extensive structural instability of RP4, the transposon
itself remaining stable. This could then lead to the loss to the RP4
resistance genes and result in the ultimate formation of a stable RP4
transposon containing plasmid which may preferentially become
integrated into the bacterial chromosome, from where it could
subsequently mediate the transfer of the Tp resistance gene.
In order to determine whether transposition of the mutated Tp
resistance transposon resulted in the simultaneous transposition of
Sm/Sp resistance, plasmid R1E was introduced into strains harbouring
RP4 containing the mutated transposons and employed as a second
vector for the transposons. However, a similar phenomenon of
resistance gene transfer in the apparent absence of plasmid DNA was
229.
again found to occur. It seems likely, therefore, that complete loss
of RP4 was not being observed, but rather that an RP4
transposon-containing remnant derivative had again integrated into
the bacterial chromosome. The spontaneous loss of plasmid R1E from
the cells could then be a result of successive subculture of the
strains in the absence of favourable selective pressures for this
plasmid, ie. subcultures in the absence of Cm.
Although plasmid integration into the chromosome is an
attractive hypothesis, it is important to consider that the observed
genetic exchange may possibly be occurring by seme specialised
transduction, by a difficult-to-detect (perhaps defective) prophage
as a means of transfer.
C. Conclusions
Although the source of the Tp resistance genes remains unsolved,
it is clear from the results of this thesis that the resistance genes
are continuing to evolve. It is difficult to assess accurately the
order in which the evolutionary processes have occurred. Never¬
theless, it would appear that since their origin the Tp resistance
genes have gradually become more efficient and promiscuous genetic
elements.
The properties of the mutant enzyme produced by E. coli J53TplKR
suggest that the plasmid genes may possibly have originated as
chromosomal genes. Alternatively, further studies of Tp-sensitive
R-plasmids may reveal the presence of DHFR genes capable of similar
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mutations to Tp resistance. The mutated gene, encoding a Tp
resistant DHFR, might then have become incorporated, through
legitimate recombination, into a wide host range plasmid, allowing
its diversification into many bacterial species. During
recombination between the resistance genes and the chromosome or
plasmid genomes, insertion of the Type I DHFR gene may conceivably
have occurred within, or close to, resident IS sequences. Such an
event may possibly contribute to the formation of a transposable
element.
Curing the last four years the spread of the TpSm/Sp resistance
transposon Tn7 has become more prevalent, with increased reports of
its presence within both the chromosome and plasmids of pathogenic
bacteria. The bacterial population studied in this thesis also owed
much of its resistance to Tp resistance transposons. However, in
addition to Tn7-like transposons, a second much smaller transposon,
epitomised by Tn4134 was also identified which confers resistance to
Tp alone. Biochemical, molecular and genetic analysis of both the
Tn7-like and new transposons suggests that they are related.
The absence of expression of the Sm/Sp resistance genes, the
lower molecular weight of the Tp resistant DHFR and the presence of
only one fragment of ENA following digestion of the small transposon
with Hind III, all suggest that the small transposon has probably
evolved from Tn7 by the loss of less important regions of Tn7 DNA
(figure 32). The ability of the small transposons to mutate back to
Sm/Sp resistance implies that these genes are still present. How-
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Figure 32. Proposed model for the evolution of transposon TrA-13^
from transposon Tn7-
IR = inverted repeat sequence; Tp = trimethoprim
resistance gene; Sm = streptomycin/'spectinomycin
resistance gene; Hind III = Hind III restriction site.
Shaded areas represent spontaneously deleted fragments
of DNA.
Note: Diagrams are not to scale.
TRANSPOSON Tn7
Hind III Hind III Hind III
IR Tp Sm IR
MP
SPONTANEOUS DELETIONS
Hind III Hind III
IR Tp Sm IR
TRANSPOSON Tn4134
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ever, if formation of the small transposon is a result of the loss of
Tn7 DNA it is possible that the excised fragment of DNA contains a
gene encoding an inducer enzyme required for Sm/Sp resistance gene
expression. The decreased DHFR molecular weight could also be
accounted for by the loss of redundant regions of DNA within the DHFR
gene. Finally, the presence of only one Hind III restriction
fragment could be a result of the excision of an internal fragment of
Tn7 containing one of the three Hind III restriction sites.
The production of this small molecular weight Tp resistance
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AN EPIDEMIC CAUSED BY TWO RELATED TRANSPOSONS
Hilary-Kay Young and Sebastian G.B. Amyes
Epidemics of trimethoprim (Tp) resistance within Enterobacteria
have been caused by the spread of Tp resistance plasmids
(R-plasmids) within the bacterial population (3,5). More
recently, transposable genes known as transposons have been
implicated in the carriage of Tp resistance. These elements have
now been found to reside not only on R-plasmids but also on the
chromosome of clinical strains (4,9) and this has given the potent¬
ial for a greater spread of resistance. Routine isolation of
strains from the orthopaedic unit of Edenhall Hospital, near
Edinburgh, has revealed that there was a surge .of Tp resistance
within the pathogenic Gram negative rods isolated from urine
specimens. Of these strains, an unprecedented 64% were insuscept¬
ible to 10 mgL-^ Tp and of these 39.8% were resistant to 1 gL~^
Tp (4).
In a representative sample of 100 strains, the highly resistant
organisms were examined initially for their ability to transfer Tp
resistance and 11 strains were shown to harbour Tp R-plasmids. A
further 12 strains possessing high level Tp resistance were unable
to transfer their resistance and R-plasmids were not detectable by
analysis of the cellular DNA.
Several of the organisms with high level, non-transferable Tp
resistance were examined for the presence of transposons located in
the chromosome. The method followed was similar to that described
by Towner et al (8). The R-plasmid RP4 was introduced into the
clinical strains during an 18 hour mating (7). After suitable
subculture, RP4 was then transferred into the rifampicin-resistant
Escherichia coli strain J6-2_2 during a five hour mating, and
selection was made for the transfer of the Tp and Kanamycin (Km)
resistance determinants. A further five hour mating was performed
with this strain using E. coli strain J5-3 as recipient. Selection
was again made for the transfer of Tp and Km resistance determin¬
ants. The two resistance determinants now transferred at the same
frequencies indicating that transposition of the Tp resistance gene
into RP4 had taken place. This was confirmed by phage sensitivit¬
ies and the physical presence of only one plasmid in the recipient
strain. The molecular weight of the transposons was determined by
measuring the increase in size of plasmid RP4 by agarose gel
electrophoresis following the method of Meyers et a1_ (6). DNA was
extracted from the bacterial cells by gentle lysis with Triton
X-100. The protein was removed by phenol extraction and the DNA
was concentrated by precipitation with absolute ethanol. The
plasmid DNA was separated by electrophoresis in 0.3% agarose gels
run horizontally. The position of the plasmids was compared with
those of standard plasmids of known molecular weight (MW) which
were run concurrently. Three strains harboured Tp transposons in
the bacterial chromosome and each transposon was 8 megadaltons
(Mdal) and carried resistance determinants to Streptomycin (Sm),
Spectinomycin (Sp) as well as Tp.
The presence of transposons in the autotransferable R-plasmids was
detected by a modification of the above method. Each R-plasmid
was transferred into strain J6-2_2» R-plasmid RP4 was then intro¬
duced into this strain during a five hour mating. The plasmids
were subsequently transferred into strain J5-3 and selection was
made for Tp and Km resistant transconjugants. The recipient
plasmid resistance determinants were then transferred back into
strain J6-2 and the transfer frequencies measured. Unlike the
transfer from strain J6-2_£ to J5-3, the transfer frequencies of
Km and Tp resistance were similar in this mating. This suggested
that the Tp resistance determinant had transposed into RP4. This
was confirmed employing the same criteria as before. Six plasmids
were tested in this manner and, in each case, a transposon carry¬
ing Tp resistance was detected.
Table 1 Properties of Tp R-plasmids and transposons
Plasmid Transposon
No. Resistance Size Resistance Size
(Mdal) (Mdal)
pSA 163 Tp Ap Sx 39.8 TP 2.1
pSA 173 Tp Ap 25.0 Tp 2.1
pSA 179 Tp Ap Sm/Sp
Sx Ce Tc 39.8 Tp Sm/Sp 7.6
pSA 176 Tp Ap Sm/Sp Sx 40.1 Tp 2.0
pSA 217 Tp Ap Sx 28.8 Tp Sm/Sp 7.2
pSA 218 Tp Ap Sx 28.8 Tp Sm/Sp 8.6
Ap = Ampicillin Ce = Cephradine
Sx = Sulphamethoxazole Tc = Tetracycline
Two different Tp resistance transposons were identified. One of
the transposons closely resembled those found in the chromosome
with a molecular weight of about 8 million and carrying resistance
determinants to Tp, Sm and Sp. Interestingly, the Sm/Sp resistance
of this transposon was sometimes not expressed in the original
plasmid. The second transposon carried the single resistance
determinant to Tp and its molecular weight is less than half that
of the other transposon. These two transposons originated from
R-plasmids which seemed closely related to one another and, to
examine the degree of similarity, the transposon gene products were
investigated.
The Tp resistant dihydrofolate reductases from each transposon were
isolated and purified by the method of Amyes and Smith (1),
modified by the use of a sephadex G-75 superfine column
(2 cm^ x 90 cm) to allow better separation and a more accurate
determination of the molecular weights of the plasmid and chromo¬
somal enzymes. The assay of the enzyme and the measurement of the
biochemical properties were performed by the methods of Amyes and
Smith (2). The specific activities (enzyme units/mg protein), the
ID50 (concentration of Tp in pmoles required to inhibit the enzyme
by 50%) and the TD5Q (time taken in minutes for enzyme to lose
half its activity at 45°) were each determined and the two trans-
poson encoded enzymes were found to be very similar. However, the
two enzymes differed markedly in their molecular weights (Table 2).
Table 2 Properties of Tp resistant dihydrofolate reductases
Plasmid Transposon Dihydrofolate Reductase
Size Size Sp. Act. ^50
(Mdal) (Mdal)
pSA 173 2.1 24000 13.25 30 2.2
pSA 179 7.6 35000 22.06 60 2.9
The results suggest the presence of two transposons encoding Tp
resistance in this clinical population. One transposon encodes
resistances for both Tp and Sm/Sp. It has a molecular weight of
about 8 million and encodes the production of a 35000 dalton DHFR
which has similar properties to the type I plasmid DHFR. The
second transposon is smaller and only encodes Tp resistance. This
transposon encodes the production of a Tp resistant DHFR with
similar properties to the type I enzyme but with a much smaller
molecular weight. These results suggest that within one hospital
the spread of resistance to Tp was being manifested by two trans¬
posons which, by virtue of the similar but not identical proper¬
ties of their gene products, were related to one another.
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Studentship to Hilary-Kay Young and we should like to thank
E.R. Squibb & Sons Ltd for their generous financial support of this
project.
' REFERENCES
1. Amyes, S. G. B. and Smith, J. T.: R-factor trimethoprim
resistance mechanism: an insusceptible target site.
Biochemical and Biophysical Research Communications. 58:
412-418, 1974.
2. Amyes, S. G. B. and Smith, J. T.: The purification and
properties of the trimethoprim-resistant dihydrofolate
reductase mediated by the R-factor, R388.' European Journal
of Biochemistry. 61:597-603, 1976.
3. Amyes, S. G. B., McMillan, C. J. and Drysdale, J. Trans¬
ferable trimethoprim resistance amongst hospital isolates. New
Trends in Antibiotics: Research and Therapy. Eds. G.G. Grassi
and L.D. Sabath. Elsevier/North Holland Biomedical Press,
Amsterdam. 325-327, 1981.
4. Amyes, S. G. B., Drysdale, J. L., McMillan, C. J. and Young,
H-K.: The diversity of trimethoprim resistance within hospital
isolates. Journal of Pharmacy and Pharmacology. 34:60p, 1982.
5. Grdneberg, R. N. and Bendall, M. J.: Hospital outbreak of
trimethoprim resistance in pathogenic coliform bacteria.
British Medical Journal. 2:7-9, 1979.
6. Meyers, J. A., Sanchez, D., Elwell, L. P. and Falkow, S.:
Simple agarose gel electrophoretic method for the identifi¬
cation and characterisation of plasmid DNA. Journal of
Bacteriology. 127:1529-1537, 1976.
7. Smith, J. T.: R-factor gene expression in Gram negative
bacteria. Journal of General Microbiology. 55: 109-120, 1969.
8. Towner, K. J.: A clinical isolate of Escherichia coli owing
its trimethoprim resistance to a chromosomally located
trimethoprim transposon. Journal of Antimicrobial Chemo¬
therapy. 7:157-162, 1981.
9. Towner, K. J., Venning, B. M. and Pinn, P. A.: Occurrence of
transposable trimethoprim resistance in clinical isolates of
Escherichia coli devoid of self-transmissible resistance
plasmids. Antimicrobial Agents and Chemotherapy. 21: 336-338,
1982.
Address:
Department of Bacteriology, The Medical School, University of
Edinburgh, Teviot Place, Edinburgh EH8 9AG, United Kingdom.
60P
THE DIVERSITY OF TRIMETHOPRIM RESISTANCE WITHIN HOSPITAL ISOLATES
5.G.B. Amyes, Judyth L. Drysdale, Catherine J. McMillan and Hilary-Kay Young,
Department of Bacteriology, The Medical School, University of Edinburgh,
Teviot Place, Edinburgh, EH8 9AG, United Kingdom.
Trimethoprim resistance within Enterobacteria can be determined either by the
chromosome or by Resistance plasmids (R-plasmids). Epidemics of trimethoprim
resistance have been caused by the spread of trimethoprim R-plasmids within the
population (Grdlneberg and Bendall 1979; Amyes et al 1980). Recently,
however, transposons carrying trimethoprim resistance have been found to reside
not only on R-plasmids but also on the chromosome of clinical strains (Towner
et al 1982).
Routine isolation of strains from Edenhall Hospital in Musselburgh has revealed
that a surge of trimethoprim resistance was occurring within the Gram-negative
rods isolated from urine specimens. Of these strains, an unprecedented 64% were
resistant to 10 mgL--'- trimethoprim and 25.5% to 1 gL"-*- trimethoprim. One hundred
isolates were examined in detail to determine which type of trimethoprim resist¬
ance was being observed. Fifteen strains were shown to possess auto-transferable
trimethoprim resistance and examination of the plasmids by their drug resistance
pattern and DNA size revealed that there was a minimum of six different types.
Nine strains were Pseudomonas aeruginosa and although some of these showed a high
degree of insusceptibility, no auto-transferable trimethoprim R-plasmids were
shown. Four Proteus species were shown to possess low insusceptibility to
trimethoprim but possessed auto-transferable R-plasmids. Within the Proteus
strains these plasmids conferred a minimum inhibitory concentration (MIC) of
trimethoprim of 100 mgL"-'-. However, when these plasmids were transferred into
the standard recipient strain, Escherichia coli 06-2-?, they nevertheless
elevated its MIC of trimethoprim to above 1 gL~l.
The R-plasmids isolated from the Musselburgh clinical isolates were examined for
the presence of transposons conferring trimethoprim resistance. It was found
that there was a predominance of transposon 7, the 8.7 Mdal plasmid that deter¬
mines trimethoprim and streptomycin resistance. The four strains that possessed
high level resistance, but were unable to transfer trimethoprim resistance, were
examined for the presence of transposons within the bacterial chromosome.
Transposon 7 was found within the chromosome of some Enterobacteria strains but
could not be detected in the chromosome of any Pseudomonas strains.
The incidence of trimethoprim resistance was higher amongst the Gram-negative
rods isolated in this hospital than in other hospitals in the district. This
seems to reflect the nature of the patients from whom the strains were isolated.
There were many types of trimethoprim-resistant organisms within this small
population and the spread of one type of strain or R-plasmid was not being
observed. The high incidence of trimethoprim resistance amongst these hospital
isolates seems to be linked to the clinical use of ampicillin rather than
trimethoprim and this supports the results we have found in other hospitals
(Amyes et al 1980). The use of ampicillin in this hospital has now been
restricted.
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this project.
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TRIMETHOPRIM RESISTANCE IN PLASMID"BEARING KLEBSIELLA
Hilary-Kay Young and S.G.B. Amyes, Department of Bacteriology, University of
Edinburgh, Teviot Place, Edinburgh EH8 9AG, United Kingdom.
Resistance plasmids (R-plasmids) conferring high level resistance to
trimethoprim (Tp) were first identified in Enterobacteria in Britain in 1971
(Fleming et al 1972). All early plasmids were members of the W
incompatibility group and a high proportion of them resided in an unusual
Klebsiella species. It therefore seemed possible that the plasmid resistance
gene could have evolved from this Klebsiella. In order to investigate this
the dihydrofolate reductase (DHFR) from the original Klebsiella was studied.
To remove the Tp R-plasmid, the plasmid-containing Klebsiella (strain A) was
grown on nutrient agar and replica-plated onto agar plates containing Tp.
The loss of Tp resistance occurred at a frequency of 3x10"^ per cell.
However, when the cellular DNA was analysed by agarose gel electrophoresis a
plasmid was still found to be present, although reduced in size by 4.7
Mdaltons, suggesting the spontaneous loss of a Tp resistance transposon. The
DHFR of this Tp sensitive derivative (strain B) was isolated and purified
(Young & Amyes 1983). The specific activity (enzyme units/mg protein), the
ID5Q (concentration of Tp in pmoles required to inhibit the enzyme by 50%)
and the TD5Q (half life of DHFR at 45 C) were determined for the enzyme as
well as the MIC (minimum inhibitory concentration in mgL-^ ) of Tp for the
strain (Amyes & Smith 1976).
Strain MIC DHFR MW Sp. Activity 1^50 TD5Q
A 1000 35000 2.32 50000 >4
B 1 22000 1.94 0.02 >4
C 1000 22000 5.64 0.50 Activated
In order to determine if the enzyme from strain B could be the precursor of
the plasmid DHFR, mutation of strain B to high level Tp resistance was
attempted but without success. To promote this mutational event, the inc W
plasmid Sa, which does not confer Tp resistance, was mated into strain B and
mutants resistant to 100 mgL-^ Tp were again selected for. This time
resistant colonies were detected. When these were purified, another
selection was made for Tp resistance to 1000 mgL-1. These mutants (strain C)
were then tested for their ability to transfer Tp resistance but this was
found to be impossible, indicating that plasmid Sa had promoted a chromosomal
mutation to high level Tp resistance. The DHFR of strain C was produced in
higher levels than the strain B enzyme. This enzyme property, coupled with
its decreased susceptibility for Tp, is likely to be the mechanism of Tp
resistance.
The results of this investigation indicate that Klebsiella spp do not provide
the source for plasmid Tp resistance genes. However, the presence of the
plasmid Sa, in a Tp sensitive Klebsiella, promotes a chromosomal mutation
resulting in Tp resistance due to the production of higher levels of a DHFR
with decreased susceptibility for Tp. Furthermore, this type of mutation may
account for the inherent Tp resistance often observed within this genus.
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